Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hypertension
  Free Subscription

Articles published in
J Hypertens
    May 2024
  1. CASIGLIA E
    AND, OR, AND/OR in hypertension guidelines.
    J Hypertens. 2024;42:934-935.
    >> Share

  2. HUTCHINGS DC, Heagerty AM
    Sleeping unsoundly: CPAP and its complexities in treating sleep apnoea hypertension.
    J Hypertens. 2024;42:766-767.
    >> Share

  3. BRASIL IA, Silva JCPL, Pescatello LS, Farinatti P, et al
    Central and peripheral mechanisms underlying postexercise hypotension: a scoping review.
    J Hypertens. 2024;42:751-763.
    >> Share

  4. WANG S, Wong SYS, Yip BHK, Lee EKP, et al
    Age-dependent association of central blood pressure with cardiovascular outcomes: a cohort study involving 34 289 participants using the UK biobank.
    J Hypertens. 2024;42:769-776.
    >> Share

  5. CELLER BG, Yong A, Rubenis I, Butlin M, et al
    Accurate detection of Korotkoff sounds reveals large discrepancy between intra-arterial systolic pressure and simultaneous noninvasive measurement of blood pressure with brachial cuff sphygmomanometry.
    J Hypertens. 2024;42:873-882.
    >> Share

  6. NATALE P, Palmer SC, Jaure A, Saglimbene V, et al
    Blood pressure lowering for kidney transplant recipients: systematic review with network meta-analysis.
    J Hypertens. 2024;42:848-855.
    >> Share

  7. SESA-ASHTON G, Carnagarin R, Nolde JM, Muente I, et al
    Salt sensitivity risk derived from nocturnal dipping and 24-h heart rate predicts long-term blood pressure reduction following renal denervation.
    J Hypertens. 2024;42:922-927.
    >> Share

    April 2024
  8. SHANTSILA E, Beevers DG, Lip GYH
    For Debate: The 2023 European Society of Hypertension guidelines - cause for concern.
    J Hypertens. 2024 Apr 15. doi: 10.1097/HJH.0000000000003733.
    >> Share

  9. SHARP ASP, Sanderson A, Hansell N, Reddish K, et al
    Renal denervation for uncontrolled hypertension: a systematic review and meta-analysis examining multiple subgroups.
    J Hypertens. 2024 Apr 15. doi: 10.1097/HJH.0000000000003727.
    >> Share

  10. BAVARESCO GAMBASSI B, Chaves LFC, Sousa TMDS, Ribeiro MJS, et al
    Short-duration dynamic power training with elastic bands combined with endurance training: a promising approach to hypertension management in older adults.
    J Hypertens. 2024;42:735-742.
    >> Share

  11. FERREIRA MJ, Dias DDS, Silva GDC, de Araujo AA, et al
    Concurrent exercise training potentiates the effects of angiotensin-converting enzyme inhibitor on regulatory systems of blood pressure control in ovariectomized hypertensive rats.
    J Hypertens. 2024;42:650-661.
    >> Share

  12. SASAKI N, Maeda R, Ozono R, Yoshimura K, et al
    Differences in the impact of newly diagnosed type 2 diabetes on cardiovascular mortality between normotensive and hypertensive individuals.
    J Hypertens. 2024;42:610-619.
    >> Share

  13. SALUJA S
    A critical commentary on the use of combined power and endurance training for hypertension management in older adults.
    J Hypertens. 2024;42:605-606.
    >> Share

  14. BARCELLOS PAM, Dall'Agnol A, Sandi GM, Remonti LR, et al
    Dietary approach for the treatment of arterial hypertension in patients with diabetes mellitus.
    J Hypertens. 2024;42:583-593.
    >> Share

  15. ZHOU T, Gu S, Shao F, Li P, et al
    Prediction of preeclampsia from retinal fundus images via deep learning in singleton pregnancies: a prospective cohort study.
    J Hypertens. 2024;42:701-710.
    >> Share

  16. ASTUDILLO Y, Kibrom S, Pereira T, Solomon S, et al
    Association between anxiety and elevated blood pressure in adolescent patients: a single-center cross-sectional study.
    J Hypertens. 2024;42:644-649.
    >> Share

  17. WADA A, Kabayama M, Godai K, Kido M, et al
    Factors influencing the continuation of home blood pressure measurement in community-dwelling older adults: the NOSE study.
    J Hypertens. 2024;42:694-700.
    >> Share

    March 2024
  18. WATZ MES, Tivesten A, Ottarsdottir K, Li Y, et al
    Reply on: Analyzing the effects of sex hormone-binding globulin levels and development of hypertension in middle-aged men and women.
    J Hypertens. 2024;42:580-581.
    >> Share

  19. PATEL J, Amin K, Lo DF
    Analyzing the effects of sex hormone-binding globulin levels and development of hypertension in middle-aged men and women.
    J Hypertens. 2024;42:579-580.
    >> Share

  20. ZHENG X, Lei Y, Cheng XW
    Resolvin D1 as a novel target in the management of hypertension.
    J Hypertens. 2024;42:393-395.
    >> Share

  21. KOLLIAS A, Kyriakoulis KG, Komnianou A, Stathopoulou P, et al
    Prognostic value of home versus ambulatory blood pressure monitoring: a systematic review and meta-analysis of outcome studies.
    J Hypertens. 2024;42:385-392.
    >> Share

  22. NAITO Y, Yasumura S, Okuno K, Asakura M, et al
    Hypoxia-inducible factor-prolyl hydroxylase inhibitor Roxadustat (FG-4592) reduces renal fibrosis in Dahl salt-sensitive rats.
    J Hypertens. 2024;42:497-505.
    >> Share

  23. LOO G, Puar T, Foo R, Ong TK, et al
    Unique characteristics of Asians with hypertension: what is known and what can be done?
    J Hypertens. 2024 Mar 1. doi: 10.1097/HJH.0000000000003706.
    >> Share

    February 2024
  24. LANG X, Peng C, Zhang Y, Gao R, et al
    Correlation between systolic blood pressure and mortality in heart failure patients with hypertension.
    J Hypertens. 2024 Feb 16. doi: 10.1097/HJH.0000000000003693.
    >> Share

  25. CARRY BJ, Miller WL
    Blood volume phenotypes and patient sex in resistant hypertension.
    J Hypertens. 2024 Feb 15. doi: 10.1097/HJH.0000000000003688.
    >> Share

  26. RAMIREZ-CARRACEDO R, Hernandez I, Moreno-Gomez-Toledano R, Diez-Mata J, et al
    NOS3 prevents MMP-9, and MMP-13 induced extracellular matrix proteolytic degradation through specific microRNA-targeted expression of extracellular matrix metalloproteinase inducer in hypertension-related atherosclerosis.
    J Hypertens. 2024 Feb 6. doi: 10.1097/HJH.0000000000003679.
    >> Share

  27. CHUNNAN L, Shaomei S, Wannian L
    Sleep and risk of hypertension in general American adults: reply.
    J Hypertens. 2024;42:382-383.
    >> Share

  28. SCORZA FA, Bombardi LM, de Almeida AG, Finsterer J, et al
    Hypertension: the dramatic rise in dangerous pesticides found on fruits and vegetables.
    J Hypertens. 2024;42:381-382.
    >> Share

  29. GUAN T, Cao M, Zheng C, Zhou H, et al
    Dose-response association between physical activity and blood pressure among Chinese adults: a nationwide cross-sectional study.
    J Hypertens. 2024;42:360-370.
    >> Share

  30. FRAVEL MA, Ernst ME, Woods RL, Beilin L, et al
    Long-term blood pressure variability and frailty risk in older adults.
    J Hypertens. 2024;42:244-251.
    >> Share

  31. KARELIUS S, Pentti J, Juhanoja E, Jula A, et al
    Association of work-related psychosocial factors and day-to-day home blood pressure variation: the Finn-Home study.
    J Hypertens. 2024;42:337-343.
    >> Share

  32. NEWTON J, Haseler E, Higgins C, Futcher C, et al
    Reliability of systolic blood pressure measured by parents in young children at home using a hand held doppler device and aneroid sphygmomanometer.
    J Hypertens. 2024;42:308-314.
    >> Share

  33. ZAMAN S, Raj IS, Yang AWH, Lindner R, et al
    Exercise training reduces arterial stiffness in women with high blood pressure: a systematic review and meta-analysis.
    J Hypertens. 2024;42:197-204.
    >> Share

  34. LIU N, Gong Z, Li Y, Xu Y, et al
    CTRP3 inhibits myocardial fibrosis through the P2X7R-NLRP3 inflammasome pathway in SHR rats.
    J Hypertens. 2024;42:315-328.
    >> Share

  35. MARQUES ER, Bernardino AC, Alvim RO, Schreiber R, et al
    Relationship of blood pressure measured in the calf with arm blood pressure and arterial stiffness: a general population study.
    J Hypertens. 2024;42:301-307.
    >> Share

  36. ZHANG L, Wang W, Gong J, Wang X, et al
    Development, validation, and clinical utility of a risk prediction model for recurrent preeclampsia.
    J Hypertens. 2024;42:236-243.
    >> Share

    January 2024
  37. SAGARA K, Goto K, Maeda M, Murata F, et al
    Medication adherence and associated factors in newly diagnosed hypertensive patients in Japan: the life study.
    J Hypertens. 2024 Jan 18. doi: 10.1097/HJH.0000000000003661.
    >> Share

  38. YE XF, Wang WY, Wang XY, Huang QF, et al
    Seasonal variation in ambulatory blood pressure control in patients on clinic blood pressure-guided antihypertensive treatment.
    J Hypertens. 2024 Jan 18. doi: 10.1097/HJH.0000000000003666.
    >> Share

  39. EGAN BM, Li J, Sutherland SE, Rakotz MK, et al
    Greater use of antihypertensive medications explains lower blood pressures and better control in statin-treated than statin-eligible untreated adults.
    J Hypertens. 2024 Jan 18. doi: 10.1097/HJH.0000000000003656.
    >> Share

  40. KIM BS, Lee Y, Shin JH, Heo R, et al
    Blood pressure and variability responses to the down-titration of antihypertensive drugs.
    J Hypertens. 2024 Jan 17. doi: 10.1097/HJH.0000000000003668.
    >> Share

  41. OKEKUNLE AP, Asowata OJ, Akpa OM, Fakunle AG, et al
    Dietary patterns associated with hypertension among stroke-free indigenous Africans: insights from the Stroke Investigative Research and Educational Network study.
    J Hypertens. 2024 Jan 17. doi: 10.1097/HJH.0000000000003662.
    >> Share


  42. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Asso
    J Hypertens. 2024;42:194.
    >> Share

  43. ABDELAZEEM B, Saleh O, Mahmoud A, Abuelazm M, et al
    Authors' response to "Impact of hypertension treatment-time on cardiovascular outcomes: erroneous trial selection leading to suspect findings".
    J Hypertens. 2024;42:191-192.
    >> Share

  44. FERNANDEZ JR, Mojon A, Smolensky MH, Hermida RC, et al
    Impact of hypertension treatment-time on cardiovascular outcomes: erroneous trial selection leading to suspect findings.
    J Hypertens. 2024;42:190-191.
    >> Share

  45. KREUTZ R, Palatini P, Stergiou G, Mancia G, et al
    Orthostatic hypotension an important phenotype in the 2023 European Society of Hypertension guidelines: how to measure it?
    J Hypertens. 2024;42:188-189.
    >> Share

  46. PAIVA AMG, Gomes MICM, Silva EAA, Feitosa ADM, et al
    Should arm positioning matter in the diagnosis of orthostatic hypotension and hypertension?
    J Hypertens. 2024;42:186-188.
    >> Share

  47. ARMANINI D, Sabbadin C, Manso J, Boscaro M, et al
    Consideration in the evaluation of follow-up of resistant hypertension.
    J Hypertens. 2024;42:56-57.
    >> Share

  48. OSCULLO G, Gomez-Olivas JD, Martinez-Garcia MA
    Nocturnal hypertension phenotypes and obstructive sleep apnoea.
    J Hypertens. 2024;42:50-52.
    >> Share

  49. RABBITT L, Curneen J, Hobbins A, Browne D, et al
    A cost-analysis of managing secondary and apparent treatment-resistant hypertension in a specialist multidisciplinary hypertension clinic.
    J Hypertens. 2024;42:58-69.
    >> Share

  50. KISHI T
    Gender differences in the association of serum uric acid with left ventricular hypertrophy should be focused.
    J Hypertens. 2024;42:53-55.
    >> Share

  51. OSMAN MMA, Mullins E, Kleprlikova H, Wilkinson IB, et al
    Beetroot juice, exercise, and cardiovascular function in women planning to conceive.
    J Hypertens. 2024;42:101-108.
    >> Share

  52. SNYMAN JR, Bortolotto LA, Degli Esposti L, Jayagopal PB, et al
    A real-world analysis of outcomes and healthcare costs of patients on perindopril/indapamide/amlodipine single-pill vs. multiple-pill combination in Italy.
    J Hypertens. 2024;42:136-142.
    >> Share

  53. SHANTSILA E, Shantsila A, Williams N, Lip GYH, et al
    Left ventricular hypertrophy and mortality in ethnic minority groups in the UK: e-ECHOES study.
    J Hypertens. 2024;42:95-100.
    >> Share

  54. GHERBESI E, Faggiano A, Sala C, Carugo S, et al
    Uric acid and left ventricular hypertrophy: a gender-based meta-analysis of echocardiographic studies.
    J Hypertens. 2024;42:109-117.
    >> Share

  55. PANAGIOTAKOS D, Antza C, Kotsis V
    Ambulatory and home blood pressure monitoring for cardiovascular disease risk evaluation: a systematic review and meta-analysis of prospective cohort studies.
    J Hypertens. 2024;42:1-9.
    >> Share

    December 2023
  56. GIBSON R, Aljuraiban GS, Oude-Griep LM, Vu TH, et al
    Relationship of calcium and magnesium intakes with the dietary approaches to stop hypertension score and blood pressure: the International Study of Macro/micronutrients and Blood Pressure.
    J Hypertens. 2023 Dec 21. doi: 10.1097/HJH.0000000000003648.
    >> Share

  57. GAN J, Shi Y, Zhao R, Li D, et al
    Adipose c-Jun NH2-terminal kinase promotes angiotensin II-induced and deoxycorticosterone acetate salt-induced hypertension and vascular dysfunction by inhibition of adiponectin production and activation of SGK1 in mice.
    J Hypertens. 2023 Dec 21. doi: 10.1097/HJH.0000000000003649.
    >> Share

  58. WANG L, Li C, Li Z, Li Q, et al
    Ten-year follow-up of very-high risk hypertensive patients undergoing renal sympathetic denervation.
    J Hypertens. 2023 Dec 21. doi: 10.1097/HJH.0000000000003650.
    >> Share

  59. SERRA MO, de Macedo LR, Silva M, Lautner RQ, et al
    Effect of Vitamin D supplementation on blood pressure in hypertensive individuals with hypovitaminosis D: a systematic review and meta-analysis.
    J Hypertens. 2023 Dec 19. doi: 10.1097/HJH.0000000000003646.
    >> Share

  60. SATHEESH G, Dhurjati R, Huffman MD, Rosende A, et al
    Standardized treatment protocols for hypertension: global availability, characteristics, and alignment with the hypertension guideline recommendations.
    J Hypertens. 2023 Dec 18. doi: 10.1097/HJH.0000000000003636.
    >> Share

  61. SALMAN UA, Schwartz JG, McMahan AC, Michalek JE, et al
    Rapid Gastric emptying in spontaneously hypertensive rats.
    J Hypertens. 2023 Dec 14. doi: 10.1097/HJH.0000000000003640.
    >> Share

  62. SASAGAWA Y, Inoue Y, Futagami K, Nakamura T, et al
    Application of deep neural survival networks to the development of risk prediction models for diabetes mellitus, hypertension, and dyslipidemia.
    J Hypertens. 2023 Dec 14. doi: 10.1097/HJH.0000000000003626.
    >> Share

  63. CIFKOVA R, Harazny JM, Bruthans J, Wohlfahrt P, et al
    Early vascular damage in retinal microcirculation in arterial hypertension: the Czech post-MONICA study.
    J Hypertens. 2023 Dec 14. doi: 10.1097/HJH.0000000000003637.
    >> Share

  64. CRUZ-LOPEZ EO, Ye D, Stolk DG, Clahsen-van Groningen MC, et al
    Combining renin-angiotensin system blockade and sodium-glucose cotransporter-2 inhibition in experimental diabetes results in synergistic beneficial effects.
    J Hypertens. 2023 Dec 11. doi: 10.1097/HJH.0000000000003633.
    >> Share

  65. ATASOY S, Henningsen P, Johar H, Middeke M, et al
    Hypertension in the first blood pressure reading and the risk of cardiovascular disease mortality in the general population: findings from the prospective KORA study.
    J Hypertens. 2023 Dec 7. doi: 10.1097/HJH.0000000000003629.
    >> Share

  66. KIM Y, Kim J, Kang E, Im DW, et al
    The association of time-updated ambulatory blood pressure and renal progression in hypertensive patients with chronic kidney disease: post hoc analysis of ACCURATE study.
    J Hypertens. 2023 Dec 7. doi: 10.1097/HJH.0000000000003625.
    >> Share

  67. BOTHE TL, Kreutz R, Glos M, Patzak A, et al
    Simultaneous 24-h ambulatory blood pressure measurement on both arms: a consideration for improving hypertension management.
    J Hypertens. 2023 Dec 7. doi: 10.1097/HJH.0000000000003632.
    >> Share

  68. THOMOPOULOS C
    Target blood pressure in isolated systolic hypertension: a meta-analysis of randomized outcome trials.
    J Hypertens. 2023;41:2113-2114.
    >> Share

  69. RAM CVS
    The latest hypertension guidelines: from encryption to decryption, finally!
    J Hypertens. 2023;41:2072-2073.
    >> Share

    November 2023
  70. NAKAGAWA K, Chen R, Ross GW, Donlon TA, et al
    FOXO3 longevity genotype attenuates the impact of hypertension on cerebral microinfarct risk.
    J Hypertens. 2023 Nov 23. doi: 10.1097/HJH.0000000000003620.
    >> Share

  71. XIONG Y, He Y, Chen Z, Wu T, et al
    Lactobacillus induced by irbesartan on spontaneously hypertensive rat contribute to its antihypertensive effect.
    J Hypertens. 2023 Nov 17. doi: 10.1097/HJH.0000000000003613.
    >> Share

  72. HALE G, Puchades E, Jacomino G, El-Mcharfie L, et al
    Use trends of chlorthalidone and hydrochlorothiazide among United States adults with hypertension: National Health and Nutrition Examination Survey 2009-2018.
    J Hypertens. 2023 Nov 16. doi: 10.1097/HJH.0000000000003622.
    >> Share

  73. KIM JH, Joo HJ, Chung SH, Yum Y, et al
    Cardiovascular outcomes according to on-treatment systolic blood pressure in older hypertensive patients: a multicenter cohort using a common data model.
    J Hypertens. 2023 Nov 15. doi: 10.1097/HJH.0000000000003544.
    >> Share

  74. BUDZYN M, Gryszczynska B, Begier-Krasinska B, Kaja E, et al
    Decreased toll-like receptor 4 and CD11b/CD18 expression on peripheral monocytes of hypertensive patients correlates with a lesser extent of endothelial damage: a preliminary study.
    J Hypertens. 2023 Nov 9. doi: 10.1097/HJH.0000000000003617.
    >> Share

  75. JOYCE OC, McHugh C, Mockler D, Wilson F, et al
    Midlife hypertension is a risk factor for some, but not all, domains of cognitive decline in later life: a systematic review and meta-analysis.
    J Hypertens. 2023 Nov 9. doi: 10.1097/HJH.0000000000003614.
    >> Share

  76. STEFANI LD, Trivedi SJ, Ferkh A, Emerson P, et al
    Left atrial mechanics evaluated by two-dimensional strain analysis: alterations in essential hypertension.
    J Hypertens. 2023 Nov 9. doi: 10.1097/HJH.0000000000003615.
    >> Share

  77. WEI C, Zhang J, Peng S, Liu J, et al
    Resolvin D1 attenuates Ang II-induced hypertension in mice by inhibiting the proliferation, migration and phenotypic transformation of vascular smooth muscle cells by blocking the RhoA/mitogen-activated protein kinase pathway.
    J Hypertens. 2023 Nov 7. doi: 10.1097/HJH.0000000000003610.
    >> Share

  78. QIU W, Cai A, Li L, Feng Y, et al
    Association of depression trajectories and subsequent hypertension and cardiovascular disease: findings from the CHARLS cohort.
    J Hypertens. 2023 Nov 2. doi: 10.1097/HJH.0000000000003609.
    >> Share


  79. Interferon regulatory factor 4 deletion protects against kidney inflammation and fibrosis in deoxycorticosterone acetate/salt hypertension: Erratum.
    J Hypertens. 2023;41:1872.
    >> Share


  80. Prevalence of non-steroidal anti-inflammatory drugs (NSAIDS) use in patients with hypertensive crisis: Erratum.
    J Hypertens. 2023;41:1871.
    >> Share


  81. PS-P12-8: The prevalence of hypertension in factory employees, detected during the periodic examination at the factory: Erratum.
    J Hypertens. 2023;41:1868.
    >> Share

  82. TABARA Y
    Reply to 'Phenotyping sleep hypertension; never forgetting the night'.
    J Hypertens. 2023;41:1867.
    >> Share

  83. CUSPIDI C, Gherbesi E, Tadic M
    Phenotyping masked hypertension: do not forget the night.
    J Hypertens. 2023;41:1865-1866.
    >> Share

  84. MOCTEZUMA-VELAZQUEZ C, Abraldes JG
    Carvedilol in patients with cirrhosis and arterial hypertension: two birds with one stone.
    J Hypertens. 2023;41:1864-1865.
    >> Share

  85. ANDERSSON U, Nilsson PM, Kjellgren K, Hoffmann M, et al
    Reply to 'Examining the impact of E-health management on hypertension'.
    J Hypertens. 2023;41:1864.
    >> Share

  86. FATIMA HE, Lo DF
    Examining the impact of E-health management on hypertension.
    J Hypertens. 2023;41:1863.
    >> Share

  87. CARDOSO AM, Aneli NM, Lammers M, Manica A, et al
    Resistance training reduces platelet activation in hypertensive women: the role of purinergic signaling.
    J Hypertens. 2023;41:1745-1752.
    >> Share

  88. SHI M, Liu Y, Wang S, Wang R, et al
    Blood pressure control and antihypertensive medication use after discharge and prognosis of ischemic stroke.
    J Hypertens. 2023;41:1730-1737.
    >> Share

  89. SHOKOPLES BG, Berillo O, Comeau K, Chen HY, et al
    P2RX7 gene knockout or antagonism reduces angiotensin II-induced hypertension, vascular injury and immune cell activation.
    J Hypertens. 2023;41:1701-1712.
    >> Share

  90. SULICKA-GRODZICKA J, Guzik TJ
    The ATP connection: a new therapeutic promise of P2X7 targeting in hypertension and vascular injury.
    J Hypertens. 2023;41:1696-1698.
    >> Share

  91. SONG J, Tan M, Wang C, Brown MK, et al
    Salt intake, blood pressure and cardiovascular disease mortality in England, 2003-2018.
    J Hypertens. 2023;41:1713-1720.
    >> Share

  92. SCHMIDT-LAUBER C, Alba Schmidt E, Hanzelmann S, Petersen EL, et al
    Increased blood pressure after nonsevere COVID-19.
    J Hypertens. 2023;41:1721-1729.
    >> Share

  93. LEE SH, Lee CJ, Kang Y, Park JM, et al
    A randomized trial of genotype-guided perindopril use.
    J Hypertens. 2023;41:1768-1774.
    >> Share

  94. WIERSINGA JHI, Rhodius-Meester HFM, Wolters FJ, Trappenburg MC, et al
    Orthostatic hypotension and its association with cerebral small vessel disease in a memory clinic population.
    J Hypertens. 2023;41:1738-1744.
    >> Share


  95. Skin NA+, K+ and water before and after surgical cure of human primary aldosteronism: Erratum.
    J Hypertens. 2023;41:1869.
    >> Share

  96. FENG L, Ye Z, Mo C, Wang J, et al
    Elevated blood pressure accelerates white matter brain aging among late middle-aged women: a Mendelian Randomization study in the UK Biobank.
    J Hypertens. 2023;41:1811-1820.
    >> Share

    October 2023
  97. ZAHNER MR, Brown MC, Chandley MJ
    Inactivation of the paraventricular nucleus attenuates the cardiogenic sympathetic afferent reflex in the spontaneously hypertensive rat.
    J Hypertens. 2023 Oct 27. doi: 10.1097/HJH.0000000000003542.
    >> Share

  98. GHAZI L, Cohen JB, Townsend RR, Drawz PE, et al
    Orthostatic hypotension, orthostatic hypertension, and ambulatory blood pressure in patients with chronic kidney disease in CRIC.
    J Hypertens. 2023 Oct 27. doi: 10.1097/HJH.0000000000003604.
    >> Share

  99. MA H, Wang C, Jiang M, Jin K, et al
    Persistently elevated sFlt-1 and recovery of reduced ADAMTS13 activity in malignant hypertension.
    J Hypertens. 2023 Oct 23. doi: 10.1097/HJH.0000000000003601.
    >> Share

  100. KASANAGOTTU K, Mukamal KJ, Landon BE
    Predictors of treatment intensification in uncontrolled hypertension.
    J Hypertens. 2023 Oct 20. doi: 10.1097/HJH.0000000000003598.
    >> Share

  101. SASAKI N, Ueno Y, Ozono R, Yoshimura K, et al
    Association of serum uric acid levels with blood pressure and the incidence of hypertension in the middle-aged and elderly populations.
    J Hypertens. 2023 Oct 12. doi: 10.1097/HJH.0000000000003597.
    >> Share

  102. ARAUJO-CASTRO M, Garcia Sanz I, Minguez Ojeda C, Hanzu F, et al
    Risk factors for intraoperative hypertensive crisis in patients with pheochromocytomas and sympathetic paragangliomas.
    J Hypertens. 2023 Oct 11. doi: 10.1097/HJH.0000000000003596.
    >> Share

  103. MANCIA G, Facchetti R, Quarti-Trevano F, Dell'Oro R, et al
    Comparison between visit-to-visit office and 24-h blood pressure variability in treated hypertensive patients.
    J Hypertens. 2023 Oct 10. doi: 10.1097/HJH.0000000000003582.
    >> Share

  104. LI M, Qu K, Wang Y, Wang Y, et al
    Associations of hypertensive disorders of pregnancy with cognition, dementia, and brain structure: a Mendelian randomization study.
    J Hypertens. 2023 Oct 10. doi: 10.1097/HJH.0000000000003593.
    >> Share

  105. PEETERS LEJ, Kappers MHW, Hesselink DA, van der Net JB, et al
    Antihypertensive drug concentration measurement combined with personalized feedback in resistant hypertension: a randomized controlled trial.
    J Hypertens. 2023 Oct 6. doi: 10.1097/HJH.0000000000003585.
    >> Share

  106. RIJAL A, Adhikari TB, Dhakal S, Maagaard M, et al
    Effects of adding exercise to usual care on blood pressure in patients with hypertension, type 2 diabetes, or cardiovascular disease: a systematic review with meta-analysis and trial sequential analysis.
    J Hypertens. 2023 Oct 6. doi: 10.1097/HJH.0000000000003589.
    >> Share

  107. BROSOLO G, Da Porto A, Bulfone L, Vacca A, et al
    Cortisol secretion and abnormalities of glucose metabolism in nondiabetic patients with hypertension.
    J Hypertens. 2023 Oct 6. doi: 10.1097/HJH.0000000000003590.
    >> Share

  108. BASTA K, Ledwaba-Chapman L, Dodhia H, Ashworth M, et al
    Hypertension prevalence, coding and control in an urban primary care setting in the UK between 2014 and 2021.
    J Hypertens. 2023 Oct 2. doi: 10.1097/HJH.0000000000003584.
    >> Share


  109. A classifier based on 273 urinary peptides predicts early renal damage in primary hypertension: Retraction.
    J Hypertens. 2023;41:1673.
    >> Share

  110. MISCHAK H
    Further comments on 'A classifier based on 273 urinary peptides predicts early renal damage in primary hypertension'.
    J Hypertens. 2023;41:1667.
    >> Share

  111. MISCHAK H
    Comment on 'A classifier based on 273 urinary peptides predicts early renal damage in primary hypertension' by Lin et al.
    J Hypertens. 2023;41:1666.
    >> Share

  112. XIE B, Li L, Lin M, Nanna M, et al
    99mTc-HFAPi imaging identifies early myocardial fibrosis in the hypertensive heart.
    J Hypertens. 2023;41:1645-1652.
    >> Share

  113. ABUELAZM M, Saleh O, Albarakat MM, Katamesh B, et al
    The effect of bedtime versus morning dosing of antihypertensive drugs on the cardiovascular outcomes: a systematic review and meta-analysis of randomized controlled trials.
    J Hypertens. 2023;41:1595-1605.
    >> Share

  114. TOMODA F, Koike T, Nitta A, Kurosaki H, et al
    Urinary levels of cortisol but not catecholamines are associated with those of 8-hydroxy-2'-deoxyguanosine in uncomplicated primary hypertension.
    J Hypertens. 2023;41:1571-1577.
    >> Share

  115. RIVASI G, Fedorowski A
    Harm vs. benefit of antihypertensive treatment in very old and frail people - do not miss the forest for the trees.
    J Hypertens. 2023;41:1551-1553.
    >> Share

  116. AKINTUNDE AA, Mutagaywa R, Manmak M, Oguntade AS, et al
    Task sharing in the management of hypertension: highlights of the African hypertension school for nonphysicians health workers.
    J Hypertens. 2023;41:1544-1550.
    >> Share

  117. ZUO X, Liu L, Liu K, Zhang X, et al
    Proximal aorta dilatation in hypertension.
    J Hypertens. 2023;41:1511-1520.
    >> Share

  118. FONSECA R, Palmer AJ, Picone DS, Cox IA, et al
    Cardiovascular and health cost impacts of cuff blood pressure underestimation and overestimation of invasive aortic systolic blood pressure.
    J Hypertens. 2023;41:1585-1594.
    >> Share

    September 2023
  119. DE LA SIERRA A, Ruilope LM, Martinez-Camblor P, Vinyoles E, et al
    Impact of timing of antihypertensive treatment on mortality: an observational study from the Spanish Ambulatory Blood Pressure Monitoring Registry.
    J Hypertens. 2023 Sep 27. doi: 10.1097/HJH.0000000000003581.
    >> Share

  120. DUTRA RT, Bensenor IM, Goulart AC, Pereira AC, et al
    Carotid intima-media thickness and incident hypertension: the Brazilian Longitudinal Study of Adult Health.
    J Hypertens. 2023 Sep 19. doi: 10.1097/HJH.0000000000003567.
    >> Share

  121. OHARA H, Takeuchi F, Kato N, Nabika T, et al
    Genotypes of Stim1 and the proximal region on chromosome 1 exert opposite effects on stroke susceptibility in stroke-prone spontaneously hypertensive rat.
    J Hypertens. 2023 Sep 15. doi: 10.1097/HJH.0000000000003566.
    >> Share

  122. RIVASI G, Ceolin L, Turrin G, Tortu' V, et al
    Prevalence and correlates of frailty in older hypertensive outpatients according to different tools: the HYPER-FRAIL pilot study.
    J Hypertens. 2023 Sep 13. doi: 10.1097/HJH.0000000000003559.
    >> Share

  123. BOS-ROUBOS AG, Wingbermuhle E, Giesen M, Kersseboom R, et al
    Hypertension with hidden causes: the cognitive and behavioral profile of an adult female with chronic stress and 16p11.2 microdeletion.
    J Hypertens. 2023 Sep 13. doi: 10.1097/HJH.0000000000003565.
    >> Share

  124. SHI Y, Zhou W
    Threshold effect of systemic immune inflammatory index on hypertension in American adults (NHANES 2017-2020).
    J Hypertens. 2023 Sep 13. doi: 10.1097/HJH.0000000000003560.
    >> Share

  125. CHARCHAR FJ, Prestes PR, Mills C, Ching SM, et al
    Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension.
    J Hypertens. 2023 Sep 13. doi: 10.1097/HJH.0000000000003563.
    >> Share

  126. MA G, Li J, Xie J, Li Y, et al
    Pulse pressure and its association with body composition among Chinese men and women without diagnosed hypertension: the China Kadoorie Biobank.
    J Hypertens. 2023 Sep 7. doi: 10.1097/HJH.0000000000003549.
    >> Share

  127. ALNAZER RM, Veldhuizen GP, de Leeuw PW, Kroon AA, et al
    Reply to 'Could we be missing something when calculating the aldosterone-to-renin ratio?'.
    J Hypertens. 2023;41:1500.
    >> Share

  128. KARADENIZ A, Babayigit E, Gorenek B
    Could we be missing something when calculating the aldosterone-to-renin ratio?
    J Hypertens. 2023;41:1499.
    >> Share

  129. KASPER P, Demir M, Steffen HM
    Liver fibrosis scores to predict cardiovascular events in hypertensive patients: old wine in new skins?
    J Hypertens. 2023;41:1498-1499.
    >> Share

  130. PHONANUWONG R, Jannoo S, Chanthanuwat S, Soonthornpun S, et al
    Using plasma aldosterone concentrations at 1 h of saline infusion test for the diagnosis of primary aldosteronism.
    J Hypertens. 2023;41:1493-1497.
    >> Share

  131. BEANEY T, Wang W, Schlaich MP, Schutte AE, et al
    Global blood pressure screening during the COVID-19 pandemic: results from the May Measurement Month 2021 campaign.
    J Hypertens. 2023;41:1446-1455.
    >> Share

  132. RENLUND MA, Jaaskelainen TJ, Kivela ASE, Heinonen ST, et al
    Blood pressure, arterial stiffness, and cardiovascular risk profiles in 8-12-year-old children following preeclampsia (FINNCARE-study).
    J Hypertens. 2023;41:1429-1437.
    >> Share

  133. WANG Y, Liu H, Wang J, Hu X, et al
    The association between brachial-ankle pulse-wave velocity and adverse cardiovascular events in 5719 community participants a prospective cohort study.
    J Hypertens. 2023;41:1411-1419.
    >> Share

  134. ALVES-LOPES R, Lacchini S, Neves KB, Harvey A, et al
    Vasoprotective effects of NOX4 are mediated via polymerase and transient receptor potential melastatin 2 cation channels in endothelial cells.
    J Hypertens. 2023;41:1389-1400.
    >> Share

  135. TROPEA T, Mavichak W, Evangelinos A, Brennan-Richardson C, et al
    Fetoplacental vascular effects of maternal adrenergic antihypertensive and cardioprotective medications in pregnancy.
    J Hypertens. 2023 Sep 1. doi: 10.1097/HJH.0000000000003532.
    >> Share

    August 2023
  136. BOUDREAUX BD, Romero EK, Diaz KM
    Sedentary behavior and risk of cardiovascular disease and all-cause mortality in United States adults with hypertension.
    J Hypertens. 2023 Aug 22. doi: 10.1097/HJH.0000000000003540.
    >> Share

  137. LIN L, Ren J, Wang C, Mei M, et al
    A set of urinary peptides can predict early renal damage in primary hypertension.
    J Hypertens. 2023 Aug 21. doi: 10.1097/HJH.0000000000003539.
    >> Share

  138. CHEN Y, Ye P, Dong H, Xu X, et al
    Clinical characteristics of pediatric hypertension: a multicenter study in China.
    J Hypertens. 2023 Aug 15. doi: 10.1097/HJH.0000000000003533.
    >> Share

  139. GRASSI G
    Sympathetic modulation as a goal of antihypertensive treatment: from drugs to devices.
    J Hypertens. 2023 Aug 15. doi: 10.1097/HJH.0000000000003538.
    >> Share

  140. KIM JH, Joo HJ, Chung SH, Yum Y, et al
    Safety and cardiovascular effectiveness of olmesartan in combination therapy for advanced hypertension: an electronic health record-based cohort study.
    J Hypertens. 2023 Aug 4. doi: 10.1097/HJH.0000000000003509.
    >> Share

  141. RAN S, Wu Y, Liu B
    Associations of appendicular lean mass and walking pace with hypertension: a two-sample Mendelian randomization study.
    J Hypertens. 2023;41:1347-1348.
    >> Share

  142. SCHUTTE AE, Tan I, Gnanenthiran SR, Chan J, et al
    Reply to 'Inadequate study designs for the evaluation of blood pressure monitoring devices and their potential misleading conclusions'.
    J Hypertens. 2023;41:1349-1350.
    >> Share

  143. ALMEIDA TP, Perruchoud D, Shah J, Sola J, et al
    Inadequate study designs for the evaluation of blood pressure monitoring devices and their potential misleading conclusions.
    J Hypertens. 2023;41:1348-1349.
    >> Share

  144. PIANI F, Agnoletti D, Baracchi A, Scarduelli S, et al
    Serum uric acid to creatinine ratio and risk of preeclampsia and adverse pregnancy outcomes.
    J Hypertens. 2023;41:1333-1338.
    >> Share

  145. LIU X, Rosenberg C, Reaso JN, Lee AM, et al
    Skin sympathetic nerve activity and nocturnal blood pressure nondipping in patients with postural orthostatic tachycardia syndrome.
    J Hypertens. 2023;41:1290-1297.
    >> Share

  146. LIULU X, Hungerford S
    Evaluation of contemporary methods to determine vascular impedance.
    J Hypertens. 2023;41:1221-1230.
    >> Share

    July 2023
  147. WOODE ME, Wong K, Reid CM, Stowasser M, et al
    Cost-effectiveness of screening for primary aldosteronism in hypertensive patients in Australia: a Markov modelling analysis.
    J Hypertens. 2023 Jul 19. doi: 10.1097/HJH.0000000000003513.
    >> Share

  148. MARQUES SM, Melo MR, Zoccal DB, Menani JV, et al
    Acute inhibition of nicotinamide adenine dinucleotide phosphate oxidase in the commissural nucleus of the solitary tract reduces arterial pressure and renal sympathetic nerve activity in renovascular hypertension.
    J Hypertens. 2023 Jul 19. doi: 10.1097/HJH.0000000000003516.
    >> Share

  149. WILSON AJ, Sands GB, Wang VY, Pontre B, et al
    Quinapril treatment curtails decline of global longitudinal strain and mechanical function in hypertensive rats.
    J Hypertens. 2023 Jul 18. doi: 10.1097/HJH.0000000000003512.
    >> Share

  150. ZHU M, An D, Zhang J, Tang X, et al
    Genome-wide analysis of DNA methylation and its relationship with serum homocysteine levels in patients with hypertension.
    J Hypertens. 2023 Jul 14. doi: 10.1097/HJH.0000000000003515.
    >> Share

  151. KOSITANURIT W, Korakot M, Burana C, Varachotisate P, et al
    Acute effect of various dosages of sugar ingestion on vascular function in offspring of hypertensive and normotensive parents.
    J Hypertens. 2023 Jul 7. doi: 10.1097/HJH.0000000000003500.
    >> Share

  152. SALMAN IM
    Functional symmetry of the aortic baroreflex in female spontaneously hypertensive rats.
    J Hypertens. 2023 Jul 6. doi: 10.1097/HJH.0000000000003493.
    >> Share

  153. WATZ MES, Tivesten A, Ottarsdottir K, Li Y, et al
    Sex hormone-binding globulin levels and development of hypertension in middle-aged men and women.
    J Hypertens. 2023 Jul 6. doi: 10.1097/HJH.0000000000003506.
    >> Share

  154. REA F, Morabito G, Savare L, Pathak A, et al
    Adherence and related cardiovascular outcomes to single pill vs. separate pill administration of antihypertensive triple-combination therapy.
    J Hypertens. 2023 Jul 6. doi: 10.1097/HJH.0000000000003497.
    >> Share

  155. TOMAZELLI CA, Ishikawa FM, Couto GK, Parente JM, et al
    Small artery remodeling and stiffening in deoxycorticosterone acetate-salt hypertensive rats involves the interaction between endogenous ouabain/Na+K+-ATPase/cSrc signaling.
    J Hypertens. 2023 Jul 6. doi: 10.1097/HJH.0000000000003502.
    >> Share

  156. ARDISSINO M, Reddy RK, Slob EAW, Griffiths J, et al
    Maternal hypertensive traits and adverse outcome in pregnancy: a Mendelian randomization study.
    J Hypertens. 2023 Jul 6. doi: 10.1097/HJH.0000000000003486.
    >> Share

  157. SHANTSILA E, Lip GYH, Shantsila A, Kurpas D, et al
    Antihypertensive treatment in people of very old age with frailty: time for a paradigm shift?
    J Hypertens. 2023 Jul 6. doi: 10.1097/HJH.0000000000003495.
    >> Share

  158. BATUBO NP, Moore JB, Zulyniak MA
    Dietary factors and hypertension risk in West Africa: a systematic review and meta-analysis of observational studies.
    J Hypertens. 2023 Jul 6. doi: 10.1097/HJH.0000000000003499.
    >> Share

  159. BUTALA S, Galido PV, Chakerian M, Woo BKP, et al
    Community-based interventions in hypertension management and its implications for the future of primary care.
    J Hypertens. 2023;41:1216-1217.
    >> Share

  160. LOVGREN T
    Reply to 'Critical commentary on labetalol and nifedipine use in postpartum hypertension management'.
    J Hypertens. 2023;41:1215-1216.
    >> Share

  161. WASIF U, Al-Shehab U, Lo DF
    Critical commentary on labetalol and nifedipine use in postpartum hypertension management.
    J Hypertens. 2023;41:1215.
    >> Share

  162. GOSSE P, Boulestreau R, Doublet J, Laurent S, et al
    How to measure arterial stiffness independently of blood pressure: the QKD method.
    J Hypertens. 2023;41:1168-1174.
    >> Share

  163. SCHNEIDER VM, Domingues LB, Umpierre D, Tanaka H, et al
    Exercise characteristics and blood pressure reduction after combined aerobic and resistance training: a systematic review with meta-analysis and meta-regression.
    J Hypertens. 2023;41:1068-1076.
    >> Share

  164. YU YL, Moliterno P, An DW, Raaijmakers A, et al
    Blood pressure and cardiovascular risk in relation to birth weight and urinary sodium: an individual-participant meta-analysis of European family-based population studies.
    J Hypertens. 2023;41:1175-1183.
    >> Share

  165. MORICONI D, Mengozzi A, Duranti E, Cappelli F, et al
    The renal resistive index is associated with microvascular remodeling in patients with severe obesity.
    J Hypertens. 2023;41:1092-1099.
    >> Share

    June 2023
  166. LI Y, Niu Y, Liu M, Lan X, et al
    First-trimester serum antiphosphatidylserine antibodies serve as candidate biomarkers for predicting pregnancy-induced hypertension.
    J Hypertens. 2023 Jun 27. doi: 10.1097/HJH.0000000000003498.
    >> Share

  167. KOCIANOVA E, Vaclavik J
    A practical approach to assessment of non-adherence to antihypertensive treatment.
    J Hypertens. 2023 Jun 21. doi: 10.1097/HJH.0000000000003492.
    >> Share

  168. MANCIA CHAIRPERSON G, Kreutz Co-Chair R, Brunstrom M, Burnier M, et al
    2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypert
    J Hypertens. 2023 Jun 21. doi: 10.1097/HJH.0000000000003480.
    >> Share

  169. STERGIOU GS, Parati G, Kollias A, Schutte AE, et al
    Requirements for design and function of blood pressure measuring devices used for the management of hypertension: Consensus Statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular variability and
    J Hypertens. 2023 Jun 12. doi: 10.1097/HJH.0000000000003482.
    >> Share

  170. STERGIOU GS, Avolio AP, Palatini P, Kyriakoulis KG, et al
    European Society of Hypertension recommendations for the validation of cuffless blood pressure measuring devices: European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability.
    J Hypertens. 2023 Jun 12. doi: 10.1097/HJH.0000000000003483.
    >> Share

  171. JESUS RLC, Araujo FA, Alves QL, Dourado KC, et al
    Targeting temperature-sensitive transient receptor potential channels in hypertension: far beyond the perception of hot and cold.
    J Hypertens. 2023 Jun 12. doi: 10.1097/HJH.0000000000003487.
    >> Share

  172. TAHERI S, Eshgabadi A, Fatuyi M, Rahima K, et al
    Eight-and-a-half syndrome in a patient with hypertensive emergencies.
    J Hypertens. 2023 Jun 9. doi: 10.1097/HJH.0000000000003468.
    >> Share

  173. KOHAGURA K, Satoh A, Kochi M, Nakamura T, et al
    Urate-lowering drugs for chronic kidney disease with asymptomatic hyperuricemia and hypertension: a randomized trial.
    J Hypertens. 2023 Jun 9. doi: 10.1097/HJH.0000000000003484.
    >> Share

  174. CHOY KW, Liwayan R
    Screening for secondary hypertension: the 'SH-Screening' Shiny app.
    J Hypertens. 2023;41:1053.
    >> Share

  175. AL-SHEHAB U, Lo DF
    Association of antihypertensive medications with the risk of dementia.
    J Hypertens. 2023;41:1051-1052.
    >> Share

  176. NILSSON PM
    Birth weight and hypertension: nature or nurture?
    J Hypertens. 2023;41:909-911.
    >> Share

  177. KYAW T, Drummond G, Bobik A
    Interferon regulatory factor 4 a master regulator of hypertensive kidney fibrosis and inflammation?
    J Hypertens. 2023;41:906-908.
    >> Share

  178. LOPEZ-SUBLET M, Merkling T, Girerd N, Xhaard C, et al
    Birth weight and subclinical cardiovascular and renal damage in a population-based study (the STANISLAS cohort study).
    J Hypertens. 2023;41:1040-1050.
    >> Share

  179. TAN I, Gnanenthiran SR, Chan J, Kyriakoulis KG, et al
    Evaluation of the ability of a commercially available cuffless wearable device to track blood pressure changes.
    J Hypertens. 2023;41:1003-1010.
    >> Share

  180. PAGEAU LM, Ng TJ, Ling J, Given BA, et al
    Associations between hair cortisol and blood pressure: a systematic review and meta-analysis.
    J Hypertens. 2023;41:875-887.
    >> Share

  181. YOSHIKAWA T, Obayashi K, Miyata K, Jimura H, et al
    Circadian blood pressure variability and asymmetric dimethylarginine in patients with glaucoma: cross-sectional study of The LIGHT cohort.
    J Hypertens. 2023;41:1018-1023.
    >> Share

  182. FACONTI L, Farukh B, McNally RJ, Brett S, et al
    Impaired beta 2 -adrenergic endothelium-dependent vasodilation in patients previously hospitalized with coronavirus disease 2019.
    J Hypertens. 2023;41:951-957.
    >> Share

  183. ROMBERGER NT, Stock JM, Patik JC, McMillan RK, et al
    Inverse salt sensitivity in normotensive adults: role of demographic factors.
    J Hypertens. 2023;41:934-940.
    >> Share

  184. GOTZINGER F, Wilke T, Hardtstock F, Krieger J, et al
    Association of hydrochlorothiazide treatment compared with alternative diuretics with overall and skin cancer risk: a propensity-matched cohort study.
    J Hypertens. 2023;41:926-933.
    >> Share

  185. DUDOIGNON B, Bokov P, Couque N, Denjoy I, et al
    Neurogenic hypertension characterizes children with congenital central hypoventilation syndrome and is aggravated by alveolar hypoventilation during sleep.
    J Hypertens. 2023 Jun 1. doi: 10.1097/HJH.0000000000003475.
    >> Share

    May 2023
  186. CHENG W, Xu W, Luan S, Wen G, et al
    Predictive value of estimated pulse wave velocity with all-cause and cause-specific mortality in the hypertensive population: the National Health and Nutrition Examination Surveys 1999-2014.
    J Hypertens. 2023 May 24. doi: 10.1097/HJH.0000000000003469.
    >> Share

  187. TONG L, Chen G, Liu T, Wang L, et al
    IFN-gamma deficiency in the rostral ventrolateral medulla contributes to stress-induced hypertension by impairing microglial synaptic engulfment.
    J Hypertens. 2023 May 24. doi: 10.1097/HJH.0000000000003470.
    >> Share

  188. LIN L, Wang C, Ren J, Mei M, et al
    A classifier based on 273 urinary peptides predicts early renal damage in primary hypertension.
    J Hypertens. 2023 May 17. doi: 10.1097/HJH.0000000000003467.
    >> Share

  189. TABARA Y, Matsumoto T, Murase K, Setoh K, et al
    Sleep-related factors associated with masked hypertension: the Nagahama study.
    J Hypertens. 2023 May 16. doi: 10.1097/HJH.0000000000003466.
    >> Share

  190. MBUTIWI FIN, Sylvestre MP
    Accounting for antihypertensive medication in Mendelian randomization studies of blood pressure: methodological considerations in the Canadian Longitudinal Study on Aging.
    J Hypertens. 2023 May 15. doi: 10.1097/HJH.0000000000003464.
    >> Share

  191. DOROBANTU M, Cojocaru C, Stanciulescu L, Pop C, et al
    Ups and downs of conducting a national representative survey on hypertension during pandemic time: main results of SEPHAR IV.
    J Hypertens. 2023 May 10. doi: 10.1097/HJH.0000000000003461.
    >> Share

  192. PEETERS LEJ, Hesselink DA, Lafeber M, Severs D, et al
    Monitoring antihypertensive drug concentrations to determine nonadherence in hypertensive patients with or without a kidney transplant.
    J Hypertens. 2023 May 8. doi: 10.1097/HJH.0000000000003459.
    >> Share


  193. Effect of intravenous antihypertensives on outcomes of severe hypertension in hospitalized patients without acute target organ damage: Erratum.
    J Hypertens. 2023;41:873.
    >> Share

  194. OMBONI S
    Reply to 'Extreme dipping: is the nocturnal blood pressure fall modulated by age?'.
    J Hypertens. 2023;41:868-869.
    >> Share

  195. PALATINI P
    Extreme dipping: is the nocturnal blood pressure fall modulated by age?
    J Hypertens. 2023;41:867.
    >> Share

  196. ALCOCER L
    Casual and inaccurate measurements of a continuous fluctuating variable: the original sin of the concept of arterial hypertension?
    J Hypertens. 2023;41:709-710.
    >> Share

  197. NILLES EK, Champon X, Mulder H, Shaw KM, et al
    Seasonal variation in blood pressure control across US health systems.
    J Hypertens. 2023;41:751-758.
    >> Share

  198. ZHONG X, Li Z, Xu Q, Peng H, et al
    Short-chain acyl-CoA dehydrogenase is a potential target for the treatment of vascular remodelling.
    J Hypertens. 2023;41:775-793.
    >> Share

  199. STERGIOU GS, Menti A, Asayama K, De La Sierra A, et al
    Accuracy of automated cuff blood pressure monitors in special populations: International Organization for Standardization (ISO) Task Group report and call for research.
    J Hypertens. 2023;41:811-818.
    >> Share

  200. HEYDARPOUR M, Parksook WW, Hopkins PN, Pojoga LH, et al
    A candidate locus in the renalase gene and susceptibility to blood pressure responses to the dietary salt.
    J Hypertens. 2023;41:723-732.
    >> Share

    April 2023
  201. SALMAN IM, Ameer OZ, McMurray S, Hassan SF, et al
    Differential central integration of left versus right baroreceptor afferent input in spontaneously hypertensive rats.
    J Hypertens. 2023 Apr 20. doi: 10.1097/HJH.0000000000003448.
    >> Share

  202. CHANG CL, Cai Z, Hsu SYT
    Stable adrenomedullin analog mitigates placental ischemia-induced hypertension and fetal growth restriction in rats.
    J Hypertens. 2023 Apr 18. doi: 10.1097/HJH.0000000000003440.
    >> Share

  203. YAMADA M, Wachsmuth J, Sambharia M, Griffin BR, et al
    The prevalence and treatment of hypertension in Veterans Health Administration, assessing the impact of the updated clinical guidelines.
    J Hypertens. 2023 Apr 18. doi: 10.1097/HJH.0000000000003424.
    >> Share

  204. CHEN J, Pei Y, Wang Q, Li C, et al
    Effect of sacubitril/valsartan or valsartan on ventricular remodeling and myocardial fibrosis in perimenopausal women with hypertension.
    J Hypertens. 2023 Apr 18. doi: 10.1097/HJH.0000000000003430.
    >> Share

  205. HU B, He X, Li F, Sun Y, et al
    Childhood obesity and hypertension in pregnancy: a two-sample Mendelian randomization analysis.
    J Hypertens. 2023 Apr 7. doi: 10.1097/HJH.0000000000003442.
    >> Share

  206. MENDOZA-QUISPE D, Chambergo-Michilot D, Moscoso-Porras M, Bernabe-Ortiz A, et al
    Hypertension prevalence by degrees of urbanization and altitude in Peru: pooled analysis of 186 906 participants.
    J Hypertens. 2023 Apr 7. doi: 10.1097/HJH.0000000000003444.
    >> Share

  207. OU YH, Ong J, Thant AT, Koo CY, et al
    The Belun sleep platform to diagnose obstructive sleep apnea in patients with hypertension and high cardiovascular risk.
    J Hypertens. 2023 Apr 7. doi: 10.1097/HJH.0000000000003426.
    >> Share

  208. CHAKRABORTY S, Lulla A, Cheng X, Yeo JY, et al
    Conjugated bile acids are nutritionally re-programmable antihypertensive metabolites.
    J Hypertens. 2023 Apr 6. doi: 10.1097/HJH.0000000000003423.
    >> Share

  209. KERKHOFS D, Helgers R, Hermes D, Steinbusch HPJ, et al
    Amlodipine limits microglia activation and cognitive dysfunction in aged hypertensive mice.
    J Hypertens. 2023 Apr 6. doi: 10.1097/HJH.0000000000003445.
    >> Share

  210. TANNER RM, Chaudary N, Colantonio LD, Merriman TR, et al
    Hypertension severity, apparent treatment resistant hypertension and hyperuricemia in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
    J Hypertens. 2023 Apr 5. doi: 10.1097/HJH.0000000000003425.
    >> Share

  211. GAO ZX, Wei QC, Shu TT, Li ST, et al
    Kir4.1 deletion prevents salt-sensitive hypertension in early streptozotocin-induced diabetic mice via Na+-Cl- cotransporter in the distal convoluted tubule.
    J Hypertens. 2023 Apr 5. doi: 10.1097/HJH.0000000000003419.
    >> Share

  212. AF GEIJERSTAM P, Engvall J, Ostgren CJ, Radholm K, et al
    Masked hypertension in a middle-aged population and its relation to manifestations of vascular disease.
    J Hypertens. 2023 Apr 4. doi: 10.1097/HJH.0000000000003431.
    >> Share

  213. MARTINS VM, Ziegelmann PK, Ferrari F, Bottino LG, et al
    Thiazide diuretics alone or combined with potassium-sparing diuretics to treat hypertension: a systematic review and network meta-analysis of randomized controlled trials.
    J Hypertens. 2023 Apr 4. doi: 10.1097/HJH.0000000000003436.
    >> Share

  214. WOODS AP, Feeney T, Papageorge MV, de Geus SWL, et al
    Addressing diagnostic inertia following incidental adrenal mass discovery in patients with hypertension.
    J Hypertens. 2023;41:680-682.
    >> Share

  215. GALLAGHER BD, Windish DM
    State of ambulatory hypertension education in U.S. internal medicine residency programs: a needs assessment survey.
    J Hypertens. 2023;41:678-679.
    >> Share

  216. CARNAGARIN R, Nolde JM, Yang J, Marques FZ, et al
    Stagnating rates of blood pressure control in Australia: insights from opportunistic screening of 10 046 participants of the May Measurement Month campaigns.
    J Hypertens. 2023;41:632-637.
    >> Share

    March 2023
  217. GALVAO L, Povoa TIR, Jardim PCV, Lima AL, et al
    Acute effects of high-intensity resistance training on central blood pressure parameters of elderly hypertensive women: a crossover clinical trial.
    J Hypertens. 2023 Mar 30. doi: 10.1097/HJH.0000000000003355.
    >> Share

  218. LACY PS, Jedrzejewski D, McFarlane E, Williams B, et al
    Blood pressure measurement modalities and indexed left ventricular mass in men with low-risk hypertension confirmed by ambulatory monitoring.
    J Hypertens. 2023 Mar 10. doi: 10.1097/HJH.0000000000003415.
    >> Share

  219. LI D, Zhang S, Cao F, Han J, et al
    The sustainable antihypertensive and target organ damage protective effect of transcranial focused ultrasound stimulation in spontaneously hypertensive rats.
    J Hypertens. 2023 Mar 3. doi: 10.1097/HJH.0000000000003407.
    >> Share

  220. XUE CC, Li C, Hu JF, Wei CC, et al
    Retinal vessel caliber and tortuosity and prediction of 5-year incidence of hypertension.
    J Hypertens. 2023 Mar 3. doi: 10.1097/HJH.0000000000003406.
    >> Share

  221. UKOHA-KALU BO, Adibe MO, Ukwe CV
    A qualitative study of patients' and carers' perspectives on factors influencing access to hypertension care and compliance with treatment in Nigeria.
    J Hypertens. 2023 Mar 3. doi: 10.1097/HJH.0000000000003409.
    >> Share

  222. GOULAS I, Evripidou K, Doundoulakis I, Kollios K, et al
    Prevalence of masked hypertension and its association with left ventricular hypertrophy in children and young adults with chronic kidney disease: a systematic review and meta-analysis.
    J Hypertens. 2023 Mar 2. doi: 10.1097/HJH.0000000000003402.
    >> Share

  223. XIONG S, Yin S, Deng W, Zhao Y, et al
    Predictive value of liver fibrosis scores in cardiovascular diseases among hypertensive population.
    J Hypertens. 2023 Mar 2. doi: 10.1097/HJH.0000000000003394.
    >> Share

  224. GAO Y, Liu B, Guo X, Nie J, et al
    Interferon regulatory factor 4 deletion protects against kidney inflammation and fibrosis in deoxycorticosterone acetate/salt hypertension.
    J Hypertens. 2023 Mar 2. doi: 10.1097/HJH.0000000000003401.
    >> Share

  225. WU S, Tian X, Chen S, Zhang Y, et al
    Arterial stiffness and blood pressure in treated hypertension: a longitudinal study.
    J Hypertens. 2023 Mar 2. doi: 10.1097/HJH.0000000000003400.
    >> Share

  226. KUMAR SM, Anandraj J, Sivanatham P, Essakky S, et al
    Control status of hypertension in India: systematic review and meta-analysis.
    J Hypertens. 2023 Mar 2. doi: 10.1097/HJH.0000000000003381.
    >> Share

  227. STERGIOU G, MacDonald T, Young R, Kyriakoulis KG, et al
    Reply to 'Evening or morning dosing of antihypertensive medications: valid epidemiological findings for consensus statement'.
    J Hypertens. 2023;41:525-526.
    >> Share

  228. KAWADA T
    Evening or morning dosing of antihypertensive medications: valid epidemiological findings for consensus statement.
    J Hypertens. 2023;41:525.
    >> Share

  229. NURKKALA J, Kauko A, FinnGen, Laivuori H, et al
    Associations of polygenic risk scores for preeclampsia and blood pressure with hypertensive disorders of pregnancy.
    J Hypertens. 2023;41:380-387.
    >> Share

  230. MEDEIROS BM, Da Silva TLN, Bloch KV, Kuschnir MCC, et al
    Adolescent blood pressure classification curves and cardiometabolic risk factors: a comparison of the Brazilian and American references.
    J Hypertens. 2023;41:420-428.
    >> Share

  231. AVILA-GANDIA V, Ramos-Campo DJ, Garcia-Sanchez E, Luque-Rubia AJ, et al
    Training, detraining and retraining effects of moderate vs. high intensity exercise training programme on cardiovascular risk factors.
    J Hypertens. 2023;41:411-419.
    >> Share

  232. ZEIJEN VJM, Hirsch A, Betjes MGH, Daemen J, et al
    Unilateral renal atrophy 4 years after renal sympathetic denervation: a case report.
    J Hypertens. 2023;41:516-519.
    >> Share

  233. KOBAYASHI A, Fujihara K, Yamada MH, Sato T, et al
    Combined effects of blood pressure and glycemic status on risk of heart failure: a population-based study.
    J Hypertens. 2023;41:470-475.
    >> Share

  234. KANTAUSKAITE M, Furst G, Minko P, Antoch G, et al
    How acute renal failure led to the diagnosis of aortic coarctation.
    J Hypertens. 2023;41:520-524.
    >> Share

  235. ZEIJEN VJM, Feyz L, Kardys I, Geleijnse ML, et al
    Association between renal sympathetic denervation and arterial stiffness: the ASORAS study.
    J Hypertens. 2023;41:476-485.
    >> Share

  236. CHALMERS J, Mourad JJ, Brzozowska-Villatte R, De Champvallins M, et al
    Benefit of treatment based on indapamide mostly combined with perindopril on mortality and cardiovascular outcomes: a pooled analysis of four trials.
    J Hypertens. 2023;41:508-515.
    >> Share

    February 2023
  237. PARATI G, Bilo G, Kollias A, Pengo M, et al
    Blood pressure variability: methodological aspects, clinical relevance and practical indications for management - a European Society of Hypertension position paper *.
    J Hypertens. 2023 Feb 16. doi: 10.1097/HJH.0000000000003363.
    >> Share

  238. PARISE BK, Santos RB, Mesas AE, Silva WA, et al
    Sleep irregularity and the association with hypertension and blood pressure levels: the ELSA-Brasil study.
    J Hypertens. 2023 Feb 13. doi: 10.1097/HJH.0000000000003392.
    >> Share

  239. CARDOSO CRL, Leite NC, Salles GF
    Relative prognostic importance of aortic and brachial blood pressures for cardiovascular and mortality outcomes in patients with resistant hypertension and diabetes: a two cohorts prospective study.
    J Hypertens. 2023 Feb 2. doi: 10.1097/HJH.0000000000003387.
    >> Share

  240. KAWADA T
    Cardiovascular disease risk in patients with type 2 diabetes and hypertension.
    J Hypertens. 2023;41:365.
    >> Share

  241. CUSPIDI C, Gherbesi E, Faggiano A, Sala C, et al
    Unmasking left ventricular systolic dysfunction in masked hypertension: looking at myocardial strain. A review and meta-analysis.
    J Hypertens. 2023;41:344-350.
    >> Share

  242. HOLWERDA SW, Gangwish ME, Luehrs RE, Nuckols VR, et al
    Concomitantly higher resting arterial blood pressure and transduction of sympathetic neural activity in human obesity without hypertension.
    J Hypertens. 2023;41:326-335.
    >> Share

  243. REN R, Zhang Y, Yang L, Shi Y, et al
    Sleep fragmentation during rapid eye movement sleep and hypertension in obstructive sleep apnea.
    J Hypertens. 2023;41:310-315.
    >> Share

  244. GHAZI L, Li F, Simonov M, Yamamoto Y, et al
    Effect of intravenous antihypertensives on outcomes of severe hypertension in hospitalized patients without acute target organ damage.
    J Hypertens. 2023;41:288-294.
    >> Share

  245. BO Y, Yu T, Guo C, Chang LY, et al
    Isolated systolic or diastolic hypertension and mortality risk in young adults using the 2017 American College of Cardiology/American Heart Association blood pressure guideline: a longitudinal cohort study.
    J Hypertens. 2023;41:271-279.
    >> Share

  246. WANG FZ, Qian P, Liu MY, Ding L, et al
    Adrenomedullin in paraventricular nucleus attenuates adipose afferent reflex and sympathoexcitation via receptors mediated nitric oxide-gamma-aminobutyric acid A type receptor pathway in rats with obesity-related hypertension.
    J Hypertens. 2023;41:233-245.
    >> Share

  247. VAN TWIST DJL, Kietselaer BLJH
    Intravenous antihypertensive drugs: a double-edged sword?
    J Hypertens. 2023;41:220-222.
    >> Share

  248. LI Y, Haseler E, McNally R, Sinha MD, et al
    A meta-analysis of the haemodynamics of primary hypertension in children and adults.
    J Hypertens. 2023;41:212-219.
    >> Share

  249. JONES L, Blair J, Hawcutt DB, Lip GYH, et al
    Hypertension in Turner syndrome: a review of proposed mechanisms, management and new directions.
    J Hypertens. 2023;41:203-211.
    >> Share

  250. BRGULJAN-HITIJ J, McNally R, Sinigoj P, Hornstrup BG, et al
    ESH Summer School 2022: great experience for participants and an important achievement for ESH organization.
    J Hypertens. 2023;41:365-368.
    >> Share

  251. KAKALETSIS N, Ntaios G, Milionis H, Protogerou AD, et al
    Time of blood pressure in target range in acute ischemic stroke.
    J Hypertens. 2023;41:303-309.
    >> Share

  252. PEWOWARUK RJ, Hein AJ, Hansen KM, Barnes JN, et al
    Exercise increases arterial stiffness independent of blood pressure in older Veterans.
    J Hypertens. 2023;41:316-325.
    >> Share

  253. OMBONI S, Ballatore T, Rizzi F, Tomassini F, et al
    Age-related patterns of ambulatory blood pressure in a large cohort of individuals referred to Italian community pharmacies: results from the templar project.
    J Hypertens. 2023;41:336-343.
    >> Share

  254. ZHOU TL, Reulen JPH, Van Der Staaij H, Stehouwer CDA, et al
    Cardiovagal baroreflex sensitivity, blood pressure and blood pressure variability - the Maastricht study.
    J Hypertens. 2023;41:254-261.
    >> Share

  255. CAMPBELL NRC, Whelton PP, Orias M, Cobb LL, et al
    It is strongly recommended to not conduct, fund, or publish research studies that use spot urine samples with estimating equations to assess individuals' sodium (salt) intake in association with health outcomes: a policy statement of the World Hyperte
    J Hypertens. 2023 Feb 1. doi: 10.1097/HJH.0000000000003385.
    >> Share

  256. SUN Y, Guo Y, Xu H, Zhao J, et al
    The relationship between arginine vasopressin gene polymorphisms and plasma copeptin and hypertensive disorders of pregnancy: a nested case-control study.
    J Hypertens. 2023 Feb 1. doi: 10.1097/HJH.0000000000003376.
    >> Share

  257. KANG YY, Chen Y, Wu QH, Dong H, et al
    Prevalence and clinical characteristics of renovascular hypertension associated with fibromuscular dysplasia in China.
    J Hypertens. 2023 Feb 1. doi: 10.1097/HJH.0000000000003382.
    >> Share

    January 2023
  258. ALNAZER RM, Veldhuizen GP, de Leeuw PW, Kroon AA, et al
    The effect of age, sex and BMI on the aldosterone-to-renin ratio in essential hypertensive individuals.
    J Hypertens. 2023 Jan 31. doi: 10.1097/HJH.0000000000003377.
    >> Share

  259. REN Y, Shi J, Liu S, Zhu W, et al
    Transcription factor AP-2 gamma/Kruppel-like factor 10 axis is involved in miR-3656-related dysfunction of endothelial cells in hypertension.
    J Hypertens. 2023 Jan 26. doi: 10.1097/HJH.0000000000003359.
    >> Share

  260. HIRAI T, Ueda S, Ogura T, Katayama K, et al
    Hyperkalemia by eplerenone or esaxerenone in the presence or absence of clarithromycin in hypertensive patients: a retrospective observational cohort study.
    J Hypertens. 2023 Jan 20. doi: 10.1097/HJH.0000000000003372.
    >> Share

  261. PEWOWARUK RJ, Colebank MJ, Spronck B, Korcarz CE, et al
    Biomechanics models predict increasing smooth muscle tone as a novel therapeutic target for central arterial dysfunction in hypertension.
    J Hypertens. 2023 Jan 18. doi: 10.1097/HJH.0000000000003370.
    >> Share

  262. BAWAND R, Ghiasian M, Khazaei M, Samadyan M, et al
    Effects of blood pressure unawareness and poor adherence to antihypertensive drugs on outcomes of cerebrovascular accidents among patients with their first-ever stroke.
    J Hypertens. 2023 Jan 13. doi: 10.1097/HJH.0000000000003358.
    >> Share

  263. BOULESTREAU R, Lorthioir A, Persu A, Sarafidis P, et al
    Revisiting malignant hypertension: rationale and design of the 'HAMA cohort', on behalf of the ESH working group 'hypertension and the kidney'.
    J Hypertens. 2023 Jan 10. doi: 10.1097/HJH.0000000000003357.
    >> Share

  264. TAKASE M, Yamada M, Nakamura T, Nakaya N, et al
    Association between lung function and hypertension and home hypertension in a Japanese population: the Tohoku Medical Megabank Community-Based Cohort Study.
    J Hypertens. 2023 Jan 4. doi: 10.1097/HJH.0000000000003356.
    >> Share


  265. Dynamic of bedside ultrasound venous and pulmonary congestion assessment in patients with arterial hypertension and decompensated heart failure: Erratum.
    J Hypertens. 2023;41:200.
    >> Share

  266. CASIGLIA E, Tikhonoff V, Virdis A, Grassi G, et al
    Serum uric acid / serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off values.
    J Hypertens. 2023;41:180-186.
    >> Share

  267. BOTHE TL, Bilo G, Parati G, Haberl R, et al
    Impact of oscillometric measurement artefacts in ambulatory blood pressure monitoring on estimates of average blood pressure and of its variability: a pilot study.
    J Hypertens. 2023;41:140-149.
    >> Share

  268. WALLE-HANSEN MM, Berge T, Vigen T, Myrstad M, et al
    Systolic blood pressure at age 40 and cognitive function 25 years later: the Akershus Cardiac Examination (ACE) 1950 Study.
    J Hypertens. 2023;41:132-139.
    >> Share

  269. PAPADOPOULOU SL, Gkaliagkousi E, Dipla K, Koletsos N, et al
    Relationship of 24-h ambulatory blood pressure variability with micro and macrovascular parameters and hypertension status.
    J Hypertens. 2023;41:74-82.
    >> Share

  270. RUS RR, Pac M, Obrycki L, Sagsak E, et al
    Systolic and diastolic left ventricular function in children with primary hypertension: a systematic review and meta-analysis.
    J Hypertens. 2023;41:51-62.
    >> Share

  271. MALHAME I, Dong S, Syeda A, Ashraf R, et al
    The use of loop diuretics in the context of hypertensive disorders of pregnancy: a systematic review and meta-analysis.
    J Hypertens. 2023;41:17-26.
    >> Share

  272. OBRYCKI L, Sarnecki J, Pac M, Derezinski T, et al
    Accelerated vascular age in adolescents with primary hypertension.
    J Hypertens. 2023;41:171-179.
    >> Share

  273. KARELIUS S, Vahtera J, Suorsa K, Heinonen OJ, et al
    Changes in ambulatory blood pressure during the transition to retirement.
    J Hypertens. 2023;41:187-193.
    >> Share

    December 2022
  274. ROSSI GP, Barton M, Dhaun N, Rizzoni D, et al
    Challenges in the evaluation of endothelial cell dysfunction: a statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors.
    J Hypertens. 2022 Dec 23. doi: 10.1097/HJH.0000000000003314.
    >> Share

  275. SCHRADER B, Conradi C, Luders S, Vaske B, et al
    Health football beats them all: subgroup analysis of the 3F (Fit&Fun with Football) study on white coat hypertension, sustained hypertension, dippers, nondippers, and on pharmacologically un(treated) arterial hypertension.
    J Hypertens. 2022 Dec 19. doi: 10.1097/HJH.0000000000003360.
    >> Share

  276. NTINERI A, Theodosiadi A, Menti A, Kyriakoulis KG, et al
    A novel professional automated auscultatory blood pressure monitor with visual display of Korotkoff sounds: InBody BPBIO480KV validation according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/Inter
    J Hypertens. 2022 Dec 15. doi: 10.1097/HJH.0000000000003341.
    >> Share

  277. LOVGREN T, Connealy B, Yao R, D Dahlke J, et al
    Postpartum medical management of hypertension and risk of readmission for hypertensive complications.
    J Hypertens. 2022 Dec 13. doi: 10.1097/HJH.0000000000003340.
    >> Share

  278. CHOI M, Hwang JR, Sung JH, Byun N, et al
    Hydroxychloroquine reduces hypertension and soluble fms-like kinase-1 in a Nomega-nitro-l-arginine methyl ester-induced preeclampsia rat model.
    J Hypertens. 2022;40:2459-2468.
    >> Share

  279. LU SY, Hong WZ, Tsai BC, Chang YC, et al
    Angiotensin II prompts heart cell apoptosis via AT1 receptor-augmented phosphatase and tensin homolog and miR-320-3p functions to enhance suppression of the IGF1R-PI3K-AKT survival pathway.
    J Hypertens. 2022;40:2502-2512.
    >> Share

  280. ALI M, Hussein Z, Marshall JM
    Young South Asian women in the United Kingdom show evidence of blunted endothelium-dependent dilatation: implications for future cardiovascular disease.
    J Hypertens. 2022;40:2438-2448.
    >> Share

  281. O'DRISCOLL JM, Edwards JJ, Coleman DA, Taylor KA, et al
    One year of isometric exercise training for blood pressure management in men: a prospective randomized controlled study.
    J Hypertens. 2022;40:2406-2412.
    >> Share

    November 2022
  282. SCHROEVERS JL, Eggink E, Hoevenaar-Blom MP, Van Dalen JW, et al
    Antihypertensive medication classes and the risk of dementia over a decade of follow-up.
    J Hypertens. 2022 Nov 18. pii: 00004872-990000000-00141.
    >> Share

  283. ANDERSSON U, Nilsson PM, Kjellgren K, Hoffmann M, et al
    PERson-centredness in Hypertension management using Information Technology: a randomized controlled trial in primary care.
    J Hypertens. 2022 Nov 18. pii: 00004872-990000000-00139.
    >> Share


  284. Renal denervation in the antihypertensive arsenal - knowns and known unknowns: Erratum.
    J Hypertens. 2022;40:2322.
    >> Share

  285. MICHAEL N, Sadananthan SA, Yuan WL, Ong YY, et al
    Associations of maternal and foetoplacental factors with prehypertension/hypertension in early childhood.
    J Hypertens. 2022;40:2171-2179.
    >> Share

  286. GNANENTHIRAN SR, Liu H, Tan I, Chan J, et al
    Cuffless blood pressure devices: the gap between patient acceptability and need for validation.
    J Hypertens. 2022;40:2317-2319.
    >> Share

  287. JONES ESW, Lee HY, Khan N, Charchar FJ, et al
    Reduction of salt intake: time for more action.
    J Hypertens. 2022;40:2130-2132.
    >> Share

  288. NOLDE JM, Hillis GS, Atkins E, Von Huben A, et al
    Impact of various night-time period definitions on nocturnal ambulatory blood pressure.
    J Hypertens. 2022;40:2271-2279.
    >> Share

  289. LUGO-GAVIDIA LM, Burger D, Nolde JM, Carnagarin R, et al
    Platelet-derived extracellular vesicles correlate with therapy-induced nocturnal blood pressure changes.
    J Hypertens. 2022;40:2210-2218.
    >> Share

  290. GAVISH B, Bursztyn M, Thijs L, Wei DM, et al
    Predictive power of 24-h ambulatory pulse pressure and its components for mortality and cardiovascular outcomes in 11 848 participants recruited from 13 populations.
    J Hypertens. 2022;40:2245-2255.
    >> Share

  291. EDWARDS JJ, Wiles J, O'Driscoll J
    Mechanisms for blood pressure reduction following isometric exercise training: a systematic review and meta-analysis.
    J Hypertens. 2022;40:2299-2306.
    >> Share

  292. BOUWMEESTER TA, van de Velde L, Galenkamp H, Postema PG, et al
    Association between the reflection magnitude and blood pressure in a multiethnic cohort: the Healthy Life in an Urban Setting study.
    J Hypertens. 2022;40:2263-2270.
    >> Share

    October 2022
  293. HORNE CE, Stayt LC, Schutz S, Smith CM, et al
    Symptom experiences in hypertension: a mixed methods systematic review.
    J Hypertens. 2022 Oct 17. pii: 00004872-990000000-00129.
    >> Share

  294. HELLEPUTTE S, Spronck B, Sharman JE, Van Bortel L, et al
    Central blood pressure estimation in type 1 diabetes: impact and implications of peripheral calibration method.
    J Hypertens. 2022 Oct 10. pii: 00004872-990000000-00126.
    >> Share

  295. WOLDSTAD C, Rusinek H, Sweeney E, Butler T, et al
    Quadratic relationship between systolic blood pressure and white matter lesions in individuals with hypertension.
    J Hypertens. 2022 Oct 5. pii: 00004872-990000000-00123.
    >> Share

  296. MIDDELDORP ME, Ariyaratnam JP, Kamsani SH, Albert CM, et al
    Hypertension and atrial fibrillation.
    J Hypertens. 2022 Oct 5. pii: 00004872-990000000-00124.
    >> Share

  297. KALA P, Gawrys O, Miklovic M, Vanourkova Z, et al
    Endothelin type A receptor blockade attenuates aorto-caval fistula-induced heart failure in rats with angiotensin II-dependent hypertension.
    J Hypertens. 2022 Oct 5. pii: 00004872-990000000-00121.
    >> Share

  298. KEEHN L, Hall WL, Berry SE, Sanders TAB, et al
    Reproducibility of sequential ambulatory blood pressure and pulse wave velocity measurements in normotensive and hypertensive individuals.
    J Hypertens. 2022 Oct 3. pii: 00004872-990000000-00120.
    >> Share


  299. Distinct transcriptomic profile of small arteries of hypertensive patients with chronic kidney disease identified miR-338-3p targeting GPX3 and PTPRS: Erratum.
    J Hypertens. 2022;40:2084.
    >> Share

  300. ZHANG Z, Zhang X, Gui Y, Wang X, et al
    Renal arteriovenous fistula complicated with malignant hypertension: a case report.
    J Hypertens. 2022;40:2076-2080.
    >> Share

  301. TSAI HR, Hsu HC, Wu CI, Lee WH, et al
    Effects of postsystolic shortening and diastolic dyssynchrony on myocardial work in untreated early hypertension patients.
    J Hypertens. 2022;40:1994-2004.
    >> Share

  302. CHUANG KH, Yao RH, Jiang YN, Gui LX, et al
    Attenuating effect of magnesium on pulmonary arterial calcification in rodent models of pulmonary hypertension.
    J Hypertens. 2022;40:1979-1993.
    >> Share

  303. PALATINI P, Mos L, Rattazzi M, Spinella P, et al
    Blood pressure response to standing is a strong determinant of masked hypertension in young to middle-age individuals.
    J Hypertens. 2022;40:1927-1934.
    >> Share

  304. ALMANSOOR ZR, Saxton SN
    Time-restricted feeding: a free and effective method of managing hypertension by ameliorating inflammation?
    J Hypertens. 2022;40:1899-1901.
    >> Share

  305. HITIJ JB
    A commentary on the article 'Antihypertensive drug treatment in white-coat hypertension: data from the Plaque Hypertension Lipid-Lowering Italian Study'.
    J Hypertens. 2022;40:1897-1898.
    >> Share

  306. MESSERLI FH, Bavishi C, Brguljan J, Burnier M, et al
    Renal denervation in the antihypertensive arsenal - knowns and known unknowns.
    J Hypertens. 2022;40:1859-1875.
    >> Share

  307. FINSTERER J
    Blood pressure regulation is multifactorial in mitochondrial disorders.
    J Hypertens. 2022;40:2081.
    >> Share

  308. OKUMURA K, Obayashi K, Tai Y, Yamagami Y, et al
    Influence of depression on the association between colder indoor temperature and higher blood pressure.
    J Hypertens. 2022;40:2013-2021.
    >> Share

  309. WANG Y, Zhang WS, Hao YT, Jiang CQ, et al
    Changes in blood pressure and cardiovascular disease in middle-aged to older Chinese: the Guangzhou Biobank Cohort Study.
    J Hypertens. 2022;40:2005-2012.
    >> Share

  310. STERNBACH TJ, Harper S, Li X, Zhang X, et al
    Effects of indoor and outdoor temperatures on blood pressure and central hemodynamics in a wintertime longitudinal study of Chinese adults.
    J Hypertens. 2022;40:1950-1959.
    >> Share

  311. SHARP ASP, Tunev S, Schlaich M, Lee DP, et al
    Histological evidence supporting the durability of successful radiofrequency renal denervation in a normotensive porcine model.
    J Hypertens. 2022;40:2068-2075.
    >> Share

    September 2022
  312. FAN JF, Wang W, Tan X, Ye P, et al
    Contribution of cyclooxygenase-2 overexpression to enhancement in tonically active glutamatergic inputs to the rostral ventrolateral medulla in hypertension.
    J Hypertens. 2022 Sep 27. pii: 00004872-990000000-00119.
    >> Share

  313. ANGELAKI E, Barmparis GD, Kochiadakis G, Maragkoudakis S, et al
    Artificial intelligence-based opportunistic screening for the detection of arterial hypertension through ECG signals.
    J Hypertens. 2022 Sep 27. pii: 00004872-990000000-00118.
    >> Share

  314. LI C, Shang S, Liang W
    Sleep and risk of hypertension in general American adults: the National Health and Nutrition Examination Surveys (2015-2018).
    J Hypertens. 2022 Sep 20. pii: 00004872-990000000-00117.
    >> Share

  315. SENDZIKAITE S, Sudikiene R, Lubaua I, Silis P, et al
    Antihypertensive therapy of late arterial hypertension in children following successful coarctation correction.
    J Hypertens. 2022 Sep 14. pii: 00004872-990000000-00115.
    >> Share

  316. LIAN J, Shi X, Jia X, Fan J, et al
    Genetically predicted blood pressure, antihypertensive drugs and risk of heart failure: a Mendelian randomization study.
    J Hypertens. 2022 Sep 14. pii: 00004872-990000000-00114.
    >> Share

  317. CHANDAK P, Kessaris N, Karunanithy N, Byrne N, et al
    Utilizing 3D printing to facilitate surgical in-situ paediatric renal artery aneurysm repair for refractory hypertension.
    J Hypertens. 2022 Sep 14. pii: 00004872-990000000-00113.
    >> Share


  318. Hyperuricemia and risk of hypertension resistant to therapy: a systematic review and meta-analysis: Erratum.
    J Hypertens. 2022;40:1845.
    >> Share

  319. LI C, Wang Q, Qing Y, Ma L, et al
    Rho kinase inhibition on renal remodeling in an apatinib-induced hypertensive rat model.
    J Hypertens. 2022;40:1838-1840.
    >> Share

  320. CALO LA, Stefanelli LF, Bertoldi G, Ravarotto V, et al
    Rho kinase inhibition: from hypertension to cardiovascular-renal remodeling and more.
    J Hypertens. 2022;40:1836-1837.
    >> Share

  321. LIU Y, Zhong C, Si J, Chen S, et al
    The impact of Sacubitril/Valsartan on cardiac fibrosis early after myocardial infarction in hypertensive rats.
    J Hypertens. 2022;40:1822-1830.
    >> Share

  322. QU Y, Guo ZN, Zhang P, Ma HY, et al
    Time course of beat-to-beat blood pressure variability and outcome in patients with spontaneous intracerebral haemorrhage.
    J Hypertens. 2022;40:1744-1750.
    >> Share

  323. CHAMBERS LC, Diaz-Otero JM, Fisher CL, Jackson WF, et al
    Mineralocorticoid receptor antagonism improves transient receptor potential vanilloid 4-dependent dilation of cerebral parenchymal arterioles and cognition in a genetic model of hypertension.
    J Hypertens. 2022;40:1722-1734.
    >> Share

  324. LIU MM, Peng J, Xu RX, Guo YL, et al
    Hypertension and clinical outcomes in patients with familial hypercholesterolemia.
    J Hypertens. 2022;40:1713-1721.
    >> Share

  325. LAU D, Ringrose J, McAlister FA, Fradette M, et al
    Telemonitoring and protocolized case management for hypertensive community dwelling older adults (TECHNOMED): a randomized controlled trial.
    J Hypertens. 2022;40:1702-1712.
    >> Share

  326. HITIJ JB
    Association of depressive symptoms and hypertension prevalence, awareness, treatment.
    J Hypertens. 2022;40:1655-1657.
    >> Share

  327. JIN X, Narisawa M, Piao L, Cheng XW, et al
    Protein tyrosine phosphatase receptor type D as a potential therapeutic target in pulmonary artery hypertension.
    J Hypertens. 2022;40:1650-1654.
    >> Share

  328. LEE EK, Zhu M, Chan DC, Yip BH, et al
    Comparing effect of definition of diurnal periods by diary, fixed periods, and actigraphy on ambulatory blood pressure parameters in a Chinese population.
    J Hypertens. 2022;40:1815-1821.
    >> Share

  329. BOGAERTS JMK, Poortvliet RKE, van der Klei VMGTH, Achterberg WP, et al
    Disentangling the varying associations between systolic blood pressure and health outcomes in the very old: an individual patient data meta-analysis.
    J Hypertens. 2022;40:1786-1794.
    >> Share

    August 2022
  330. GEWA CA, Onyango AC, Opiyo RO, Gittelsohn J, et al
    Patterns and predictors of elevated blood pressure and hypertension among primary school children in urban Kenya.
    J Hypertens. 2022 Aug 30. pii: 00004872-990000000-00111.
    >> Share

  331. ARAUJO-CASTRO M, Paja Fano M, Gonzalez Boillos M, Pla Peris B, et al
    Predictive model of hypertension resolution after adrenalectomy in primary aldosteronism: the SPAIN-ALDO score.
    J Hypertens. 2022 Aug 24. pii: 00004872-990000000-00101.
    >> Share

  332. LEE YH, Kim JS, Song SH, Song SH, et al
    Impact of donor hypertension on graft survival and function in living and deceased donor kidney transplantation: a nationwide prospective cohort study.
    J Hypertens. 2022 Aug 24. pii: 00004872-990000000-00103.
    >> Share

  333. KWON CH, Lee HY, Lee JH, Kim M, et al
    Optimal office blood pressure levels in younger (<50 years old) Korean hypertensive patients: a nationwide cohort study in South Korea.
    J Hypertens. 2022 Aug 19. pii: 00004872-990000000-00091.
    >> Share

  334. GRONEWOLD J, Jokisch M, Schramm S, Himpfen H, et al
    Periventricular rather than deep white matter hyperintensities mediate effects of hypertension on cognitive performance in the population-based 1000BRAINS study.
    J Hypertens. 2022 Aug 19. pii: 00004872-990000000-00086.
    >> Share

  335. SALICE P, Mircoli L, Butera G, Burdick L, et al
    Percutaneous cutting balloon angioplasty for the treatment of renovascular hypertension in children and adolescents.
    J Hypertens. 2022 Aug 19. pii: 00004872-990000000-00089.
    >> Share

  336. HATA S, Ushigome E, Yoshimura T, Takegami M, et al
    Maximum home blood pressure and cardiovascular outcomes in patients with type 2 diabetes: KAMOGAWA-HBP study.
    J Hypertens. 2022 Aug 19. pii: 00004872-990000000-00088.
    >> Share

  337. GAFFEY AE, Rosman L, Sico JJ, Haskell SG, et al
    Military sexual trauma and incident hypertension: A 16-year cohort study of young and middle-aged men and women.
    J Hypertens. 2022 Aug 18. pii: 00004872-990000000-00085.
    >> Share

  338. STERGIOU G, Brunstrom M, MacDonald T, Kyriakoulis KG, et al
    Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension.
    J Hypertens. 2022 Aug 16. pii: 00004872-990000000-00084.
    >> Share

  339. VELDHUIZEN GP, Alnazer RM, Kroon AA, de Leeuw PW, et al
    Variability of aldosterone, renin and the aldosterone-to-renin ratio in hypertensive patients without primary aldosteronism.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00078.
    >> Share

  340. KABIA AU, Li P, Jin Z, Tan X, et al
    The effects of hypertension on the prognosis of coronavirus disease 2019: a systematic review and meta-analysis on the interactions with age and antihypertensive treatment.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00080.
    >> Share

  341. IATRIDI F, Theodorakopoulou MP, Papagianni A, Sarafidis P, et al
    Management of intradialytic hypertension: current evidence and future perspectives.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00071.
    >> Share

  342. ZHENG X, Han L, Shen S
    Hypertension, remnant cholesterol and cardiovascular disease: evidence from the China health and retirement longitudinal study.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00079.
    >> Share

  343. LI J, Tong D, Song B, Xie F, et al
    Inflammatory cytokines induce neutrophil extracellular traps interaction with activated platelets and endothelial cells exacerbate coagulation in moderate and severe essential hypertension.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00070.
    >> Share

  344. KANG MY
    Occupational risk factors for hypertension.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00074.
    >> Share

  345. FALLO F, Di Dalmazi G, Beuschlein F, Biermasz NR, et al
    Diagnosis and management of hypertension in patients with Cushing's syndrome: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00081.
    >> Share

  346. COSTA TJ, Linder BA, Hester S, Fontes M, et al
    The janus face of ketone bodies in hypertension.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00064.
    >> Share

  347. LIN Y, Li YQ, Wang H, Wu HJ, et al
    Increasing angiotensin-converting enzyme 1 regulated by histone 3 lysine 27 hyperacetylation in high-fat diet-induced hypertensive rat kidney.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00065.
    >> Share

  348. GEORGE R, Thomas C, Joy CA, Varghese B, et al
    Comparative efficacy and safety of oral nifedipine with other antihypertensive medications in the management of hypertensive disorders of pregnancy: a systematic review and meta-analysis of randomized controlled trials.
    J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00069.
    >> Share

  349. FANG X, Ma L, Wang Y, Ren F, et al
    Neutrophil extracellular traps accelerate vascular smooth muscle cell proliferation via Akt/CDKN1b/TK1 accompanying with the occurrence of hypertension.
    J Hypertens. 2022 Aug 4. pii: 00004872-990000000-00062.
    >> Share

  350. NAKAGAWA K, Chen R, Greenberg SM, Ross GW, et al
    Forkhead box O3 longevity genotype may attenuate the impact of hypertension on risk of intracerebral haemorrhage.
    J Hypertens. 2022 Aug 4. pii: 00004872-990000000-00061.
    >> Share

  351. TABARA Y, Chin K
    Sleep duration and sleep blood pressure: the Nagahama study.
    J Hypertens. 2022;40:1624-1625.
    >> Share

  352. WARD NC, Carnagarin R, Nolde JM, Lugo-Gavidia LM, et al
    Circulating short-chain fatty acids in hypertension: a reflection of various hypertensive phenotypes.
    J Hypertens. 2022;40:1589-1596.
    >> Share

  353. NARITA K, Hoshide S, Ae R, Kario K, et al
    Simple predictive score for nocturnal hypertension and masked nocturnal hypertension using home blood pressure monitoring in clinical practice.
    J Hypertens. 2022;40:1513-1521.
    >> Share

  354. CUKA E, Simonini M, Lanzani C, Zagato L, et al
    Inverse salt sensitivity: an independent risk factor for cardiovascular damage in essential hypertension.
    J Hypertens. 2022;40:1504-1512.
    >> Share

  355. JIMENEZ-BALADO J, Riba-Llena I, Nafria C, Pizarro J, et al
    Silent brain infarcts, peripheral vascular disease and the risk of cardiovascular events in patients with hypertension.
    J Hypertens. 2022;40:1469-1477.
    >> Share

  356. SATOH M, Hirose T, Satoh H, Nakayama S, et al
    Actual impact of angiotensin II receptor blocker or calcium channel blocker monotherapy on renal function in real-world patients.
    J Hypertens. 2022;40:1564-1576.
    >> Share

    July 2022
  357. SAVARE L, Rea F, Corrao G, Mancia G, et al
    Use of initial and subsequent antihypertensive combination treatment in the last decade: analysis of a large Italian database.
    J Hypertens. 2022 Jul 26. pii: 00004872-990000000-00054.
    >> Share

  358. JONES S, Schultz MG, Park C, Tillin T, et al
    Antihypertensive treatment effect on exercise blood pressure and exercise capacity in older adults.
    J Hypertens. 2022 Jul 26. pii: 00004872-990000000-00058.
    >> Share

  359. CHAINOGLOU A, Sarafidis K, Chrysaidou K, Farmaki E, et al
    Arterial stiffness and nocturnal hypertension in preterm children and adolescents.
    J Hypertens. 2022 Jul 26. pii: 00004872-990000000-00055.
    >> Share

  360. MANCIA G, Facchetti R, Quarti-Trevano F, Grassi G, et al
    Antihypertensive drug treatment in white-coat hypertension: data from the Plaque HYpertension Lipid-Lowering Italian Study.
    J Hypertens. 2022 Jul 26. pii: 00004872-990000000-00056.
    >> Share

  361. MAGHAJOTHI S, Subramanian L, Mani P, Singh M, et al
    A common Matrix metalloproteinase 8 promoter haplotype enhances the risk for hypertension via diminished interactions with nuclear factor kappa B.
    J Hypertens. 2022 Jul 25. pii: 00004872-990000000-00050.
    >> Share

  362. XU J, Zhong Y, Yin H, Linneman J, et al
    Methylation-mediated silencing of PTPRD induces pulmonary hypertension by promoting pulmonary arterial smooth muscle cell migration via the PDGFRB/PLCgamma1 axis.
    J Hypertens. 2022 Jul 14. pii: 00004872-990000000-00040.
    >> Share

  363. SIMS BM, Goodlett BL, Allbee ML, Pickup EJ, et al
    Time restricted feeding decreases renal innate immune cells and blood pressure in hypertensive mice.
    J Hypertens. 2022 Jul 12. pii: 00004872-990000000-00037.
    >> Share

  364. AGBAJE AO
    Arterial stiffness precedes hypertension and metabolic risks in youth: a review.
    J Hypertens. 2022 Jul 11. pii: 00004872-990000000-00039.
    >> Share

  365. POUDEL B, Viera AJ, Shimbo D, Schwartz JE, et al
    Comparison of the association of masked hypertension defined by the 2017 ACC/AHA BP guideline versus the JNC7 guideline with left ventricular hypertrophy.
    J Hypertens. 2022 Jul 6. pii: 00004872-990000000-00030.
    >> Share

  366. ZHU Y, Tao Y, Wu C, Zeng Y, et al
    Renal Farnesoid X Receptor improves high fructose-induced salt-sensitive hypertension in mice by inhibiting DNM3 to promote nitro oxide production.
    J Hypertens. 2022 Jul 6. pii: 00004872-990000000-00029.
    >> Share

  367. SRIVASTAVA S, Vemulapalli B, Okoh AK, Kassotis J, et al
    Disparity in hospital admissions and length of stay based on income status for emergency department hypertensive crisis visits.
    J Hypertens. 2022 Jul 6. pii: 00004872-990000000-00024.
    >> Share

  368. THEODORAKOPOULOU MP, Karagiannidis AG, Alexandrou ME, Polychronidou G, et al
    Sex differences in ambulatory blood pressure levels, control and phenotypes of hypertension in hemodialysis patients.
    J Hypertens. 2022 Jul 6. pii: 00004872-990000000-00031.
    >> Share

  369. DU TOIT WL, Kruger R, Gafane-Matemane LF, Schutte AE, et al
    Urinary metabolomics profiling by cardiovascular risk factors in young adults: the African Prospective study on Early Detection and Identification of Cardiovascular disease and Hypertension study.
    J Hypertens. 2022 Jul 6. pii: 00004872-990000000-00032.
    >> Share

  370. FANG J, Zhang Z, Greenlund KJ
    Association of depressive symptoms and hypertension prevalence, awareness, treatment and control among USA adults.
    J Hypertens. 2022 Jul 6. pii: 00004872-990000000-00035.
    >> Share

  371. BIRUKOV A, Glintborg D, Schulze MB, Jensen TK, et al
    Elevated blood pressure in pregnant women with gestational diabetes according to the WHO criteria: importance of overweight.
    J Hypertens. 2022 Jul 6. pii: 00004872-990000000-00028.
    >> Share

  372. SOHN CS, Chang JW, George B, Chen S, et al
    Role of the angiotensin type 1 receptor in modulating the carotid chemoreflex in an ovine model of renovascular hypertension.
    J Hypertens. 2022;40:1421-1430.
    >> Share

  373. CAVAGNA P, Kramoh KE, Diop IB, Kouam Kouam C, et al
    Barriers to up-titrated antihypertensive strategies in 12 sub-Saharan African countries: the Multination Evaluation of hypertension in Sub-Saharan Africa Study.
    J Hypertens. 2022;40:1411-1420.
    >> Share

  374. KYRIAKOULIS KG, Ntineri A, Niiranen TJ, Lindroos A, et al
    Home blood pressure monitoring schedule: optimal and minimum based on 2122 individual participants' data.
    J Hypertens. 2022;40:1380-1387.
    >> Share

  375. AZUKAITIS K, Sinha MD, Obrycki L, Pac M, et al
    Disparities between determinants of impaired vascular structure and function in young people with primary hypertension: a systematic review.
    J Hypertens. 2022;40:1369-1379.
    >> Share

  376. AN H, Jin M, Li Z, Zhang L, et al
    Association of gestational hypertension and preeclampsia with nonsyndromic orofacial clefts in China: a large prospective cohort study.
    J Hypertens. 2022;40:1352-1358.
    >> Share

  377. TATSUMI Y, Satoh M, Asayama K, Murakami T, et al
    Association of home and office systolic and diastolic hypertension with glucose metabolism in a general population: the Ohasama study.
    J Hypertens. 2022;40:1336-1343.
    >> Share

  378. CHEDIER B, Roderjan CN, Cavalcanti AH, de Souza F, et al
    Prevalence and associated factors of obstructive sleep apnea in refractory hypertension.
    J Hypertens. 2022;40:1327-1335.
    >> Share

  379. ARIFEN N, Li Y, Srivastava AK, Anand-Srivastava MB, et al
    Sirtuin1 inhibitor attenuates hypertension in spontaneously hypertensive rats: role of Gialpha proteins and nitroxidative stress.
    J Hypertens. 2022;40:1314-1326.
    >> Share

  380. ANTZA C, Stabouli S, Kotsis V
    Practical guide for the management of hypertensive disorders during pregnancy.
    J Hypertens. 2022;40:1257-1264.
    >> Share

  381. KALAGARA R, Chennareddy S, Scaggiante J, Matsoukas S, et al
    Blood pressure management through application-based telehealth platforms: a systematic review and meta-analysis.
    J Hypertens. 2022;40:1249-1256.
    >> Share

    June 2022
  382. LIAO Y, Chu C, Wang Y, Zheng W, et al
    Isolated diastolic hypertension in childhood and risk of adult subclinical target organ damage: a 30-year prospective cohort study.
    J Hypertens. 2022 Jun 22. pii: 00004872-990000000-00010.
    >> Share

  383. OGGERO S, Godec T, van Gorp R, Pinto LA, et al
    Role of plasma extracellular vesicles in prediction of cardiovascular risk and alterations in response to statin therapy in hypertensive patients.
    J Hypertens. 2022 Jun 22. pii: 00004872-990000000-00012.
    >> Share

  384. STERGIOU GS, Mukkamala R, Avolio A, Kyriakoulis KG, et al
    Cuffless blood pressure measuring devices: review and statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability.
    J Hypertens. 2022 Jun 17. pii: 00004872-990000000-00007.
    >> Share

  385. POTHURU S, Chan WC, Ranka S, Acharya P, et al
    Epidemiology and outcomes of hypertensive crisis in patients with chronic kidney disease: a nationwide analysis.
    J Hypertens. 2022 Jun 13. pii: 00004872-990000000-00003.
    >> Share

  386. SMITH PJ, Andrew S, Hinderliter AL, Mabe S, et al
    Lifestyle modification and cognitive function among individuals with resistant hypertension: cognitive outcomes from the TRIUMPH trial.
    J Hypertens. 2022 Jun 13. pii: 00004872-990000000-00005.
    >> Share

  387. MARQUES-VIDAL P, Chekanova V, Vaucher J
    Association between genetic risk of high SBP and hypertension control: the CoLaus|PsyColaus study.
    J Hypertens. 2022 Jun 13. pii: 00004872-990000000-00002.
    >> Share

  388. BERILLO O, Huo KG, Richer C, Fraulob-Aquino JC, et al
    Distinct transcriptomic profile of small arteries of hypertensive patients with chronic kidney disease identified miR-338-3p targeting GPX3 and PTPRS.
    J Hypertens. 2022 Jun 13. pii: 00004872-990000000-00006.
    >> Share


  389. Impact of early glomerular filtration rate decline in response to antihypertensive treatment on risk of end-stage kidney disease and cardiovascular outcomes: a systematic review and meta-analysis: Erratum.
    J Hypertens. 2022;40:1248.
    >> Share

  390. RIETZ H, Pennlert J, Nordstrom P, Brunstrom M, et al
    Prevalence, time-trends and clinical characteristics of hypertension in young adults: nationwide cross-sectional study of 1.7 million Swedish 18-year-olds, 1969-2010.
    J Hypertens. 2022;40:1231-1238.
    >> Share

  391. SADANANTHAN SA, Michael N, Tint MT, Thirumurugan K, et al
    Associations of maternal periconceptional alcohol consumption with offspring prehypertension/hypertension at age 6 years: the Growing Up in Singapore Towards healthy Outcomes prospective mother-offspring cohort study.
    J Hypertens. 2022;40:1212-1222.
    >> Share

  392. FERMOYLE CC, Broxterman RM, La Salle DT, Ratchford SM, et al
    Persistent vascular dysfunction following an acute nonpharmacological reduction in blood pressure in hypertensive patients.
    J Hypertens. 2022;40:1115-1125.
    >> Share

  393. ABRAHIN O, Abrahin RP, de Sousa EC, Cortinhas-Alves EA, et al
    Inter-individual variations in response to aerobic and resistance training in hypertensive older adults.
    J Hypertens. 2022;40:1090-1098.
    >> Share

  394. ANTZA C, Farmakis I, Doundoulakis I, Akrivos E, et al
    Reproducibility of masked hypertension and office-based hypertension: a systematic review and meta-analysis.
    J Hypertens. 2022;40:1053-1059.
    >> Share

  395. ALIMENTO ML, Palermo P, Italiano G, Antonioli L, et al
    Can beta-blockers influence regular daily physical activity?
    J Hypertens. 2022;40:1199-1203.
    >> Share

  396. KOU C, Zhao X, Lin X, Fan X, et al
    Effect of different treatments for obstructive sleep apnoea on blood pressure.
    J Hypertens. 2022;40:1071-1084.
    >> Share

  397. GUTTERIDGE DS, Tully PJ, Ghezzi ES, Jamadar S, et al
    Blood pressure variability and structural brain changes: a systematic review.
    J Hypertens. 2022;40:1060-1070.
    >> Share

  398. AUNE A, Gerdts E, Kokorina M, Kringeland E, et al
    Persistent cardiac organ damage in surgically and medically treated primary aldosteronism.
    J Hypertens. 2022;40:1204-1211.
    >> Share

  399. BUFFOLO F, Burrello J, Burrello A, Heinrich D, et al
    DEVELOPMENT OF CLINICAL SCORING SYSTEM AND MACHINE LEARNING-BASED MODEL TO PREDICT DIAGNOSIS OF PRIMARY ALDOSTERONISM IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  400. ZHOU H, Wang X, Chen Z, Zhang L, et al
    EFFECT OF A WEB-BASED MANAGEMENT PLATFORM ON HYPERTENSION CONTROL IN COMMUNITY: A RANDOMIZED CLINICAL TRIAL.
    J Hypertens. 2022;40.
    >> Share

  401. UAGBOE AA, Ogboye A, Munee MM, Rahman KJ, et al
    LEVERAGING TECHNOLOGY TO SUPPORT PEOPLE LIVING WITH HYPERTENSION AND DIABETES DURING THE COVID-19 PANDEMIC.
    J Hypertens. 2022;40.
    >> Share

  402. LUQUE P, Castilla-Guerra L, Sanchez N, Delgado M, et al
    THE IMPACT OF HYPERTENSION AND ANTIHIPERTENSIVE TREATMENTS ON PATIENTS WITH SARS-COV-2: A RETROSPECTIVE-COHORT STUDY.
    J Hypertens. 2022;40.
    >> Share

  403. SHALAEVA E, Shamsutdinova M, Shadmanov A, Boymuradov S, et al
    COVID-19 AND NEW ONSET HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  404. WEBER T, Kreutz R, Januszewicz A, Mayer C, et al
    COVID-19 ASSOCIATED REDUCTION IN HYPERTENSION-RELATED DIAGNOSTIC AND THERAPEUTIC PROCEDURES IN EXCELLENCE CENTERS OF THE EUROPEAN SOCIETY OF HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  405. CANDUSSO G, Catena C, Soardo G, Baiano V, et al
    NON-INVASIVE BIOCHEMICAL SCORES OF NAFLD AND CAROTID MORPHOFUNCTIONAL ALTERATIONS IN NEVER TREATED ESSENTIAL HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  406. AZUKAITIS K, Rus R, Sagsak E, Jankauskiene A, et al
    SYSTOLIC AND DIASTOLIC LEFT VENTRICULAR DYSFUNCTION IN CHILDREN WITH PRIMARY HYPERTENSION: A SYSTEMATIC REVIEW.
    J Hypertens. 2022;40.
    >> Share

  407. MYETTE R, Obrycki L, Litwin M, Seeman T, et al
    THE PREVALENCE AND IMPACT OF ISOLATED DIASTOLIC HYPERTENSION IN CHILDREN.
    J Hypertens. 2022;40.
    >> Share

  408. SKRZYPCZYK P, Ofiara A, Szyszka M, Wabik A, et al
    CIRCADIAN BLOOD PRESSURE PROFILE IN PEDIATRIC PATIENTS WITH PRIMARY HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  409. SKRZYPCZYK P, Pawlik K, Bujanowicz A, Wroniewicz T, et al
    LIPID INDICES, ARTERIAL DAMAGE AND ALBUMINURIA IN PEDIATRIC PATIENTS WITH UNTREATED PRIMARY HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  410. SZYSZKA M, Skrzypczyk P, Ofiara A, Wabik A, et al
    COMMON CAROTID ARTERY ELASTICITY, INTIMA-DIAMETER RATIO, AND TENSILE STRESS IN PEDIATRIC PATIENTS WITH PRIMARY HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  411. ARNOLDI C, Capellini S, Zuccotti L, Paini A, et al
    RELATIONSHIP BETWEEN COGNITIVE IMPAIRMENT AND HYPERTENSION MEDIATED ORGAN DAMAGE: THE VOBARNO STUDY.
    J Hypertens. 2022;40.
    >> Share

  412. DE LA COLINA AN, Vasiliadis HM, Berbiche D, Bherer L, et al
    IMPACT OF SEX AND ANTIHYPERTENSIVE MEDICATION ON GLOBAL COGNITION IN PRIMARY CARE OLDER ADULTS.
    J Hypertens. 2022;40.
    >> Share

  413. SUKHAREVA A, Falkovskaya A, Baev AE, Mochula OV, et al
    MRI IN THE ASSESSMENT OF CEREBRAL INJURY AND CEREBROPROTECTIVE EFFECTS OF RENAL DENERVATION IN RESISTANT ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  414. TRIANTAFYLLOU G, Triantafyllou A, Dipla K, Zafeiridis A, et al
    ASSOCIATION OF CEREBRAL OXYGENATION DURING EXERCISE WITH TARGET ORGAN DAMAGE IN HYPERTENSIVE AND NORMOTENSIVE INDIVIDUALS.
    J Hypertens. 2022;40.
    >> Share

  415. LIAKOS C, Karpanou E, Markou M, Grassos C, et al
    SYNERGISTIC EFFECT OF HIGH HOMOCYSTEINE AND LOW VITAMIN B12 LEVELS ON CARDIOVASCULAR AND STROKE RISK OF HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  416. NGUYEN K, Abrahams N, Jewkes R, Mhlongo S, et al
    EXPOSURES TO INTIMATE PARTNER VIOLENCE AND NON-PARTNER SEXUAL VIOLENCE ARE ASSOCIATED WITH HYPERTENSION IN SOUTH AFRICAN WOMEN.
    J Hypertens. 2022;40.
    >> Share

  417. PALATINI P, Mos L, Rattazzi M, Vriz O, et al
    ORTHOSTATIC HYPERREACTIVITY AND THE CARDIOVASCULAR RISK IN JUVENILE AND MIDDLE-AGE HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  418. THEODORAKOPOULOU M, Iatridi F, Alexandrou ME, Karpetas A, et al
    THE INFLUENCE OF AMBULATORY BLOOD PRESSURE ON THE ASSOCIATIONS OF INTRADIALYTIC HYPERTENSION WITH FUTURE CARDIOVASCULAR EVENTS AND MORTALITY IN HEMODIALYSIS PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  419. KHOMOVA I, Khramkova A, Shavarova E, Ezhova N, et al
    ASSOCIATIONS BETWEEN EPICARDIAL FAT AND LEFT VENTRICULAR GEOMETRY IN YOUNG NON-OBESE HYPERTENSIVES.
    J Hypertens. 2022;40.
    >> Share

  420. NARITA K, Hoshide S, Kario K
    SIMPLE PREDICTIVE SCORE FOR NOCTURNAL HYPERTENSION AND MASKED NOCTURNAL HYPERTENSION USING HOME BLOOD PRESSURE MONITORING IN CLINICAL PRACTICE.
    J Hypertens. 2022;40.
    >> Share

  421. QUARTI-TREVANO F, Seravalle G, Dell'Oro R, Facchetti R, et al
    ANTIHYPERTENSIVE DRUG TREATMENT IN WHITE-COAT HYPERTENSION: DATA FROM THE PLAQUE HYPERTENSION LIPID-LOWERING ITALIAN STUDY (PHYLLIS).
    J Hypertens. 2022;40.
    >> Share

  422. RATTAZZI M, Saladini F, Mos L, Fania C, et al
    BLOOD PRESSURE RESPONSE TO STANDING IS A STRONG PREDICTOR OF MASKED HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  423. SERAVALLE G, Facchetti R, Vanoli J, Dell'oro R, et al
    WHITE-COAT HYPERTENSION WITHOUT ORGAN DAMAGE: IMPACT OF LONG-TERM MORTALITY, NEW HYPERTENSION AND NEW ORGAN DAMAGE.
    J Hypertens. 2022;40.
    >> Share

  424. CONSTANTINOS K, Stevens R, Hobbs FDR, McManus RJ, et al
    PREDICTING THE RISK OF SYNCOPE IN PATIENTS WITH AN INDICATION FOR ANTIHYPERTENSIVE TREATMENT: DEVELOPMENT OF THE STRATIFY-SYNCOPE PREDICTION MODEL.
    J Hypertens. 2022;40.
    >> Share

  425. NADERI H, Ramirez J, Van Duijvenboden S, Aung N, et al
    PREDICTING THE PATTERN OF ANATOMICAL LEFT VENTRICULAR HYPERTROPHY USING ELECTROPHYSIOLOGICAL BIOMARKERS FROM THE ECG QRS COMPLEX IN HYPERTENSIVE INDIVIDUALS FROM UK BIOBANK.
    J Hypertens. 2022;40.
    >> Share

  426. KJELDSEN SE, Zachs ES, Stokke IM, Wachtell K, et al
    TIME-VARYING SERUM URIC ACID PREDICTS NEW-ONSET ATRIAL FIBRILLATION IN TREATED HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  427. BOGAERTS J, Gussekloo J, De Jong-Schmit B, Achterberg W, et al
    THE DANTON STUDY - DISCONTINUATION OF ANTIHYPERTENSIVE TREATMENT IN OLDER PEOPLE WITH DEMENTIA LIVING IN A NURSING HOME: RESULTS OF A RANDOMIZED CONTROLLED TRIAL.
    J Hypertens. 2022;40.
    >> Share

  428. RANCEVIENE D, Azukaite J, Rysevaite-Kyguoliene K, Pauziene N, et al
    IMPACT OF ARTERIAL HYPERTENSION VERSUS AGING TO THE STRUCTURES OF EPICARDIAC NERVES IN SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2022;40.
    >> Share

  429. MENDEZ I, Saiz LC, Leache L, Gutierrez M, et al
    BLOOD PRESSURE TARGETS AND MORTALITY IN HYPERTENSIVE PATIENTS WITH CHRONIC RENAL DISEASE. SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2022;40.
    >> Share

  430. BERGLUND J, Wijkman MO, Nilsson S
    HIGHER PREVALENCE OF MASKED UNCONTROLLED HYPERTENSION WITH NEW EUROPEAN BLOOD PRESSURE TARGETS IN AN ELDERLY PRIMARY CARE POPULATION.
    J Hypertens. 2022;40.
    >> Share

  431. BURTSEV Y, Boytsov S, Karpov Y, Khomitskaya Y, et al
    EFFECTIVENESS AND TOLERABILITY OF BISOPROLOL/PERINDOPRIL SINGLE-PILL COMBINATION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE AND CONCOMITANT HYPERTENSION WHO HAD A HISTORY OF MIOCARDIAL INFARCTION.
    J Hypertens. 2022;40.
    >> Share

  432. GRECA E, Wireko AA, Abdul-Rahman T, Kacimi SEO, et al
    ANTI-INFLAMMATORY EFFECTS AND PPAR GAMMA-ACTIVATING PROPERTIES OF TELMISARTAN IN PATIENTS WITH THE HYPERTENSION'S ON METABOLIC SYNDROME: METANALYSIS OF RCT.
    J Hypertens. 2022;40.
    >> Share

  433. KOVAL S, Penkova M, Mysnychenko O, Reznik L, et al
    AMBULATORY BLOOD PRESSURE MONITORING PARAMETERS IN HYPERTENSIVE PATIENTS WITH ABDOMINAL OBESITY IN THE DYNAMICS OF OLMESARTAN/ AMLODIPINE THERAPY.
    J Hypertens. 2022;40.
    >> Share

  434. LEITE V, Abecasis F, Beirao P, Cunha V, et al
    INTENSIVE SYSTOLIC BLOOD PRESSURE TARGET IN OLDER HYPERTENSIVE PATIENTS - IS IT BENEFICIAL?
    J Hypertens. 2022;40.
    >> Share

  435. PEI Y, Yu J
    EFFECT OF SACUBITRIL-VALSARTAN ON EARLY RENAL FUNCTION AND VASCULAR FUNCTION IN PATIENTS DURING PERIMENOPAUSE WITH HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  436. BARRAGAN ACP, Leiva VG, Espejel LD
    REACHING OF THERAPEUTICS GOALS IN PATIENTS WITH HYPERTENSION AND DIABETES MELLITUS. DO MULTIPLE THERAPY WORKS?
    J Hypertens. 2022;40.
    >> Share

  437. ZBYSHEVSKAYA E, Makeeva T, Gumerova V, Erinchek V, et al
    VASCULAR STIFFNESS AS AN TARGET OF OPTIMAL ANTIHYPERTENSIVE THERAPY.
    J Hypertens. 2022;40.
    >> Share

  438. ZHUANG C, Wang W, Sun R, Qi M, et al
    SACUBITRIL/VALSARTAN IMPROVES SEXUAL FUNCTION AND FIBROSIS OF THE CLITORAL AND VAGINAL TISSUES IN FEMALE SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2022;40.
    >> Share

  439. AJOSE A, Odukoya OO, Akodu B
    PERCEIVED STRESS, DEPRESSION AND MEDICATION ADHERENCE AMONG HYPERTENSIVE PATIENTS ATTENDING A SECONDARY CARE HOSPITAL IN LAGOS, NIGERIA.
    J Hypertens. 2022;40.
    >> Share

  440. JUG J, Prkacin I
    ADHERENCE TO THE ANTIHYPERTENSIVE THERAPY - A VIEW FROM THE FAMILY MEDICINE PERSPECTIVE.
    J Hypertens. 2022;40.
    >> Share

  441. PAPPACCOGLI M, Georges CM, Petit G, Ritscher S, et al
    DRUG ADHERENCE AND PSYCHOLOGICAL FACTORS MATTER IN PATIENTS WITH RESISTANT HYPERTENSION - YES BUT WHICH ONES?
    J Hypertens. 2022;40.
    >> Share

  442. BUFFOLO F, Sconfienza E, Burrello J, Losano I, et al
    ESTIMATE OF ANTI-HYPERTENSIVE DRUG ADHERENCE THROUGH SERIAL MEASUREMENTS OF ALDOSTERONE-TO-RENIN RATIO.
    J Hypertens. 2022;40.
    >> Share

  443. COELHO J, Guimaraes M, Dos Santos J, Vaz A, et al
    ADHERENCE TO ANTIHYPERTENSIVE DRUG TREATMENT IN BRAZIL: SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2022;40.
    >> Share

  444. HALVORSEN LV, Gognstad S, Soraas CL, Agnes C, et al
    IMPLICATIONS OF CYP2D6 POLYMORPHISMS FOR THERAPEUTIC DRUG MONITORING IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  445. LEE EK, Poon P, Bo Y, Zhu MT, et al
    GLOBAL BURDEN, REGIONAL DIFFERENCES, TRENDS, AND HEALTH CONSEQUENCES OF MEDICATION NON-ADHERENCE IN PATIENTS WITH HYPERTENSION DURING 2010-2020: A SYSTEMATIC REVIEW AND META-ANALYS.
    J Hypertens. 2022;40.
    >> Share

  446. LEITE V, Coelho RP, Abecasis F, Beirao P, et al
    HYPERTENSIVE CRISIS AT THE EMERGENCY DEPARTMENT OF A CENTRAL HOSPITAL.
    J Hypertens. 2022;40.
    >> Share

  447. LOPES S, Diniz F, Oliveira J, Mesquita-Bastos J, et al
    RESISTANT HYPERTENSION PATIENTS' PERSPECTIVES ABOUT AN AEROBIC EXERCISE PROGRAM: INSIGHTS FROM THE ENRICH TRIAL.
    J Hypertens. 2022;40.
    >> Share

  448. MONTEALEGRE L, Navarro G, Amador E, Arteta M, et al
    BELIEFS IN HEALTH AND ADHERENCE TO TREATMENT IN HYPERTENSIVE PATIENTS IN BARRANQUILLA- COLOMBIA.
    J Hypertens. 2022;40.
    >> Share

  449. MONTEALEGRE L, Amador E, Pulido T, Cabrera C, et al
    MAIN FACTORS THAT DETERMINE ADHERENCE TO PHARMACOLOGICAL TREATMENT IN HYPERTENSIVE PATIENTS. SYSTEMATIC REVIEW.
    J Hypertens. 2022;40.
    >> Share

  450. OLIVERAS A, Galceran I, Camps C, Faura A, et al
    MEDICATION NON-ADHERENCE IN UNCONTROLLED HYPERTENSION: SELECTIVE DETECTION AND EFFICIENCY AND EFFECTIVENESS OF A PROGRAM TO IMPROVE COMPLIANCE (ATHAN TRIAL).
    J Hypertens. 2022;40.
    >> Share

  451. PEETERS L, Kappers MHW, Hesselink DA, Net JBV, et al
    RESISTANT HYPERTENSION IMPROVED AFTER 3 AND 6 MONTHS BY MEASURING DRUG LEVELS TO IDENTIFY NON-ADHERENCE.
    J Hypertens. 2022;40.
    >> Share

  452. RENNA N, Diez E, Vissani S, Farez B, et al
    ASSESSMENT OF ADHERENCE TO ANTIHYPERTENSIVE MEDICATION IN A POPULATION OF ARGENTINA DURING THE COVID-19 PANDEMIC.
    J Hypertens. 2022;40.
    >> Share

  453. RIETZSCHEL E, Descamps O, De Sutter J, Philips JC, et al
    ATHERO: AN OBSERVATIONAL CROSS-SECTIONAL EVALUATION OF ATHEROSCLEROTIC RISK CONTROL IN THE BELGIAN POPULATION TREATED WITH AT LEAST ONE ANTIHYPERTENSIVE AND ONE LIPID-LOWERING DRUG.
    J Hypertens. 2022;40.
    >> Share

  454. POLACZYK M, Olszanecka A, Wojciechowska W, Rajzer M, et al
    MULTIPLE DRUG INTOLERANCE IN PATIENTS WITH ARTERIAL HYPERTENSION: PREVALENCE AND DETERMINING FACTORS.
    J Hypertens. 2022;40.
    >> Share

  455. TARNOVSKI L, Frkanec S, Frkanec S, Katic L, et al
    THE PHARMACISTS' AND MOBILE APPLICATIONS' ROLE IN THE TREATMENT OF HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  456. FRAGOULIS C, Prentakis AG, Kontogianni E, Polyzos D, et al
    DEPENDENCY RELATIONSHIP OF EXERCISE AND MEDICATION ADHERENCE IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  457. YOUSSEF G, Mohamed M, Remisy DE, Hamid MA, et al
    REASONS OF NON-COMPLIANCE TO OFFICE VISITS IN HYPERTENSIVE PATIENTS: RESULTS FROM THE REGISTRY OF SPECIALIZED HYPERTENSION CLINICS.
    J Hypertens. 2022;40.
    >> Share

  458. HUANG JF, Zhang DY, An DW, Li MX, et al
    ANTIHYPERTENSIVE TREATMENT IN MASKED HYPERTENSION FOR TARGET ORGAN PROTECTION (ANTI-MASK): A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL.
    J Hypertens. 2022;40.
    >> Share

  459. BAGADIA L
    A RANDOMIZED CONTROLLED TRIAL OF INDIVIDUALIZED HOMOEOPATHIC TREATMENT TO REDUCE ANGER & THEREBY REDUCING HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  460. FILHO GG, Inuzuka S, Vitorino P, Sousa ALL, et al
    PHARMACOLOGICAL TREATMENT OF ARTERIAL HYPERTENSION GUIDED BY PERIPHERAL OR CENTRAL BLOOD PRESSURE: COMPARISON OF THE TWO STRATEGIES IN THE INCIDENCE OF INTERMEDIATE OUTCOMES.
    J Hypertens. 2022;40.
    >> Share

  461. KONRADI A, Hassan H, Lefay D, Isachenko E, et al
    CLINICAL EFFICACY AND SAFETY OF AMLODIPINE/BISOPROLOL/PERINDOPRIL SINGLE-PILL AND FREE COMBINATION THERAPY IN PATIENTS WITH UNCONTROLLED ESSENTIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  462. JARAI Z, Amon T, Baracsi-Botos V, Meszaros A, et al
    TELMISARTAN/AMLODIPINE SINGLE-PILL COMBINATION THERAPY TO ACHIEVE BLOOD PRESSURE GOAL VALUES IN HYPERTENSIVE PATIENTS IN GPS' PRACTICE - AN OBSERVATIONAL STUDY.
    J Hypertens. 2022;40.
    >> Share

  463. KAM E, Lee P, Poon P, Yu CP, et al
    CONTROLLED-RELEASED ORAL MELATONIN SUPPLEMENTATION FOR HYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2022;40.
    >> Share

  464. GUO Q, Lin J, Peng F, Chai D, et al
    CARDIOVASCULAR OUTCOMES OF INITIAL BETA-BLOCKER + CALCIUM CHANNEL BLOCKER THERAPY VS OTHER DUAL THERAPIES IN CHINESE PATIENTS WITH NEWLY DIAGNOSED HYPERTENSION: A REAL-WORLD STUDY.
    J Hypertens. 2022;40.
    >> Share

  465. LOPES S, Mesquita-Bastos J, Garcia C, Oliveira J, et al
    ACUTE AEROBIC EXERCISE-INDUCED DECREASE IN BLOOD PRESSURE IS ASSOCIATED WITH CHRONIC BLOOD PRESSURE CHANGES IN PATIENTS WITH RESISTANT HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  466. MIKHAILOVA O, Elfimova E, Khachatryan N, Litvin A, et al
    PRESCRIBED ANTIHYPERTENSIVE AGENTS IN PATIENTS WITH AND WITHOUT ITS "ESCAPE'' PHENOMENON.
    J Hypertens. 2022;40.
    >> Share

  467. MOURAD JJ, Jamet P, Huguet M, Loubiere M, et al
    TRIPLE ANTIHYPERTENSIVE THERAPY TYPE AND USE IN FRENCH GENERAL PRACTICE AND CARDIOLOGY IN 2021.
    J Hypertens. 2022;40.
    >> Share

  468. RADCHENKO G, Sirenko Y, Torbas O
    THE OPEN-LABEL MULTICENTRAL STUDY OF ANTIHYPERTENSIVE FIXED-DOSE COMBINATION EFFECTIVENESS IN UKRAINE.
    J Hypertens. 2022;40.
    >> Share

  469. SHEPPARD J, Koshiaris C, Stevens R, McManus R, et al
    THE ASSOCIATION BETWEEN ANTIHYPERTENSIVE TREATMENT AND SERIOUS ADVERSE EVENTS BY AGE AND FRAILTY: AN OBSERVATIONAL COHORT STUDY OF 3.8 MILLION PATIENTS FOLLOWED UP FOR 10 YEARS.
    J Hypertens. 2022;40.
    >> Share

  470. SHUPENINA E, Vasyuk Y, Namazova G
    OBSERVATIONAL PROSPECTIVE STUDY OF AZILSARTAN MEDOXOMIL/ CHLORTALIDONE COMPARED WITH IRBESARTAN/ HYDROCHLOROTHIAZIDE COMBINATION THERAPY IN OBESE HYPERTENSIVES (PUZZLE).
    J Hypertens. 2022;40.
    >> Share

  471. FRAGOULIS C, Polyzos D, Konstantinidis D, Mavroudis A, et al
    GENDER AS A RISK FACTOR FOR CARDIOVASCULAR EVENTS IN PATIENTS WITH HYPERTENSIVE CRISES AFTER 12-MONTH FOLLOW-UP: A GREEK REGISTRY.
    J Hypertens. 2022;40.
    >> Share

  472. KOUREMETI M, Iliakis P, Konstantinidis D, Polyzos D, et al
    EPLERENONE VS IRBESARTAN AS FIRST LINE THERAPY IN OBESE HYPERTENSIVE PATIENTS: PRELIMINARY RESULTS FROM HEBRO STUDY.
    J Hypertens. 2022;40.
    >> Share

  473. YU X, Xu R
    DAPAGLIFLOZIN'S EFFECT ON SERUM HOMOCYSTEINE IN PATIENTS WITH HYPERTENSION COMPLIACTED WITH INSULIN RESISTANCE.
    J Hypertens. 2022;40.
    >> Share

  474. BOULESTREAU R, Tillement J, Lucas L, Cremer A, et al
    IS HEADACHE AT ADMISSION ASSOCIATED WITH HIGHER RATE OF RECENT BRAIN MRI INJURY DURING MALIGNANT HYPERTENSION CRISIS?
    J Hypertens. 2022;40.
    >> Share

  475. LUIS CG, Linero PL, Moreno MDCF, Fito MS, et al
    TRENDS IN ANTIHYPERTENSIVE MEDICATION USE AFTER ISCHEMIC STROKE (1999-2020).
    J Hypertens. 2022;40.
    >> Share

  476. PINTO D, Rato ND, Garcia C, Teixeira M, et al
    ADHERENCE TO PHYSICAL ACTIVITY IN OLDER ADULTS WITH HYPERTENSION: LESSONS FROM THE HOLDAGE RANDOMIZED CONTROLLED TRIAL.
    J Hypertens. 2022;40.
    >> Share

  477. NUNEZ URQUIZA JP, Marti A, Cervantes N, Reza APS, et al
    EVALUATION OF BLOOD PRESSURE CONTROL AND THE EFFECTIVENESS OF DIFFERENT ANTIHYPERTENSIVES BY MEANS OF THE STRESS TEST.
    J Hypertens. 2022;40.
    >> Share

  478. SENER YZ, Durukan BN, Ozcan EB, Kutukcu EC, et al
    EFFECTS OF LEFT VENTRICULAR MASS INDEX AND LEFT VENTRICULAR GEOMETRY ON 6 MINUTE STEPPER TEST RESULTS IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  479. NEMER CB, Chedier B, de Hollanda Cavalcanti A, Nejm Roderjan C, et al
    IMPACT OF LONG-TERM USE OF CPAP TREATMENT ON BLOOD PRESSURE AMONG REFRACTORY HYPERTENSIVE PATIENTS WITH OBSTRUCTIVE SLEEP APNEA.
    J Hypertens. 2022;40.
    >> Share

  480. RODERJAN CN, de Souza F, Chedier B, de Hollanda Cavalcanti A, et al
    EFFECT OF LONG-TERM USE OF CONTINUOUS POSITIVE AIRWAY PRESSURE TREATMENT ON ARTERIAL STIFFNESS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA AND RESISTANT HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  481. DENISOVA A, Solntseva T, Sivakova O, Chazova I, et al
    FACTORS ASSOCIATED WITH AN INCREASED RISK OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  482. FERRAO D, Silva C, Matos M, Ferreira S, et al
    VASCULITIS AND RENOVASCULAR HYPERTENSION - A CASE REPORT.
    J Hypertens. 2022;40.
    >> Share

  483. VARETA G, Georgianos P, Vaios V, Sgouropoulou V, et al
    PREVALENCE OF APPARENT-TREATMENT RESISTANT HYPERTENSION IN PERITONEAL DIALYSIS PATIENTS ASSESSED WITH THE USE OF 24-HOUR AMBULATORY BLOOD PRESSURE MONITORING.
    J Hypertens. 2022;40.
    >> Share

  484. IONOV M, Emelyanov I, Vakhrushev A, Alieva A, et al
    RADIOFREQUENCY RENAL SYMPATHETIC DENERVATION WITH MULTIELECTRODE CATHETERS IN PATIENTS WITH RESISTANT HYPERTENSION: EARLY PROCEDURAL RESULTS.
    J Hypertens. 2022;40.
    >> Share

  485. KVAPIL T, Vaclavik J, Kocianova E, Benesova K, et al
    SHOULD ALL SECONDARY CAUSES OF HYPERTENSION BE SCREENED IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION?
    J Hypertens. 2022;40.
    >> Share

  486. MANUKYAN M, Falkovskaya A, Mordovin V, Zyubanova I, et al
    A CLINICAL CASE OF SECONDARY HYPERTENSION IN A 20-YEAR-OLD FEMALE WITH COARCTATION OF THE AORTA.
    J Hypertens. 2022;40.
    >> Share

  487. MANUKYAN M, Falkovskaya A, Mordovin V, Zyubanova I, et al
    SYSTEMIC VASCULAR RESISTANCE AS A PREDICTOR OF ANTIHYPERTENSIVE EFFICIENCY OF RENAL DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUS.
    J Hypertens. 2022;40.
    >> Share

  488. MATOVA O, Mishchenko L, Talaeva T
    CARDIOVASCULAR AND KIDNEY OUTCOMES IN TREATED RESISTANT HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  489. DE CARVALHO FORTES C, Chedier B, Roderjan CN, Viegas B, et al
    CHANGES IN CLINICAL PROFILE OF REFRACTORY HYPERTENSIVES AFTER THE INTRODUCTION OF SPIRONOLACTONE.
    J Hypertens. 2022;40.
    >> Share

  490. CHEDIER B, Souza F, Viegas B, Carlos FOC, et al
    PROGNOSTIC OF PATIENTS WITH REFRACTORY HYPERTENSION IN A COHORT OF RESISTANT HYPERTENSIVES.
    J Hypertens. 2022;40.
    >> Share

  491. RAMIK Z, Vaclavik J, Kvapil T, Jelinek L, et al
    LONG TERM EFFECT OF RESISTANT ARTERIAL HYPERTENSION ON RENAL FUNCTION IN COMPARISON TO NON-RESISTANT ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  492. SHALIMOVA A, Isayeva G, Buriakovska O, Vovchenko M, et al
    DISTURBANCES OF THE CIRCADIAN RHYTHM AND BLOOD PRESSURE LEVELS IN OBESE PATIENTS WITH TRUE AND PSEUDO-RESISTANT HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  493. SOLNTSEVA T, Denisova A, Sivakova O, Chazova I, et al
    STATE OF TARGET ORGANS DAMAGE AND PREVALENCE OF CLINICAL ASSOCIATED CONDITIONS IN PATIENTS WITH A HYPERTENSIVE CRISIS AND UNCONTROLLED HYPERTENSION. (PILOT STUDY).
    J Hypertens. 2022;40.
    >> Share

  494. SUKHAREVA A, Falkovskaya A, Baev AE, Mochula OV, et al
    MRI POTENTIAL FOR PREDICTION OF THE ANTIHYPERTENSIVE EFFECT OF RFA IN PATIENTS WITH TREATMENT-RESISTANT HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  495. TABBALAT R, Al-Hayek T, Al Ani H, Barghouthi H, et al
    PRIMARY ALDOSTERONISM: INITIAL EXPERIENCE FROM A NEWLY ESTABLISHED ESH HYPERTENSION CENTER OF EXCELLENCE - WORK IN PROGRESS.
    J Hypertens. 2022;40.
    >> Share

  496. KUZIOR A, Hernandez-Lazaro A, De Leon-Durango R, Rios-Gomez C, et al
    EXTREMELY HIGH DIRECT PLASMA RENIN IN A YOUNG WOMAN WITH NEGATIVE IMAGING FOR RENOVASCULAR HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  497. BOSCH A, Poglitsch M, Kannenkeril D, Ott C, et al
    ANGIOTENSIN PROFILES IN PATIENTS WITH HYPERTENSION AND TYPE 2 DIABETES WITH COMBINATION THERAPY OF EMPAGLIFLOZIN AND LINAGLIPTIN VERSUS METFORMIN AND INSULIN GLARGINE.
    J Hypertens. 2022;40.
    >> Share

  498. BOULESTREAU R, Lorthioir A, Persu A, Cremer A, et al
    MALIGNANT HYPERTENSION HAMA COHORT: WHERE DO WE STAND IN 2021?
    J Hypertens. 2022;40.
    >> Share

  499. VISCHER A, Socrates T, Glinz D, Mayr M, et al
    ASSOCIATION OF BASELINE ALDOSTERONE/RENIN WITH MAGNITUDE OF BLOOD PRESSURE REDUCTION FROM FIRST-LINE TREATMENT IN TREATMENT-NAIVE HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  500. BEKBERGENOVA Z, Derbissalina G, Umbetzhanova A, Batarbekova S, et al
    EVALUATION OF THE QUALITY OF SCREENING FOR HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  501. BEKBERGENOVA Z, Derbissalina G, Umbetzhanova A, Batarbekova S, et al
    INFLUENCE OF FACTORS ON SYSTOLIC BLOOD PRESSURE IN PATIENTS WITH HYPERTENSION IDENTIFIED DURING SCREENING.
    J Hypertens. 2022;40.
    >> Share

  502. BEKBERGENOVA Z, Derbissalina G, Umbetzhanova A, Batarbekova S, et al
    THE INFLUENCE OF HEREDITY ON LIFESTYLE CHANGES AND PARTICIPATION IN SCHOOL OF CHRONIC PATIENTS IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  503. HUMBERT X, Rabiaza A
    PRESCRIPTIONS OF ANTIHYPERTENSIVE DRUGS ARE INFLUENCED BY THE CHARACTERISTICS OF GENERAL PRACTITIONERS AND THEIR PATIENTS: A CROSS-SECTIONAL STUDY IN NORMANDY (FRANCE).
    J Hypertens. 2022;40.
    >> Share

  504. JUG J, Lang VB, Prkacin I
    ARTERIAL STIFFNESS IN PATIENTS WITH HYPERTENSIVE CRISIS.
    J Hypertens. 2022;40.
    >> Share

  505. MOURAD JJ, Jamet P, Huguet M, Suhl J, et al
    ANTIHYPERTENSIVE TREATMENT INITIATION IN FRANCE: WHAT DID GENERAL PRACTITIONERS PRESCRIBE IN 2021?
    J Hypertens. 2022;40.
    >> Share

  506. GUIMIL PD, Herranz ED, Gonzalez ER, Testillano LM, et al
    WOMEN WITH HYPERTENSIVE STATES OF PREGNANCY FOLLOW IN NEPHROLOGY: CHARACTERISTICS AND EVOLUTION AFTER DELIVERY.
    J Hypertens. 2022;40.
    >> Share

  507. SOCRATES T, Wenker C, Blaschke C, Vischer A, et al
    FEASIBILITY, ACCEPTANCE AND SAFETY OF A HOME BASED TELEMONITORING STRATEGY IN WOMEN WITH POSTPARTUM HYPERTENSION. INTERIM ANALYSIS OF THE SWISS REGISTER FOR WOMEN WITH PPHT.
    J Hypertens. 2022;40.
    >> Share

  508. DA SILVA IV, Santos AC, Matos A, Ferreira J, et al
    AQUAPORIN-3 AND HEPARANASE GENETIC POLYMORPHISMS MAY MODULATE ANGIOGENESIS INFLUENCING THE RISK OF HYPERTENSIVE DISORDERS IN WOMEN.
    J Hypertens. 2022;40.
    >> Share

  509. STIRBAN R, Dragoi D, Grigore C, Balaceanu B, et al
    IT IS SOMETHING MAKING THE DIFFERENCE BETWEEN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME VERSUS HYPERTENSIVE PATIENTS WITHOUT METABOLIC SYNDROME IN SARS-COV-2 INFECTION?
    J Hypertens. 2022;40.
    >> Share

  510. CANTU SM, Lee HJ, Mikusic NLR, Kouyoumdzian NM, et al
    ALTERATION OF RENAL DOPAMINERGIC SYSTEM IN RATS FED WITH HIGH FAT DIET: A POSSIBLE MECHANISM PROMOTING ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  511. GASPAR L, Mesarosova D
    PECULIARITIES OF TREATMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH METABOLIC SYNDROME.
    J Hypertens. 2022;40.
    >> Share

  512. KOKAEVA I, Zhernakova Y, Blinova N, Elfimova E, et al
    ENDOTHELIAL COMPLICATIONS IN HYPERTENSIVE PATIENTS WITH OBESITY OR NORMAL BODY WEIGHT AFTER COVID-19.
    J Hypertens. 2022;40.
    >> Share

  513. KOVAL S, Snihurska I, Yushko K
    CHANGES IN THE COMPOSITION OF THE GUT MICROBIOTA IN THE OBESE HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  514. MASTROGIANNIS K, Lazaridis A, Triantafillou A, Koletsos N, et al
    CORRELATION OF COGNITIVE STATUS WITH IMPAIRED SKIN MICROVASCULAR REACTIVITY IN NEWLY DIAGNOSED UNTREATED HYPERTENSIVES.
    J Hypertens. 2022;40.
    >> Share

  515. ZAMMANIS I, Konstantinidis D, Tatakis F, Drogkaris S, et al
    THE ROLE OF MICROCIRCULATION ON BLOOD PRESSURE AND HEART RATE RESPONSE DURING EXERCISE STRESS TESTING IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  516. YAROVOY S, Chazova I, Danilov N, Matchin Y, et al
    POSITIVE PULMONARY ARTERY REMODELING AFTER A SERIES OF BALLOON PULMONARY ANGIOPLASTIES IN A PATIENT WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  517. PINTO D, Rato ND, Garcia C, Teixeira M, et al
    EFFECTS OF HOME-BASED ISOMETRIC HANDGRIP OR AEROBIC EXERCISE TRAINING IN OLDER ADULTS WITH PRE-HYPERTENSION AND HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  518. MANTA E, Thomopoulos C, Konstantinidis D, Tatakis F, et al
    EFFECT OF DIETARY APPROACHES TO STOP HYPERTENSION DIET OR MEDITERRANEAN DIET ON BLOOD PRESSURE IN INDIVIDUALS WITH OR WITHOUT HYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2022;40.
    >> Share

  519. PRATISTITA PTP, Marbun MB
    THE ROLE OF DIETARY APPROACHES TO STOP HYPERTENSION (DASH DIET) ON BLOOD PRESSURE IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  520. SPRONCK B, Caulk AW, Ramachandra AB, Murtada SI, et al
    DIFFERENTIAL AORTIC REMODELING EFFECTS OF NOREPINEPHRINE- AND ANGIOTENSIN II-INDUCED HYPERTENSION IN MICE.
    J Hypertens. 2022;40.
    >> Share

  521. MCDERMOTT EA, Mensah EA, Fantin F, Okorie M, et al
    WHITE-COAT HYPERTENSION: SIZE OF THE WHITE-COAT EFFECT IS STRONGLY ASSOCIATED WITH CENTRAL ARTERIAL STIFFNESS.
    J Hypertens. 2022;40.
    >> Share

  522. REKOVETS O, Sirenko Y, Torbas O, Kushnir S, et al
    DINAMICS OF ARTERIAL STIFFNESS USING CAVI INDEX DEPENDS ON ADDED STATIN TO FIXED COMBINATION ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  523. SALADINI F, Rattazzi M, Faggin E, Palatini P, et al
    CAROTID ELASTICITY IS IMPAIRED IN STAGE 1 HYPERTENSIVE PATIENTS EVEN IF BLOOD PRESSURE IS WELL CONTROLLED BY TREATMENT.
    J Hypertens. 2022;40.
    >> Share

  524. THEODORAKOPOULOU M, Alexandrou ME, Iatridi F, Faitatzidou D, et al
    COMPARISON OF AMBULATORY CENTRAL HEMODYNAMICS AND ARTERIAL STIFFNESS IN HEMODIALYSIS PATIENTS WITH AND WITHOUT INTRADIALYTIC HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  525. JAQUES DA, Vollenweider P, Bochud M, Ponte B, et al
    AGING AND HYPERTENSION IN KIDNEY FUNCTION DECLINE: A 10-YEAR POPULATION-BASED STUDY.
    J Hypertens. 2022;40.
    >> Share

  526. MAHMOUD NB, Hamouda M, Maatoug J, Salem MB, et al
    HYPERTENSION AS A RISK FACTOR FOR MORTALITY AND THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE AFTER AN EPISODE OF ACUTE KIDNEY INJURY WITH FULL RECOVERY.
    J Hypertens. 2022;40.
    >> Share

  527. BEZRODNA L, Mishchenko L, Serbenjuk K, Matova O, et al
    EARLY MARKERS OF THE KIDNEYS DAMAGE IN PATIENTS WITH RESISTANT HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  528. DE LEEUW PW, Houben AJ, Kroon AA
    RENAL EXTRACTION EFFICIENCY FOR PAH IS COMPARABLE IN ESSENTIAL HYPERTENSION AND RENAL FIBROMUSCULAR DYSPLASIA.
    J Hypertens. 2022;40.
    >> Share

  529. HENDRIKS-BALK M, Damianaki A, Polychronopoulou E, Brito W, et al
    RENAL MICROPERFUSION RESPONSE TO A COLD PRESSURE TEST IS DECREASED IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  530. KNEZEVIC T, Padjen I, Laganovic M, Ivkovic V, et al
    TRAJECTORIES OF BLOOD PRESSURE, TREATMENT PATTERNS AND HYPERTENSION CONTROL IN PATIENTS WITH LUPUS NEPHRITIS - DATA FROM A RETROSPECTIVE COHORT STUDY.
    J Hypertens. 2022;40.
    >> Share

  531. LEIBA A, Rappoport V, Hausmann M
    ACUTE RENAL FAILURE PROGRESSING TO ESRD IN A PATIENT WITH UNTREATED HIGH GRADE HYPERTENSION - THE MALIGNANT NATURE OF "BENIGN'' NEPHROSCLEROSIS.
    J Hypertens. 2022;40.
    >> Share

  532. MARTINEZ-ARROYO O, Ortega A, Solaz E, Martinez F, et al
    DECREASED URINARY LEVELS OF SIRT1 AS NON-INVASIVE BIOMARKER OF EARLY RENAL DAMAGE IN HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  533. SCHASTLIVENKO A, Vykhrystenka L
    HIGH INCIDENCE OF CHRONIC KIDNEY DISEASE IN THE BELARUSIAN POPULATION PARTICULARLY IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  534. DZHURYAK V, Sydorchuk A, Voroniuk K, Sydorchuk L, et al
    ALDOSTERONE SYNTHASE CYP11B2 (-344C/T) GENE POLYMORPHISM INFLUENCES RISK OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  535. TAKENAKA T
    CENTRAL AND BRACHIAL PULSE PRESSURE PREDICTS CARDIOVASCULAR AND RENAL EVENTS IN TREATED HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  536. ANNA M, Alexandru C, Marcel A, Nicolae C, et al
    THE EFFECT OF RENAL DENERVATION ON THE CIRCADIAN BLOOD PRESSURE PATTERN IN PATIENTS WITH RESISTANT HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  537. FALKOVSKAYA A, Mordovin V, Pekarskiy S, Manukyan M, et al
    FEATURES OF CHANGES IN THE LEVELS OF MATRIX METALLOPROTEINASES AND THEIR INHIBITORS IN DIABETIC PATIENTS WITH RESISTANT HYPERTENSION AFTER RENAL DENERVATION.
    J Hypertens. 2022;40.
    >> Share

  538. FALKOVSKAYA A, Mordovin V, Pekarskiy S, Manukyan M, et al
    THE EFFECT OF RENAL DENERVATION ON CEREBRAL BLOOD FLOW IN DIABETIC PATIENTS WITH RESISTANT HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  539. FALKOVSKAYA A, Mordovin V, Pekarskiy S, Manukyan M, et al
    THE EFFECT OF RENAL DENERVATION ON PERIPHERAL AND CEREBRAL VASOREACTIVITY IN PATIENTS WITH RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUS.
    J Hypertens. 2022;40.
    >> Share

  540. MANUKYAN M, Falkovskaya A, Mordovin V, Zyubanova I, et al
    LEPTIN AS A PREDICTOR OF CARDIOPROTECTIVE EFFICIENCY OF RENAL DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUS.
    J Hypertens. 2022;40.
    >> Share

  541. BOUHANICK B, Amar J, Amar L, Courand PY, et al
    ANTIPLATELET AND ANTICOAGULANT THERAPY DURING ANGIOPLASTY PROCEDURES FOR ATHEROMATOUS OR FIBROMUSCULAR DYSPLASIA RENAL ARTERY STENOSIS: A SURVEY OF PRACTICES IN EUROPEAN SOCIETY OF HYPERTENSION EXCELLENCE CENTRES (ESH-EC) IN FRANCE.
    J Hypertens. 2022;40.
    >> Share

  542. YOUSSEF G, Mesalm MH, Reda G, Bakhoum S, et al
    EFFECT OF AN ELECTRO-STIMULATOR DEVICE ON THE AVERAGE 24-HOUR BLOOD PRESSURE IN PATIENTS WITH MILD AND MODERATE HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  543. ZHIPENG Z, Xiaoping C
    PATIENT PREFERENCE FOR RENAL DENERVATION THERAPY IN HYPERTENSION: A CROSS-SECTIONAL SURVEY IN CHENGDU, CHINA.
    J Hypertens. 2022;40.
    >> Share

  544. ZHAO S, Yu S, Tang J, Maimaitiaili R, et al
    INFLAMMATORY MARKERS AND HYPERTENSION-MEDIATED ORGAN DAMAGE IN COMMUNITY-DWELLING ELDERLY INDIVIDUALS: THE NORTHERN SHANGHAI STUDY.
    J Hypertens. 2022;40.
    >> Share

  545. HAJRI SE, Messaoudi Y, Ernez S, Bouraoui H, et al
    LONGITUDINAL LEFT VENTRICULAR FUNCTION IN HYPERTENSIVE SUBJECTS WITH NORMAL EJECTION FRACTION: NEW INSIGHT BY SPECKLE TRACKING ECHOCARDIOGRAPHY.
    J Hypertens. 2022;40.
    >> Share

  546. FARHAN HA, Ybeer HF
    GLOBAL LOGITUDINAL STRAIN IN HYPERTENSIVE DISORDERS DURING PREGNANCY AS A PREDICTOR FOR EARLY DETECTION OF SUBCLINICAL LEFT VENTRICULAR DYSFUNCTION.
    J Hypertens. 2022;40.
    >> Share

  547. HENDRIKS-BALK M, Da Costa S, Polychronopoulou E, Damianaki K, et al
    DIFFERENCES IN BOLD MRI SIGNAL INTENSITY BETWEEN HYPERTENSIVE PATIENTS AND HEALTHY VOLUNTEERS.
    J Hypertens. 2022;40.
    >> Share

  548. KOCIANOVA E, Kamasova M, Hanajikova B, Jelinek L, et al
    LEFT ATRIAL VOLUME INDEX (LAVI) AS A PREDICTOR OF PAROXYSMAL ATRIAL FIBRILLATION IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  549. LIU Y, Sun Q, Fu T, Pan Y, et al
    THE IMPACT AND INTERACTION OF METABOLIC ELEMENTS ON LEFT ATRIAL STIFFNESS IN HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  550. OUABDESSELAM S, Mokhtar OA, Bendiab NTS, Henaoui L, et al
    THE TRIGLYCERIDE- GLUCOSE INDEX: AN INDEPENDENT FACTOR OF A SUBCLINICAL LEFT VENTRICULAR DYSFUNCTION IN TREATED HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  551. SHAVAROV A, Kobalava Z
    DISSOCIATION BETWEEN LEFT ATRIAL AND LEFT VENTRICULAR CHANGES IN HYPERTENSIVE PATIENTS WITH ATRIAL CARDIOMYOPATHY.
    J Hypertens. 2022;40.
    >> Share

  552. BENDIAB NT, Henaoui L, Benkhedda S
    HYPERTENSIVE HEART DISEASE, WHAT ARE THE FACTORS PRECIPITATING ITS EARLY ONSET?
    J Hypertens. 2022;40.
    >> Share

  553. ZERVAKIS S, Marketou M, Danelatos C, Maragkoudakis S, et al
    RIGHT VENTRICULAR LONGITUDINAL SYSTOLIC STRAIN AS A PREDICTION MARKER OF NEW ONSET HEART FAILURE WITH PRESERVED EJECTION FRACTION IN ESSENTIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  554. KRAMER T, Hoenemann J, Weis H, Jordan J, et al
    EFFECTS OF ACUTE NORMOBARIC HYPOXIA-INDUCED PULMONARY HYPERTENSION ON ELECTROCARDIGRAPHIC MEASURES IN POST-MYOCARDIAL INFARCTION PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  555. EZHOVA N, Bazdyreva E, Shavarova E, Khomova I, et al
    LEFT ATRIAL RESERVOIR FUNCTION DECLINES IN HYPERTENSIVE SUBJECTS WITH DYSLIPIDEMIA.
    J Hypertens. 2022;40.
    >> Share

  556. PAFFER MT, Paffer PT, Procopio A, Ribeiro F, et al
    RENAL SYMPATHETIC DENERVATION AS TREATMENT FOR REFRACTORY HYPERTENSION: CASE REPORT.
    J Hypertens. 2022;40.
    >> Share

  557. VRIZ O, Rudski L, Frumento P, Limongelli G, et al
    RIGHT HEART PULMONARY CIRCULATION UNIT RESPONSE TO EXERCISE IN PATIENTS WITH SYSTEMIC ARTERIAL HYPERTENSION. INSIGHTS FROM THE RIGHT-NET STUDY.
    J Hypertens. 2022;40.
    >> Share

  558. RIBEIRO C, Neiva R, Silva D, Correia-De-Sa P, et al
    REDUCTION OF HEART RATE VIA P2X4 RECEPTOR ACTIVATION AS A PROMISING TREATMENT STRATEGY IN PULMONARY ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  559. ABDULLAEVA G, Kevorkov A, Yusupova K, Khamidullaeva G, et al
    THE RELATIONSHIP OF ARTERIAL AND MYOCARDIAL STIFFNESS WITH LEFT VENTRICLE DIASTOLIC DYSFUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  560. SAHOO SK, Pathni AK, Krishna A, Sharma B, et al
    ESTIMATES ON MEDICATION COST OF DRUG DOSE SPECIFIC TREATMENT PROTOCOL FOR HYPERTENSION MANAGEMENT IN PUBLIC AND PRIVATE HEALTHCARE SECTORS IN INDIA.
    J Hypertens. 2022;40.
    >> Share

  561. OUAIL DE, Tebbani M, Bouali F
    THE CHRONOLOGY OF ONSET OF TARGET ORGAN DAMAGE IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  562. LEE HY
    CLINICAL CHARACTERISTICS AND OUTCOME OF KOREAN HYPERTENSION COHORT.
    J Hypertens. 2022;40.
    >> Share

  563. MEAZZA R, Rossi M, Guareschi A, Iaci G, et al
    VASCULAR OR CARDIAC? DIFFERENT TARGET ORGAN DAMAGE IN HYPERTENSIVE PATIENTS WITH OR WITHOUT CHRONIC KIDNEY DISEASE.
    J Hypertens. 2022;40.
    >> Share

  564. FLORIDO CF, Pierin AMG
    COHORT STUDY IN PATIENTS WITH HYPERTENSIVE CRISIS: CHARACTERISTICS AND FOLLOW-UP AFTER 30 DAYS.
    J Hypertens. 2022;40.
    >> Share

  565. MAMDOUH H, Alnakhi W, Hussain H, Ibrahim G, et al
    PREVALENCE AND ASSOCIATED RISK FACTORS OF HYPERTENSION AND PRE-HYPERTENSION AMONG THE ADULT POPULATION: FINDINGS FROM THE DUBAI HOUSEHOLD SURVEY, 2019.
    J Hypertens. 2022;40.
    >> Share

  566. STEFFEN HM, Nhlema A, Phiri S, Kasper P, et al
    PREVALENCE AND INCIDENCE OF ARTERIAL HYPERTENSION OVER 36 MONTHS IN AMBULATORY HIV INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY IN LILONGWE, MALAWI.
    J Hypertens. 2022;40.
    >> Share

  567. CONG DT, Ngoc HC
    HEALTH-RELATED QUALITY OF LIFE AND ASSOCIATED FACTORS AMONG HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  568. CRUZ PV, Ang W, Calatrava J
    EFFICACY AND SAFETY OF SACUBITRIL/VALSARTAN (LCZ696) IN HYPERTENSION CONTROL AND ADVERSE CARDIOVASCULAR EVENT REDUCTION AMONG ASIANS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2022;40.
    >> Share

  569. ZHANG W, Liu CY, Bilo G, Soranna D, et al
    EFFICACY AND SAFETY OF NIFEDIPINE GASTROINTESTINAL THERAPEUTIC SYSTEM VERSUS RAMIPRIL IN CHINESE AND EUROPEAN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  570. GALLO G, Forte M, Tocci G, Cotugno M, et al
    ASSOCIATION OF NDUFC2 POLYMORPHIC VARIANTS WITH LEFT VENTRICULAR HYPERTROPHY IN HUMAN HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  571. OTMANE A, Makrelouf M, Zenati A
    APO E GENE POLYMORPHISM (C112R, R158C) AND LIPID PROFILE IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  572. ANDELOVA K, Bacova BS, Sykora M, Pavelka S, et al
    SPONTANEOUSLY HYPERTENSIVE RATS EXHIBIT ENHANCED CARDIAC CONNEXIN-43 AND REDUCED PRO-FIBROTIC MARKERS IN RESPONSE TO COLD ACCLIMATION.
    J Hypertens. 2022;40.
    >> Share

  573. CAMARGO L, Samji S, Lilla S, Zanivan S, et al
    PROTEOMIC PROFILE OF CYSTEINE OXIDATION IN VASCULAR SMOOTH MUSCLE CELLS IN HUMAN HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  574. NAWRES BT, Sabra A, Meriem BS, Manel BS, et al
    POST PARTUM HYPERTENSIVE EMERGENCY REVEALING ATYPICAL HEMOLYTIC AND URAEMIC SYNDROME IN TWO SISTERS.
    J Hypertens. 2022;40.
    >> Share

  575. PODPALOVA O, Kaliadka M, Babenka A, Mrochek A, et al
    TELOMERE LENGTH IS NEGATIVELY ASSOCIATED WITH BMI, R WAVE IN AVL AND IL-6 LEVEL IN PATIENTS WITH NEW CASES OF HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  576. REPCHUK Y
    OBESITY AND VITAMIN D RECEPTOR (VDR, RS2228570) GENE POLYMORPHISM ASSOCIATION IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  577. REPCHUK Y, Sydorchuk L, Semianiv M, Voronyuk K, et al
    THE CHANGES IN VITAMIN D AND IONIZED CALCIUM LEVELS IN PATIENTS WITH ESSENTIAL HYPERTENSION DEPENDING ON THE AGT GENE (RS699) POLYMORPHISM.
    J Hypertens. 2022;40.
    >> Share

  578. SEMIANIV M
    25(OH)D AS A RISK FACTOR OF ESSENTIAL ARTERIAL HYPERTENSION CONSIDERING THE GENES POLYMORPHISM AGTR1 (RS5186) AND VDR (RS2228570).
    J Hypertens. 2022;40.
    >> Share

  579. SHORIKOVA D, Shorikov E, Shorikov P, Ismael O, et al
    POLYMORPHISMS NOS3-T-786C IN MACROANGIOPATHIES IN PATIENTS WITH COMBINED HYPERTENSION AND TYPE DIABETES MELLITUS 2.
    J Hypertens. 2022;40.
    >> Share

  580. STRAUSS-KRUGER M, Kruger R, Vuren EJV, Jacobs A, et al
    IDENTIFYING A METABOLOMICS PROFILE ASSOCIATED WITH MASKED HYPERTENSION IN TWO INDEPENDENT COHORTS: DATA FROM THE AFRICAN-PREDICT AND SABPA STUDIES.
    J Hypertens. 2022;40.
    >> Share

  581. SYDORCHUK A, Voroniuk K, Sydorchuk L, Semianiv M, et al
    LINKAGE BETWEEN NOS3 (RS2070744) AND GNB3 (RS5443) GENES' POLYMORPHISM, CAROTID ARTERIES STRUCTURAL CHANGES AND ENDOTHELIAL DYSFUNCTION IN ESSENTIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  582. SYDORCHUK A, Voronyuk K, Sydorchuk L, Repchuk Y, et al
    ARE METABOLIC DISORDERS IN HYPERTENSIVE PATIENTS ASSOCIATED WITH GNB3 (RS5443) GENETIC POLYMORPHISMS?
    J Hypertens. 2022;40.
    >> Share

  583. DZHURYAK V, Sydorchuk L, Repchuk Y, Semianiv M, et al
    DEPENDENCE OF METABOLIC DISORDERS ON ALDOSTERONE SYNTHASE CYP11B2 (-344C/T) GENE POLYMORPHISM IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  584. DZHURYAK V, Sydorchuk A, Sydorchuk L, Sydorchuk R, et al
    ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE POLYMORPHISM (894G>T, 786T>C) CONTRIBUTE TO HYPERTENSION RISK AND LIPIDS PROFILE DISORDERS.
    J Hypertens. 2022;40.
    >> Share

  585. ALGHAMDI R, Muhammad F, Osman H, Salim F, et al
    THE PHARMACOKINETIC PARAMETERS DATA OF THE 20 MOST COMMONLY PRESCRIBED ANTIHYPERTENSIVE MEDICATIONS.
    J Hypertens. 2022;40.
    >> Share

  586. ARTEMIEVA M, Biriukova N, Kuropatkina T, Medvedeva N, et al
    GONADOECTOMY REDUCED THE DEGREE OF DEVELOPMENT OF RENOVASCULAR HYPERTENSION IN FEMALE RATS CAUSED BY STOP OF HIGH-SALT DIET.
    J Hypertens. 2022;40.
    >> Share

  587. MAZZA A, Bregola G, Cavazzin E, Dell'avvocata F, et al
    COST-EFFECTIVENESS OF POLYPILL TREATMENT IN HIGH-RISK HYPERTENSIVE SUBJECTS WITH HYPER-CHOLESTEROLAEMIA.
    J Hypertens. 2022;40.
    >> Share

  588. SYKORA M, Kratky V, Tribulova N, Kopkan L, et al
    INHIBITION OF RAS COMPONENTS ATTENUATES PROGRESSION OF MYOCARDIAL REMODELING IN BOTH NORMOTENSIVE AND HYPERTENSIVE RATS IN EXPERIMENTAL HEART FAILURE.
    J Hypertens. 2022;40.
    >> Share

  589. VARBIRO S, Josvai A, Hetthessy J, Matrai M, et al
    ADDITIVE DAMAGE IN THE CONTRACTILITY OF INTRAMURAL CORONARY ARTERIOLES IN A RAT MODEL OF ANDROPAUSAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  590. BENDOUDOUCH H, Dahmani I, Mahdi Z, Benali M, et al
    RESTING ELECTROCARDIOGRAM ABNORMALITIES IN PATIENTS WITH ARTERIAL HYPERTENSION AND THEIR ASSOCIATION WITH CARDIOVASCULAR RISK FACTORS.
    J Hypertens. 2022;40.
    >> Share

  591. ABDREBBI SB, Meguenni K
    EPIDEMIOLOGY OF ARTERIAL HYPERTENSION IN A UNIVERSITY HOSPITAL CENTER IN NORTH-WEST OF ALGERIA.
    J Hypertens. 2022;40.
    >> Share

  592. ABDREBBI SB, Meguenni K
    HYPERTENSION, THE MAIN RISK FACTOR FOR STROKE IN A UNIVERSITY HOSPITAL CENTER IN NORTHWEST ALGERIA.
    J Hypertens. 2022;40.
    >> Share

  593. RUF R, Grinshtein Y, Shabalin V
    A COMBINATION OF HYPERTENSION AND A HIGH ATHEROGENIC INDEX OF PLASMA AS AN INDICATOR OF A CORONARY HEART DISEASE RISK.
    J Hypertens. 2022;40.
    >> Share

  594. RUF R, Grinshtein Y, Shabalin V
    THE INTERRELATION OF HYPERTENSION AND HYPERURICEMIA THE PRISM OF SCORE2.
    J Hypertens. 2022;40.
    >> Share

  595. BENTZEL S, Ohman O, Abdulla K, Manhem K, et al
    HIGH BLOOD PRESSURE IN THE EMERGENCY DEPARTMENT. A TOOL FOR DETECTION OF HYPERTENSION? A FOLLOW-UP STUDY OF UNSELECTED PATIENTS ATTENDING AN EMERGENCY DEPARTMENT.
    J Hypertens. 2022;40.
    >> Share

  596. BIRULINA Y, Buyko E, Ivanov V, Dzyuman A, et al
    MORPHOFUNCTIONAL ABNORMALITIES WITHIN THE AORTA AS A PREDICTOR OF ARTERIAL HYPERTENSION IN METABOLIC SYNDROME.
    J Hypertens. 2022;40.
    >> Share

  597. SHAMSUDDIN S, Davis K, Moorhouse L, Mandizvidza P, et al
    ASSOCIATION BETWEEN PSYCHOLOGICAL DISTRESS AND LATER REPORTS OF HYPERTENSION AMONG ADULTS IN EAST ZIMBABWE.
    J Hypertens. 2022;40.
    >> Share

  598. EASON S, Sayers M
    A COMPARISON OF EUROPEAN AND AMERICAN GUIDELINES TO GAUGE THE PREVALENCE OF HYPERTENSION IN 16-19 YEAR OLD BLOOD DONORS.
    J Hypertens. 2022;40.
    >> Share

  599. FRKANEC S, Katic L, Strbac T, Trobonjaca A, et al
    ELECTROCARDIOGRAM CHANGES IN PREHYPERTENSIVE SUBJECTS - EPIDEMIOLOGY OF HYPERTENSION IN CROATIA-1 (EH UH-1) STUDY.
    J Hypertens. 2022;40.
    >> Share

  600. FRKANEC S, Katic L, Strbac T, Tarnovski L, et al
    EPIDEMIOLOGY OF HYPERTENSION IN CROATIA (EHUH STUDY) -ECG FINDINGS AND CARDIOVASCULAR MORTALITY DATA AFTER 17 YEARS OF FOLLOW-UP.
    J Hypertens. 2022;40.
    >> Share

  601. VARETA G, Georgianos P, Vaios V, Sgouropoulou V, et al
    PREVALENCE, PHENOTYPES AND CONTROL OF HYPERTENSION IN END-STAGE KIDNEY DISEASE PATIENTS UNDERGOING PERITONEAL DIALYSIS.
    J Hypertens. 2022;40.
    >> Share

  602. GEORGIANOU E, Markakis K, Georgianos P, Zografou I, et al
    PREVALENCE AND CONTROL OF HYPERTENSION IN DIABETIC PATIENTS WITH VERSUS WITHOUT CHRONIC KIDNEY DISEASE.
    J Hypertens. 2022;40.
    >> Share

  603. LEROUX D, Cloutier L
    GEOGRAPHICAL ANALYSIS OF HYPERTENSION IN CANADIAN POPULATION.
    J Hypertens. 2022;40.
    >> Share

  604. LEWANDOWSKA K, Lipski D, Pawlak-Chomicka R, Uruski P, et al
    THE PREVALENCE OF WHITE-COAT EFFECT AND REVERSE WHITE-COAT EFFECT IN TREATED HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  605. MIRADA M, Pessana F, Acuna MIR, Ramirez A, et al
    ARTERIAL HYPERTENSION (HT) IS ONE OF THE MOST PREDICTIVE RISK FACTORS FOR TYPE 2 DIABETES (DM2). THE FINDRISC IS VALIDATED FOR THE EARLY DETECTION OF SUFFERING FROM DM2.
    J Hypertens. 2022;40.
    >> Share

  606. MOURAD JJ, Jamet P, Huguet M, Bourbia S, et al
    ANTIHYPERTENSIVE TREATMENT PRESCRIBING BEHAVIOURS IN FRENCH GENERAL PRACTICE IN 2021.
    J Hypertens. 2022;40.
    >> Share

  607. PALMU J, Tikkanen E, Havulinna AS, Vartiainen E, et al
    COMPREHENSIVE BIOMARKER PROFILING OF HYPERTENSION IN 36,985 FINNISH INDIVIDUALS.
    J Hypertens. 2022;40.
    >> Share

  608. REPCHUK Y, Sydorchuk L
    LIPIDS' METABOLISM AND ANGIOTENSINOGEN GENE (AGT, RS699) POLYMORPHISM ASSOCIATION IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  609. DE PAULA ARAUJO T, Borges LGS, Barroso WKS, Batista SR, et al
    WHAT ARE THE FACTORS ASSOCIATED WITH UNCONTROLLED BLOOD PRESSURE IN BRAZILIAN HYPERTENSIVE PATIENTS?
    J Hypertens. 2022;40.
    >> Share

  610. SHIN JH, Kim BS, Kim HJ, Yu MY, et al
    IMPACT OF THE ESTIMATED GLOMERULAR FILTRATION RATE ON LONG-TERM MORTALITY IN PATIENTS WITH HYPERTENSIVE CRISIS VISITING THE EMERGENCY DEPARTMENT.
    J Hypertens. 2022;40.
    >> Share

  611. SHIN JH, Kim BS, Kim HJ, Yu MY, et al
    IMPACT OF PROTEINURIA ON LONG-TERM MORTALITY IN PATIENTS WITH HYPERTENSIVE CRISIS VISITING THE EMERGENCY DEPARTMENT.
    J Hypertens. 2022;40.
    >> Share

  612. SHIN JH, Kim BS, Kim W, Kim HJ, et al
    CLINICAL IMPLICATIONS OF CARDIAC TROPONIN-I IN PATIENTS WITH HYPERTENSIVE CRISIS VISITING THE EMERGENCY DEPARTMENTS.
    J Hypertens. 2022;40.
    >> Share

  613. TARNOVSKI L, Frkanec S, Katic L, Strbac T, et al
    POOR HYPERTENSION CONTROL AND DISAPPEARANCE OF MEDITERRANEAN LIFE STYLE ON THE CROATIAN ADRIATIC ISLANDS. HUNT ON THE SILENT KILLER (HSK) - OPPORTUNISTIC PUBLIC HEALTH ACTION.
    J Hypertens. 2022;40.
    >> Share

  614. VAY-DEMOUY J, Blacher J, Olie V
    LACK OF LIFESTYLE MODIFICATIONS IN GLOBAL HYPERTENSION MANAGEMENT.
    J Hypertens. 2022;40.
    >> Share

  615. OUAIL DE, Tebbani M, Bouali F
    INTEREST OF MEASURING THE INTIMA MEDIA THICKNESS IN THE EVALUATION OF HYPERTENSIVE.
    J Hypertens. 2022;40.
    >> Share

  616. SYDORCHUK A, Voroniuk K, Sydorchuk L, Repchuk Y, et al
    ENDOTHELIUM DYSFUNCTION PATHWAY AND CAROTID INTIMA-MEDIA THICKNESS IN HYPERTENSIVE PATIENTS: ROLE OF NOS3 (RS2070744) AND GNB3 (RS5443) GENES' POLYMORPHISMS.
    J Hypertens. 2022;40.
    >> Share

  617. YUAN Y, Sun W, Kong X
    COMPARISON BETWEEN DISTINCT INSULIN RESISTANCE INDICES IN MEASURING THE DEVELOPMENT OF HYPERTENSION: THE CHINA HEALTH AND NUTRITION SURVEY.
    J Hypertens. 2022;40.
    >> Share

  618. YUAN Y, Sun W, Kong X
    RELATIONSHIP BETWEEN METABOLICALLY HEALTHY OBESITY AND THE DEVELOPMENT OF HYPERTENSION: A NATIONWIDE POPULATION-BASED STUDY.
    J Hypertens. 2022;40.
    >> Share

  619. CHEN J, Yu J
    MTOR INHIBITOR IMPROVES TESTOSTERONE-INDUCED MYOCARDIAL HYPERTROPHY IN HYPERTENSIVE RATS.
    J Hypertens. 2022;40.
    >> Share

  620. VACLAVIK J, Hartmann I, Hruska F, Kocianova E, et al
    HYPERTENSION OUTCOMES OF ADRENALECTOMY FOR UNILATERAL PRIMARY ALDOSTERONISM.
    J Hypertens. 2022;40.
    >> Share

  621. ANDERSSON U, Kjellgren K, Hoffmann M, Wennersten A, et al
    PERSON-CENTREDNESS IN HYPERTENSION MANAGEMENT USING INFORMATION TECHNOLOGY (PERHIT): A RANDOMISED CONTROLLED TRIAL IN PRIMARY HEALTH CARE.
    J Hypertens. 2022;40.
    >> Share

  622. GIRERD X, Canipel L, Hanon O, Pathak A, et al
    EVALUATION OF A DIGITAL THERAPY FOR UNCONTROLLED HYPERTENSIVE PATIENTS FOLLOWED BY GENERAL PRACTITIONERS IN FRANCE.
    J Hypertens. 2022;40.
    >> Share

  623. MAIMAITIAILI R, Li Y, Zhang Y, Feng T, et al
    SIMPLIFIED REGIMEN FOR THE MANAGEMENT OF HYPERTENSION WITH TELEMEDICINE AND BLOOD PRESSURE SELF-MONITORING (SIMPLE): STUDY PROTOCOL FOR A RANDOMIZED CONTROLLED TRIAL.
    J Hypertens. 2022;40.
    >> Share

  624. OGBOYE A, Rahman KMJ, Odukwe A, Mobisson N, et al
    DIGITAL INTERVENTIONS TO DRIVE SELF-MANAGEMENT IN PEOPLE WITH HYPERTENSION IN NIGERIA.
    J Hypertens. 2022;40.
    >> Share

  625. JACOBS M, Ogboye A, Mobisson N
    HARNESSING HUMAN-CENTRED DESIGN APPROACHES TO BUILD A CHATBOT FOR PEOPLE LIVING WITH HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  626. ZANINI C, Teixeira D, Pereira D, Sousa ALL, et al
    MUSIC THERAPY WITH HYPERTENSIVE PATIENTS DURING THE PANDEMIC PERIOD - ONLINE MEETINGS AS PART OF MULTIPROFESSIONAL TREATMENT.
    J Hypertens. 2022;40.
    >> Share

  627. PAPAVASILEIOU M, Aravantinos D, Karamanou A, Moustakas G, et al
    PROGNOSTIC VALUE OF THE GLYCOSYLATED HEMOGLOBIN TO THE MACE IN HYPERTENSIVE NON DIABETIC PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  628. DOAN L
    SGLT2I - A POTENTIAL ANTIHYPERTENSIVE AGENT IN HYPERTENSION PATIENTS WITH TYPE 2 DIABETES MELLITUS.
    J Hypertens. 2022;40.
    >> Share

  629. GEORGIANOU E, Markakis K, Georgianos P, Zografou I, et al
    THE ASSOCIATION OF EGFR AND ALBUMINURIA WITH SYSTOLIC HYPERTENSION IN PATIENTS WITH DIABETES.
    J Hypertens. 2022;40.
    >> Share

  630. KOTZE-HORSTMANN L, Hill J, Kengne AP, Peer N, et al
    MANAGEMENT OF DYSLIPIDAEMIA AND HYPERTENSION BY GLYCAEMIC STATUS IN URBAN SOUTH AFRICANS.
    J Hypertens. 2022;40.
    >> Share

  631. PAPADAKIS JA, Ioannou P, Theodorakopoulou V, Papanikolaou K, et al
    INCREASED INCIDENCE OF IMPAIRED FASTING GLUCOSE (IFG) AMONG HYPERTENSIVE PATIENTS NAIVE TO HYPOLIPIDEMIC TREATMENT.
    J Hypertens. 2022;40.
    >> Share

  632. PAPAZOGLOU S, Toutouzas K, Tsioufis K
    DO INCREASED LEVELS OF TRIGLYCERIDES CONSIST AN INDEPENDENT RISK FACTOR DEFINING THE SEVERITY OF CARDIOMYOPATHY IN T2DM PATIENTS WITH KNOWN HYPERTENSION ?
    J Hypertens. 2022;40.
    >> Share

  633. WANG Q, Tian L, Sun R, Qi M, et al
    EFFECTS OF SGLT-2 INHIBITORS ON 24H AMBULATORY BLOOD PRESSURE IN PATIENTS WITH TYPE 2 DIABETIC AND HYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2022;40.
    >> Share

  634. CHALAKOVA T, Tsochev K, Yotov Y, Bocheva Y, et al
    ARTERIAL HYPERTENSION IN PATIENTS WITH LONG DURATION TYPE 1 DIABETES MELLITUS.
    J Hypertens. 2022;40.
    >> Share

  635. ZHURAVLYOVA L, Rogachova T, Sokolnikova N, Filonenko M, et al
    THE EFFECT OF DAPAGLIFLOZIN ON THE LEVEL OF SYSTOLIC BLOOD PRESSURE AND GLYCEMIC CONTROL IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES.
    J Hypertens. 2022;40.
    >> Share

  636. FEJES I, Roka R, Abraham G, Varkonyi T, et al
    EFFECT OF HYPERTENSION AND RAS INHIBITORS TO ADULT PATIENTS (OVER 18 YEARS OLD) WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV2) INFECTION WHO WERE ADMITTED TO HOSPital.
    J Hypertens. 2022;40.
    >> Share

  637. LOZADA MC, Medina H Jr, Sucaldito MSF, Santos LE, et al
    ASSOCIATION OF IN-PATIENT OUTCOMES AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITOR USE AMONG HYPERTENSIVE PATIENTS WITH CORONAVIRUS DISEASE 2019 (COVID-19).
    J Hypertens. 2022;40.
    >> Share

  638. POLYZOS D, Konstantinidis D, Drogkaris S, Tatakis F, et al
    SURGICAL MASKS AND UNATTENDED BLOOD PRESSURE CHANGES IN TREATED HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  639. STIRBAN R, Grigore C, Dragoi D, Balaceanu B, et al
    PARTICULARITIES OF HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME, ADMITTED FOR SARS-COV-2 INFECTION TO A CLINICAL EMERGENCY HOSPITAL.
    J Hypertens. 2022;40.
    >> Share

  640. STIRBAN R, Grigore C, Dragoi D, Balaceanu B, et al
    NEW ONSET OF HYPERTENSION IN PATIENTS ADMITTED FOR INFECTION WITH SARS-COV-2 VIRUS.
    J Hypertens. 2022;40.
    >> Share

  641. KYYA Y, Barnett O, Halkevych M, Labinska O, et al
    RED BLOOD CELL COLOUR VARIATION AS A MARKER OF CALCIUM DISTRIBUTION: WHAT ROLE DOES IT HAVE IN HEART FAILURE PATIENTS WITH HYPERTENSION AND LONG COVID?
    J Hypertens. 2022;40.
    >> Share

  642. DENISOVA A, Sivakova O, Solntseva T, Chazova I, et al
    EFFECT OF CORONAVIRUS INFECTION ON PATIENTS WITH CONTROLLED AND UNCONTROLLED ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  643. TSOUTSOULI V, Sachla Z, Efstathiou K, Foutsitsakis D, et al
    COVID-19 RELATED CHANGE IN DAILY LIFE OF HYPERTENSIVE PATIENTS MAY AFFECT HYPERTENSION MANAGEMENT.
    J Hypertens. 2022;40.
    >> Share

  644. RODRIGUES FF, Sa J
    COVID-19 INFECTION AND ARTERIAL HYPERTENSION - A RECIPROCAL INTERACTION?
    J Hypertens. 2022;40.
    >> Share

  645. GAVRILA A
    THE PROGNOSTIC VALUE OF THE BIOLOGICAL PROFILE OF INFLAMMATION AND COAGULATION AT HYPERTENSIVE PATIENTS AFTER COVID-19.
    J Hypertens. 2022;40.
    >> Share

  646. HAZARAPETYAN L, Grigoryan S, Zeveian P
    THE FEATURE OF ATRIAL FIBRILLATION OCCURRENCE AND PROGRESSION IN PATIENTS WITH ARTERIAL HYPERTENSION, WHO HAVE UNDERGONE COVID-19.
    J Hypertens. 2022;40.
    >> Share

  647. DELALIC D, Jug J, Varahabhatla V, Prkacin I, et al
    ARTERIAL HYPERTENSION FOLLOWING COVID-19.
    J Hypertens. 2022;40.
    >> Share

  648. KOH JH, Kang MJ
    ASSOCIATION BETWEEN DEPRESSION DISORDER AND INCIDENTAL HYPERTENSION IN COVID 19 POSITIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  649. MAKEEVA T, Zbyshevskaya E, Bitakova F, Erinchek V, et al
    CLINICAL AND MORPHOLOGICAL FEATURES OF KIDNEY DAMAGE IN PATIENTS WITH ARTERIAL HYPERTENSION DIED OF SARS-COV-2 INFECTION.
    J Hypertens. 2022;40.
    >> Share

  650. MAKEEVA T, Zbyshevskaya E, Bitakova F, Butaev T, et al
    RISK FACTORS FOR POST-COVID-19 SYNDROME DEVELOPMENT IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  651. MONTEALEGRE L, Amador E, Pulido T, Rebolledo R, et al
    FACTORS THAT INFLUENCE THE SURVIVAL RATE IN PATIENTS WITH COVID-19 WITH A PREVIOUS DIAGNOSIS OF HYPERTENSION AND/OR DIABETES: A SYSTEMATIC REVIEW.
    J Hypertens. 2022;40.
    >> Share

  652. OLIE V, Grave C, Tuppin P, Lesuffleur T, et al
    IMPACT OF THE COVID-19 PANDEMIC ON THE INITIATION OF ANTIHYPERTENSIVE DRUG THERAPY IN FRANCE.
    J Hypertens. 2022;40.
    >> Share

  653. KARIORI M, Fragoulis C, Polyzos D, Leontsinis I, et al
    IMPACT OF HYPERTENSION AS AN ADDITIONAL RISK FACTOR IN CARDIORESPIRATORY STATUS OF POST SARS-COV-2 INFECTED SUBJECTS.
    J Hypertens. 2022;40.
    >> Share

  654. KARIORI M, Fragoulis C, Chrysochoou C, Leontsinis I, et al
    CARDIOPULMONARY EXERCISE TEST AND ECHOCARDIOGAPHIC FINDINGS IN HOSPITALISED POST SARS-COV-2 PATIENTS: THE EFFECT OF ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  655. VINTILA AM, Horumba M, Miron P, Balan R, et al
    ARTERIAL HYPERTENSION SEVERITY INFLUENCE ON COVID19 SEVERITY AND ICU ADMISSION.
    J Hypertens. 2022;40.
    >> Share

  656. WOJCIECHOWSKA W, Terlecki M, Klocek M, Januszewicz A, et al
    IMPACT OF ARTERIAL HYPERTENSION AND ANTIHYPERTENSIVE PHARMACOTHERAPY ON IN-HOSPITAL MORTALITY IN COVID-19 PATIENTS: THE CRACOV-HHS STUDY.
    J Hypertens. 2022;40.
    >> Share

  657. YUFEREVA Y, Shevchenko O, Ginzburg L, Zakirzyanov A, et al
    COVID-19 IMPACT ON THE PREVALENCE OF SUBCLINICAL HYPERTENSION AMONG PRACTICALLY HEALTHY MEDICAL STUDENTS.
    J Hypertens. 2022;40.
    >> Share

  658. JAIN R, Hosseini J, Shoghli R
    COVID19 INFECTION IN CORONARY ARTERY DISEASE WITH DIABETES AND HYPERTENSION IN VALVULAR SURGERY PATIENTS IN TERTIARY HEART CENTRE.
    J Hypertens. 2022;40.
    >> Share

  659. VINTILA AM, Horumba M, Miron P, Balan R, et al
    ARTERIAL HYPERTENSION AND COVID19 IN HOSPITAL MORTALITY.
    J Hypertens. 2022;40.
    >> Share

  660. SOLIMENE MC, Drager L, Bortolotto L
    GENDER-RELATED DIFFERENCES IN CORONARY ARTERY DISEASE IN PATIENTS WITH RESISTANT HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  661. GHRAB A, Chamtouri I, Louati M, Abdallah W, et al
    SMOKING PARADOX IN HYPERTENSIVE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS: 25-YEAR POPULATION-BASED STUDY.
    J Hypertens. 2022;40.
    >> Share

  662. SAKALIDIS A, Dimitriadis K, Dri E, Soulaidopoulos S, et al
    HYPERTENSIVE PATIENTS WITH ANGINA AND NON-OBSTRUCTIVE CORONARY ARTERY DISEASE ARE CHARACTERIZED BY INCREASED SYMPATHETIC NERVOUS SYSTEM ACTIVATION.
    J Hypertens. 2022;40.
    >> Share

  663. SAKALIDIS A, Dimitriadis K, Dri E, Soulaidopoulos S, et al
    ARTERIAL STIFNESS AND SYMPATHETIC OVERDRIVE IN HYPERTENSIVE PATIENTS WITH ANGINA AND NON-OBSTRUCTIVE CORONARY ARTERY DISEASE.
    J Hypertens. 2022;40.
    >> Share

  664. TSYGANKOVA O, Ponkin S, Veretyuk V
    EFFECT OF MOBILE APPLICATIONS FOR PHYSICAL ACTIVITY TRACKING ON EXERCISE TOLERANCE IN PATIENTS WITH HYPERTENSION AND CORONARY ARTERY DISEASE.
    J Hypertens. 2022;40.
    >> Share

  665. PAPAVASILEIOU M, Karamanou A, Moustakas G, Aravantinos D, et al
    PROGNOSTIC VALUE OF THE REMNANT CHOLESTEROL AND OTHER LIPID PARAMETERS TO THE MACE IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  666. PAPAVASILEIOU MV, Doumas M, Karamanou A, Moustakas G, et al
    ASSOCIATION OF SERUM URIC ACID LEVELS AND ATHEROMATOSIS OF CAROTID ARTERIES IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  667. DE SOUSA A, Magalhaes FG, da Silva SB, Inuzuka S, et al
    ASSOCIATION BETWEEN THE PRESENCE OF COMORBIDITIES AND CARDIOVASCULAR OUTCOMES IN A HYPERTENSIVE LATIN AMERICAN POPULATION.
    J Hypertens. 2022;40.
    >> Share

  668. DUNAIEVA I, Bilovol O, Knyazkova I, Kirienko O, et al
    THE EFFECTIVENESS OF ANTIHYPERTENSIVE THERAPY IN COMORBID PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  669. FEDORISHINA O, Protasov K, Torunova A
    THE RELATIONSHIPS BETWEEN ANXIETY AND BLOOD PRESSURE DYNAMICS UNDER THE ANTIHYPERTENSIVE TREATMENT.
    J Hypertens. 2022;40.
    >> Share

  670. KRYVOSHEI V, Filippova A
    THE STATE OF ELASTIC PROPERTIES OF ARTERIES IN PATIENTS WITH CHRONIC PANCREATITIS IN COMBINATION WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  671. NEMCSIK J, Korosi B, Gyongyosi H, Batta D, et al
    SIMILARITIES IN DEPRESSION AND ANXIETY BETWEEN WHITE-COAT AND RESISTANT HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  672. OKPARA C, Mobisson N, Moosa M, Rahman KJ, et al
    THE EFFECT OF A DIGITAL HEALTH INTERVENTION ON THE CONTROL OF HYPERTENSION AMONG PEOPLE LIVING WITH CANCER.
    J Hypertens. 2022;40.
    >> Share

  673. BATISTA SR, Vitorino PVO, Silva RR, Sousa ALL, et al
    CARDIOMETABOLIC MULTIMORBIDITY AND ASSOCIATED FACTORS: THE FIRST BRAZILIAN REGISTRY OF PATIENTS WITH HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  674. SIRENKO O, Kuryata O
    ANDROGEN DEFICIENCY ASSOCIATES WITH INCREASED ADVANCED GLYCATED END PRODUCTS, GALECTIN-3 IN HYPERTENSIVE MEN WITH BENIGN PROSTATIC HYPERPLASIA.
    J Hypertens. 2022;40.
    >> Share

  675. BILALOVA D, Nigmatullina R, Mustafin A
    ROLE OF SEROTONIN AND ITS METABOLITE 5-HIAA IN THE DEVELOPMENT OF PULMONARY HYPERTENSION. NEW APPROACHES TO TREATMENT AND NON-INVASIVE DIAGNOSTICS?
    J Hypertens. 2022;40.
    >> Share

  676. CHAINOGLOU A, Sarafidis K, Chrysaidou K, Farmaki E, et al
    HYPERTENSION AND ARTERIAL STIFFNESS IN PRETERM CHILDREN AND ADOLESCENTS.
    J Hypertens. 2022;40.
    >> Share

  677. GOULAS I, Evripidou K, Doundoulakis I, Nika T, et al
    PREVALENCE OF MASKED HYPERTENSION IN CHILDREN AND YOUNG ADULTS WITH CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2022;40.
    >> Share

  678. KOS M, Mihalj M, Hamidovic N, Dumancic D, et al
    ESTIMATION OF DAILY SALT INTAKE IN CHILDREN WITH ESSENTIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  679. OBRYCKI L, Pac M, Sarnecki J, Feber J, et al
    VASCULAR AGE IN ADOLESCENTS WITH PRIMARY HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  680. PATERNO CA
    THE IMPORTANCE OF THE SYMPTOMS FOR DIAGNOSING AND TREATING OF HYPERTENSION IN CHILDREN, ADOLESCENTS AND YOUNG-AGED, ASSESSED WITH APPLANATION TONOMETRY.
    J Hypertens. 2022;40.
    >> Share

  681. FERNANDEZ GAP
    HYPERTENSIVE HEART DISEASE IN ADOLESCENCE. PRELIMINARY RESULTS OF THE PESESCAD-HTA STUDY.
    J Hypertens. 2022;40.
    >> Share

  682. SHORT B, Moon K, Larkins NG, Hijazzi S, et al
    ISRADIPINE FOR THE TREATMENT OF ACUTE SEVERE HYPERTENSION IN CHILDREN.
    J Hypertens. 2022;40.
    >> Share

  683. SKRZYPCZYK P, Bujanowicz A, Pawlik K, Wroniewicz T, et al
    MEAN PLATELET VOLUME IS A PREDICTOR OF BLOOD PRESSURE NORMALIZATION IN PEDIATRIC HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  684. KOLLIAS A, Ntineri A, Zeniodi ME, Stambolliu E, et al
    HYPERTENSION PHENOTYPES IN YOUNG INDIVIDUALS BASED ON COMBINED OR ISOLATED ELEVATION OF OFFICE, HOME AND AMBULATORY BLOOD PRESSURE MEASUREMENTS AND ASSOCIATION WITH ORGAN DAMAGE.
    J Hypertens. 2022;40.
    >> Share

  685. GULKEVYCH O, Mishchenko L, Logvynenko A, Matova O, et al
    COGNITIVE IMPAIRMENT AND CAROTID INTIMA-MEDIA THICKNESS IN PATIENTS WITH RESISTANCE HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  686. BOULESTREAU R, Lucas L, Cremer A, Doublet J, et al
    NEUROLOGICALLY ASYMPTOMATIC PATIENTS FREQUENTLY PRESENT CEREBRAL INJURIES DURING MALIGNANT HYPERTENSION: A MRI STUDY.
    J Hypertens. 2022;40.
    >> Share

  687. GERMAN-SALLO M, Preg Z, Pal T, Andrassy K, et al
    HEART RATE VARIABILITY AND BRAIN FUNCTIONING IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  688. ULBRICH P, Morton L, Briese M, Lammlin N, et al
    STAGE-DEPENDENT RESPONSES OF VASCULAR AND PARENCHYMAL CELLS IN THE HYPERTENSIVE RAT BRAIN.
    J Hypertens. 2022;40.
    >> Share

  689. WOJCIECHOWSKA E, Gryglas P
    CASE REPORT: HELLP-LIKE SYNDROME IN A 19-YEAR-OLD WOMAN WITH NOT WELL - CONTROLLED HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  690. GEORGIEVA N, Kinova E, Borizanova A, Shopov L, et al
    ASSOCIATION BETWEEN ARTERIAL STIFFNESS AND LEFT VENTRICULAR FUNCTION IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  691. LIAKOS C, Karpanou E, Markou M, Grassos C, et al
    SYNERGISTIC EFFECT OF HIGH HOMOCYSTEINE AND LOW VITAMIN B12 LEVELS ON THE PREVALENCE OF ATRIAL FIBRILLATION IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  692. CHEN J, Yu J
    ASSOCIATION OF FREE ANDROGEN INDEX AND SEX HORMONE BINDING GLOBULIN AND LEFT VENTRICULAR HYPERTROPHY IN POSTMENOPAUSAL HYPERTENSIVE WOMEN.
    J Hypertens. 2022;40.
    >> Share

  693. DUARTE F, Santos I, Barrada MI, Oliveira L, et al
    ACUTE ST-ELEVATION MYOCARDIAL INFARCTION IN OBESE HYPERTENSIVE PATIENTS - CAN WE CONSIDER A DIFFERENT APPROACH?
    J Hypertens. 2022;40.
    >> Share

  694. OTMANE A, Makrelouf M, Zenati A
    ASSOCIATION BETWEEN URIC ACID AND METABOLIC SYNDROME IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  695. ABDELHALIM T, Nadia DD, Abdelghani BC
    ARTERIAL HYPERTENSION, THE MOST FREQUENT CARDIOVASCULAR RISK FACTOR, BUT HITHERTO UNRECOGNIZED IN THE NOMADIC POPULATION OF SOUTHERN ALGERIA.
    J Hypertens. 2022;40.
    >> Share

  696. ALI U, Podpalov V
    HIGH LEVEL OF THE AMOUNT OF ECG PEAKS SV1+RV5-V6 PREDICT NEW CASES OF HYPERTENSION IN THE ORGANIZED POPULATION OF THE PETROCHEMICAL INDUSTRY WORKERS.
    J Hypertens. 2022;40.
    >> Share

  697. PAPAVASILEIOU MV, Mytas D, Karamanou A, Moustakas G, et al
    ASSOCIATION OF SERUM URIC ACID WITH LEFT VENTRICLE, LEFT VENTRICULAR FILLING PRESSURE AND LEFT ATRIAL SIZE IN HYPERTENSIVE PATIENTS WITHOUT ATRIAL FIBRILLATION.
    J Hypertens. 2022;40.
    >> Share

  698. BUILA N, Kabanda G, Nkodila A, Mundu G, et al
    IMPACT OF ADAPTED PHYSICAL ACTIVITY ON BLOOD PRESSURE AND HYPERTENSION CONTROL IN MILITARY OF THE KINSHASA GARNISON.
    J Hypertens. 2022;40.
    >> Share

  699. VACCA A, Catena C, Soardo G, Spagnol F, et al
    RELATIONSHIPS BETWEEN NAFLD BIOCHEMICAL SCORES AND LEFT VENTRICULAR GEOMETRIC PATTERN IN NAIVE ESSENTIAL HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  700. CHINNAAIAH K, Lo FA, Sule AA, Chin TJ, et al
    INCREASE ARTERIAL STIFFNESS IN MOYAMOYA DISEASE PRESENTING WITH HYPERTENSION AND STROKE: A NOVEL FINDING IN A VERY RARE CASE IN SINGAPORE.
    J Hypertens. 2022;40.
    >> Share

  701. DE ROSA ML, Zuccarino M, Di Sarro E, Iovino MD, et al
    THE IMPACT OF POLLUTION ON HYPERTENSION AND ECONOMY.
    J Hypertens. 2022;40.
    >> Share

  702. HAKO Y, Bika C, Okala C, Dissongo JI, et al
    HYPERTENSION IN CAMEROONIAN RURAL AND URBAN PYGMIES AND BANTUS OF THE SOUTHERN REGION.
    J Hypertens. 2022;40.
    >> Share

  703. INUZUKA S, Filho GG, Vitorino P, Barroso A, et al
    CARDIOVASCULAR RISK RECLASSIFICATION BY PULSE WAVE VELOCITY IN BRAZILIAN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  704. KLAUS KK, Lukas K, Bernhard G, Jutta S, et al
    INCREASED IONIZED CALCIUM-MAGNESIUM-RATIO IN ELDERLY HYPERTENSIVES - RELATIONSHIP TO ARTHERIOSCLEROSIS.
    J Hypertens. 2022;40.
    >> Share

  705. LI Y, Xinhua T, Xiaoling X, Guoxiong C, et al
    COMPARISON OF HYPERTENSION PREVALENCE AND ASSOCIATED RISK FACTORS IN MONKS AND COMMON RESIDENTS FROM ZHEJIANG PROVINCE, SOUTHEAST CHINA.
    J Hypertens. 2022;40.
    >> Share

  706. MALOBERTI A, Fumagalli S, Garofani I, Ghidini S, et al
    RESTING HEART RATE AND ARTERIAL STIFFNESS: A LONGITUDINAL PROSPECTIVE STUDY IN A POPULATION OF HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  707. NAZ Q, Verma N, Serajuddin M, Patel ML, et al
    ALPHA ADDUCIN GENE POLYMORPHISM IS MORE COMMON IN MALE AS COMPARE TO FEMALE IN ESSENTIAL HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  708. OOI IJ, Chia YC
    PREVALENCE AND RISK FACTORS OF POSTURAL HYPOTENSION AMONG HYPERTENSIVE PATIENTS IN A PRIMARY CARE SETTING.
    J Hypertens. 2022;40.
    >> Share

  709. LONG NP, Kim NHT
    STUDYING THE SITUATION OF CAROTID ATHEROSCLEROSIS OF HYPERTENSIVE PATIENTS IN THE NORTH OF BINH DINH PROVINCE VIETNAM 2019.
    J Hypertens. 2022;40.
    >> Share

  710. SAFRONENKO V, Chesnikova A, Sementsova N, Skarzhinskaya N, et al
    INFLUENCE OF CONCOMITANT ATHEROSCLEROSIS OF THE ARTERIES OF THE LOWER EXTREMITIES ON THE PARAMETERS OF ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  711. SEMIANIV M, Sydorchuk L, Biletsky S, Petrynych O, et al
    LIPID DISORDERS AND ESSENTIAL ARTERIAL HYPERTENSION RISK DEPENDING ON AGTR1 (RS5186) AND VDR (RS2228570) GENES POLYMORPHISM.
    J Hypertens. 2022;40.
    >> Share

  712. SURUNOVICH J, Podpalov V
    HYPERTENSION AND COMORBIDITY AS MACE DEVELOPMENT RISK FACTORS IN THE EAST EUROPEAN REGION.
    J Hypertens. 2022;40.
    >> Share

  713. BACOVA BS, Benova TE, Sykora M, Zurmanova J, et al
    CONTINUOUS EXPOSURE OF THE HYPERTENSIVE RATS TO LIGHT INCREASES THE RISK OF MALIGNANT CARDIAC ARRHYTHMIAS - OMACOR CARDIOPROTECTION.
    J Hypertens. 2022;40.
    >> Share

  714. TRIANTAFYLLIDI H, Benas D, Fabri A, Birmpa D, et al
    SMOKING HABIT IS NOT RELATED WITH HYPERTENSION MEDIATED ORGAN DAMAGE IN YOUNG PATIENTS WITH FIRST DIAGNOSED AND NEVER TREATED ESSENTIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  715. TRIANTAFYLLIDI H, Birmpa D, Benas D, Fabri A, et al
    ISOLATED DIASTOLIC HYPERTENSION IS NOT A BENIGN SITUATION REGARDING HYPERTENSION MEDIATED ORGAN DAMAGE IN PATIENTS WITH FIRST DIAGNOSED AND NEVER TREATED ESSENTIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  716. TRIANTAFYLLIDI H, Fabri A, Benas D, Birmpa D, et al
    REDUCED ENDOTHELIAL GLYCOCALYX IS ASSOCIATED WITH HYPERTENSION BURDEN ONLY IN MALE SMOKERS WITH FIRST DIAGNOSED AND NEVER TREATED STAGE I AND II ESSENTIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  717. TRIANTAFYLLIDI H, Vlachos S, Benas D, Fabri A, et al
    HEPATIC STEATOSIS INDEX IS INDEPENDENTLY RELATED TO HYPERTENSION MEDIATED ORGAN DAMAGE IN PATIENTS WITH FIRST DIAGNOSED AND NEVER TREATED ESSENTIAL HYPERTENSION AND SMOKING HABIT.
    J Hypertens. 2022;40.
    >> Share

  718. SIAFI E, Andrikou I, Thomopoulos C, Konstantinidis D, et al
    THE PROGNOSTIC VALUE OF FATTY LIVER INDEX FOR CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  719. KAKOURI N, Andrikou I, Konstantinidis D, Siafi E, et al
    SYMPATHETIC NERVOUS SYSTEM ACTIVITY AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    J Hypertens. 2022;40.
    >> Share

  720. WANG Q, Zhang H, Wang W, Fan X, et al
    EFFECT OF HYPOKALEMIA ON LEFT VENTRICULAR STRUCTURE AND FUNCTION IN PATIENTS WITH ESSENTIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  721. WANG Q, Zhang H, Wang W, Pei Y, et al
    STUDY ON HYPERTENSION-RELATED TARGET ORGAN DAMAGE IN ESSENTIAL HYPERTENSION PATIENTS WITH HYPOKALEMIA.
    J Hypertens. 2022;40.
    >> Share

  722. WOZNICKA-LESKIEWICZ L, Posadzy-Malaczynska A
    CARDIOVASCULAR RISK AND SUBCLINICAL VASCULAR ORGAN DAMAGE IN PATIENTS WITH AND WITHOUT HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  723. LI C, Wang Q, Ma L, Wang W, et al
    RHO KINASE BLOCKADE ALLEVIATE BLOOD PRESSURE ELEVATION AND INHIBIT VASCULAR REMODELING IN APATINIB-INDUCED HYPERTENSION-TO BE CONFERMED.
    J Hypertens. 2022;40.
    >> Share

  724. LI C, Wang Q, Ma L, Wang W, et al
    RHO KINASE BLOCKADE ALLEVIATE BLOOD PRESSURE ELEVATION AND INHIBIT VASCULAR REMODELING IN APATINIB-INDUCED HYPERTENSION TO BE CONFERMED.
    J Hypertens. 2022;40.
    >> Share

  725. VAN DORST D, Colafella KM, Van Doorn L, Van Veghel R, et al
    CYCLOOXYGENASE-2 INHIBITION AS A NEW TOOL TO COMBAT ANGIOGENESIS INHIBITOR-INDUCED HYPERTENSION AND RENAL TOXICITY.
    J Hypertens. 2022;40.
    >> Share

  726. WANG W, Zhan H, Wang Q, Zhuang C, et al
    RHOA/ROCK PATHWAY PARTICIPATES IN THE STUDY OF RELATED MECHANISMS OF APATINIB IN THE TREATMENT OF BREAST CANCER-INDUCED HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  727. FERREIRA MJ, Silva GDC, Bernardes N, De Araujo AA, et al
    DIURETIC ASSOCIATED WITH CONCURRENT EXERCISE PROMOTES ADDITIONAL PHYSICAL, AUTONOMIC AND INFLAMMATORY ADAPTATIONS IN HYPERTENSIVE RATS SUBMITTED TO OVARIAN HORMONE PRIVATION.
    J Hypertens. 2022;40.
    >> Share

  728. BILO G, Kyriakoulis K, Liu CY, Soranna D, et al
    EFFECT OF NIFEDIPINE GITS OR RAMIPRIL ON BLOOD PRESSURE VARIABILITY IN PREVIOUSLY UNTREATED HYPERTENSIVE PATIENTS: RESULTS OF REVERENT RANDOMIZED TRIAL.
    J Hypertens. 2022;40.
    >> Share

  729. ILIC MD, Stojanovic S, Krstic I, Stojanovic M, et al
    ASSOCIATION BETWEEN VARIABILITY IN SYSTOLIC BLOOD PRESSURE AND CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS: 60 MONTHS FOLLOW UP.
    J Hypertens. 2022;40.
    >> Share

  730. KERRIDGE T, Gupta A
    NOCTURNAL DIPPING PATTERN IN 24-HOUR AMBULATORY BLOOD PRESSURE RECORDINGS OF HYPERTENSIVE INDIVIDUALS IN THE BAY OF PLENTY (BOP).
    J Hypertens. 2022;40.
    >> Share

  731. KEZHUN L
    EFFECT OF CHOLECALCIFEROL ON RATE OF MORNING BLOOD PRESSURE RISE IN WOMEN WITH ARTERIAL HYPERTENSION IN PREMENOPAUSAL AND EARLY POSTMENOPAUSAL PERIODS.
    J Hypertens. 2022;40.
    >> Share

  732. LIN Z, Zhang YH
    ISCHEMIC REPERFUSION INJURY IN HYPERTENSIVE RAT HEART.
    J Hypertens. 2022;40.
    >> Share

  733. MOJAAT M, Ben Salah M, Salem MB, Handous I, et al
    HYPERTENSION FOLLOWING LIVING KIDNEY-DONATION: BETTER SAFE THAN SORRY. A SINGLE-CENTER STUDY.
    J Hypertens. 2022;40.
    >> Share

  734. SILVA S, Sousa AC, Sousa AL, Vitorino P, et al
    BEHAVIOR OF PRESSURE VARIABILITY IN PATIENTS WITH ARTERIAL HYPERTENSION AND DIABETES MELLITUS WITH OR WITHOUT INSULIN USE AND THE INFLUENCE OF THE NUTRITIONAL STATE IN BRAZIL.
    J Hypertens. 2022;40.
    >> Share

  735. SOUSA AC, Magalhaes FG, Silva SB, Simeoni AR, et al
    ASSOCIATION OF SHORT-TERM BLOOD PRESSURE VARIABILITY WITH DIABETES IN HYPERTENSIVE INDIVIDUALS.
    J Hypertens. 2022;40.
    >> Share

  736. KYRIAKOULIS K, Kollias A, Bilo G, Soranna D, et al
    BLOOD PRESSURE VARIABILITY ASSESSED WITH OFFICE, HOME AND AMBULATORY MEASUREMENTS BEFORE AND AFTER ANTIHYPERTENSIVE DRUG TREATMENT: THE REVERENT TRIAL.
    J Hypertens. 2022;40.
    >> Share

  737. KOLLIAS A, Kyriakoulis K, Bilo G, Soranna D, et al
    IDENTIFICATION OF HYPERTENSIVE PATIENTS WITH INCREASED BLOOD PRESSURE VARIABILITY USING DIFFERENT MEASUREMENT METHODS BEFORE AND AFTER TREATMENT: THE REVERENT TRIAL.
    J Hypertens. 2022;40.
    >> Share

  738. PAPADOPOULOU SL, Gkaliagkousi E, Dipla K, Koletsos N, et al
    RELATIONSHIP OF 24-HOUR AMBULATORY BLOOD PRESSURE VARIABILITY WITH MICRO- AND MACROVASCULAR PARAMETERS AND HYPERTENSION STATUS.
    J Hypertens. 2022;40.
    >> Share

  739. VULIN A, Sucur N, Delic Z, Poljak JP, et al
    SHORT-TERM BLOOD PRESSURE VARIBILITY AND LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  740. CARBONELL AMP, Anton PR, Carrasco RO, Suarez MJC, et al
    CIRCADIAN PATTERN IN PATIENTS OLDER THAN 75 YEARS WITH HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  741. ANDREEVA G, Deev A, Gorbunov V
    PSYCHOLOGICAL AND QUALITY OF LIFE SCALE SCORES CORRELATED WITH THE WINTER INCREASE OF AMBULATORY BLOOD PRESSURE IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  742. ANDREEVA G, Koshelyaevskaya Y, Smirnova M, Gorbunov V, et al
    THE WHITE COAT EFFECT LEVEL CORRELATED WITH LIFESTYLE COMPONENTS AND SOCIO-DEMOGRAPHIC DATA IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  743. ANDREEVA G, Koshelyaevskaya Y, Smirnova M, Gorbunov V, et al
    WHITE COAT EFFECT LEVEL CORRELATED WITH THE ECHOCARDIOGRAPHIC PARAMETERS AND COMPOSITE ENDPOINT DATA IN TREATED PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  744. ANDREEVA G, Gorbunov V, Lyusin D
    THE PERSONAL TRAIT CORRELATED WITH THE NIGHT BLOOD PRESSURE LEVEL IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  745. ANTZA C, Farmakis I, Doundoulakis I, Akrivos E, et al
    REPRODUCIBILITY OF MASKED HYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2022;40.
    >> Share

  746. ANTZA C, Farmakis I, Doundoulakis I, Akrivos E, et al
    REPRODUCIBILITY OF WHITE COAT HYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2022;40.
    >> Share

  747. GIRERD X, De Buyer P, Boualit R, Hanon O, et al
    HOW MANY DAYS TO CONFIRM HYPERTENSION USING HOME BOOD PRESSURE MONITORING.
    J Hypertens. 2022;40.
    >> Share

  748. GIRERD X, Boualit R, Pathak A, Perruchod D, et al
    ADVANTAGES AND LIMITATIONS OF USING THE AKTIIA CUFFLESS BRACELET FOR A HYPERTENSION SPECIALIST.
    J Hypertens. 2022;40.
    >> Share

  749. KOU C, Zhao X, Fan X, Wang Q, et al
    EFFECT OF DIFFERENT TREATMENT OF HYPERTENSIVE PATIENTS WITH OBSTRUCTIVE SLEEP APNEA ON BLOOD PRESSURE: A NETWORK META-ANALYSIS.
    J Hypertens. 2022;40.
    >> Share

  750. LEGRADY P, Fejes I, Czombos A, Abraham G, et al
    UNATTENDED AUTOMATED OFFICE BLOOD PRESSURE MEASUREMENT VERSUS CLASSIC OFFICE AUTOMATED BLOOD PRESSURE MEASUREMENT IN A HYPERTENSION OUTPATIENT CLINIC.
    J Hypertens. 2022;40.
    >> Share

  751. LOGUNOVA N, Karpov Y, Khomitskaya Y
    PREDICTORS OF BISOPROLOL ON-TREATMENT STATUS AT THE TIME OF INCLUSION OF HYPERTENSIVE PATIENTS IN THE STUDY: POST-HOC ANALYSIS OF THE TRICOLOR STUDY.
    J Hypertens. 2022;40.
    >> Share

  752. LOGUNOVA N, Karpov Y, Khomitskaya Y, Kvasnikov B, et al
    BASELINE CHARACTERISTICS, ANTIHYPERTENSIVE EFFECTIVENESS, AND TREATMENT ADHERENCE IN HYPERTENSIVE PATIENTS DEPENDING ON AGE: POST-HOC ANALYSIS OF THE TRICOLOR STUDY.
    J Hypertens. 2022;40.
    >> Share

  753. RADOVANOVIC D, Schoenenberger-Berzins R, Muggli F, Gallino A, et al
    COMPARISON OF OFFICE, HOME AND AMBULATORY BLOOD PRESSURE MEASUREMENT IN HYPERTENSIVE PARTICIPANTS IN THE POPULATION-BASED SWISS LONGITUDINAL COHORT STUDY (SWICOS).
    J Hypertens. 2022;40.
    >> Share

  754. RANCEVIENE D, Zigmantaite V, Jurevicius J, Pauziene N, et al
    THE DESIGNING EXPERIMENT OF ESSENTIAL HYPERTENSION: THE CHOICE OF A CONTROL GROUP FOR SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2022;40.
    >> Share

  755. SNINCAK M, Pella J, Hrabcakova P, Kolesar K, et al
    MASKED ARTERIAL HYPERTENSION IN MIDDLE-AGE PATIENTS AND THE ELDERLY. PREVALENCE, CARDIOVASCULAR RISK FACTORS AND SOME LONG-TERM RISK TRENDS.
    J Hypertens. 2022;40.
    >> Share

  756. THEODORAKOPOULOU M, Alexandrou ME, Iatridi F, Karpetas A, et al
    PERIDIALYTIC AND INTRADIALYTIC BLOOD PRESSURE MEASUREMENTS ARE NOT VALID ESTIMATES OF 44-HOUR AMBULATORY BLOOD PRESSURE IN PATIENTS WITH INTRADIALYTIC HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  757. TOBA A, Ishikawa J, Harada K
    AUTOMATED OFFICE BLOOD PRESSURE MEASUREMENT ASSITED BY INSTRUCTIONAL VIDEO IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  758. KOUREMETI M, Konstantinidis D, Andrikou I, Terentes-Printzios D, et al
    SYSTOLIC VERSUS DIASTOLIC BLOOD PRESSURE AS PREDICTORS OF CARDIOVASCULAR EVENTS AMONG TREATED HYPERTENSIVE PATIENTS: A 6-YEAR PROSPECTIVE STUDY.
    J Hypertens. 2022;40.
    >> Share

  759. KALOS T, Dimitriadis K, Konstantinidis D, Siafi E, et al
    PARAMETERS INDICATING DEVELOPMENT OF HYPERTENSION IN THREE-YEAR FOLLOW-UP STUDY OF SUBJECTS WITH HIGH NORMAL BLOOD PRESSURE.
    J Hypertens. 2022;40.
    >> Share

  760. PAPAVASILEIOU MV, Karamanou A, Aravantinos D, Moustakas G, et al
    ROLE OF SERUM URIC ACID LEVELS AND CRP IN THE EXISTENCE OF ATRIAL FIBRILLATION IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  761. ARISIDO MW, Foco L, Gogele M, Melotti R, et al
    ANALYSIS OF RAAS BIOMARKERS TO CLASSIFY ANTI-HYPERTENSIVE DRUG TREATMENTS IN THE GENERAL POPULATION: THE CHRIS STUDY.
    J Hypertens. 2022;40.
    >> Share

  762. CZAJKOWSKA K, Zbroch E, Bielach-Bazyluk A, Koc-Zorawska E, et al
    MID-REGIONAL PROADRENOMEDULLIN (MR-PROADM) AS A BIOMARKER IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HYPERTENSION - STUDY CONTINUATION.
    J Hypertens. 2022;40.
    >> Share

  763. JEKELL A, Lundwall K, Spaak J, Kahan T, et al
    VASCULAR BIOMARKERS IN RELATION TO INDICES OF AORTIC STIFFNESS AND RENAL FUNCTION IN PRIMARY HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  764. ORTEGA A, Martinez-Arroyo O, Riffo-Campos AL, Perez-Hernandez J, et al
    COMBINED EXOSOMAL AND PLASMA NON-CODING RNA SIGNATURE ASSOCIATED WITH URINARY ALBUMIN EXCRETION IN HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  765. CRUZ GD, Oliveira KB, Barroso WKS, Batista SR, et al
    INCREASED PULSE WAVE VELOCITY AND ASSOCIATED FACTORS IN BRAZILIAN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  766. MANZANO-LISTA FJ, Sanz-Gomez M, Gonzalez-Moreno D, Vega-Martin E, et al
    IMBALANCE IN BONE MORPHOGENIC PROTEINS 2 AND 7 IS ASSOCIATED WITH HYPERTENSION AND ARTERIAL STIFFNESS IN CHRONIC KIDNEY DISEASE.
    J Hypertens. 2022;40.
    >> Share

  767. BENDIAB NT, Bouanane S, Baba Ahmed FZ
    EVALUATION OF PLASMA HOMOCYSTEINE LEVELS AND ERYTHROCYTE ANTIOXIDANT ENZYMATIC ACTIVITIES IN TYPE 2 DIABETICS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  768. BENDIAB NT, Bouanane S, Ahmed FZB
    IMPACT OF POLYCYSTIC OVARIAN SYNDROME (PCOS) ASSOCIATED WITH HYPERTENSION ON SOME METABOLIC MARKERS.
    J Hypertens. 2022;40.
    >> Share

  769. VAZQUEZ-AGRA N, Marques-Afonso AT, Fernandez-Castro I, Lopez-Paz JE, et al
    CORRELATION OF CAROTID INTIMA-MEDIA THICKNESS AND PULSE WAVE VELOCITY WITH HEMATOCRIT, PLATELET COUNT AND FIBRINOGEN LEVELS IN DIPPER AND NON-DIPPER HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  770. WANG K, Chu C, Wang Y, Yu Y, et al
    ASSOCIATION OF SERUM RENALASE WITH THE RISK OF HYPERTENSION IN CHINESE ADULTS WITH NORMAL KIDNEY FUNCTION.
    J Hypertens. 2022;40.
    >> Share

  771. DU TOIT C, Tran T, Aryal S, Lip S, et al
    INVESTIGATING THE QUALITY OF MACHINE LEARNING RESEARCH AND REPORTING IN HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  772. ARCHER L, Koshiaris C, Snell Ie K, Riley RD, et al
    PREDICTING THE RISK OF FALLS IN PATIENTS WITH AN INDICATION FOR ANTIHYPERTENSIVE TREATMENT: DEVELOPMENT AND VALIDATION OF THE STRATIFY-FALLS PREDICTION MODEL.
    J Hypertens. 2022;40.
    >> Share

  773. ASLANOVA R, Lapshin A, Andriamanohery R, Abdulloev D, et al
    DYNAMICS OF VENOUS CONGESTION (VEXUS) AND LIVER STIFFNESS BY TRANSIENT ELASTOGRAPHY IN PATIENTS WITH ARTERIAL HYPERTENSION AND DECOMPENSATED HEART FAILURE.
    J Hypertens. 2022;40.
    >> Share

  774. ASLANOVA R, Andriamanohery R, Abdulloev D, Montoya F C, et al
    DYNAMIC OF BEDSIDE ULTRASOUND VENOUS AND PULMONARY CONGESTION ASSESSMENT IN PATIENTS WITH ARTERIAL HYPERTENSION AND DECOMPENSATED HEART FAILURE.
    J Hypertens. 2022;40.
    >> Share

  775. IONIN V, Elizaveta B, Viktorya P, Georgy B, et al
    BIOMARKERS OF FIBROSIS AND INFLAMMATION IN PATIENTS WITH METABOLIC SYNDROME AND ATRIAL FIBRILLATION: WHAT ARE THE DIFFERENCES IN MOLECULAR MECHANISMS IN HYPERTENSION AND OBESITY?
    J Hypertens. 2022;40.
    >> Share

  776. MAZZA A, Baracca A, Schiavon L, Torin G, et al
    IRON DEFICIENCY MANAGEMENT IN HYPERTENSIVE SUBJECTS WITH ACUTE HEART FAILURE: FROM CLINICAL TRIALS TO CLINICAL PRACTICE.
    J Hypertens. 2022;40.
    >> Share

  777. MZOUGHI K, Zairi I, Marwa C, Belkahla N, et al
    HYPERTENSION AND QUALITY OF LIFE OF PATIENTS WITH HEART FAILURE.
    J Hypertens. 2022;40.
    >> Share

  778. PAPAKONSTANTINOU P, Andrikou I, Konstantinidis D, Tsioufis K, et al
    PR INTERVAL DURATION AS A RISK FACTOR FOR NEW-ONSET ATRIAL FIBRILLATION IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  779. PITTARAS A, Faselis C, Samuel IBH, Doumas M, et al
    EXERCISE CAPACITY AND ATRIAL FIBRILLATION RISK IN 459,592 HYPERTENSIVES: A COHORT STUDY.
    J Hypertens. 2022;40.
    >> Share

  780. SYCHOV O, Stasyshena O, Ilchyshyna O, Zinchenko Y, et al
    THE COURSE OF ATRIAL FIBRILLATION AFTER A PREVIOUS INFECTION WITH COVID-19 DEPENDING ON THE PRESENCE OF ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  781. CARBONELL AMP, Anton PR, Carrasco RO, Suarez MJC, et al
    EPISODES OF HYPOTENSION AND DEGREE OF HBP CONTROL IN THE ELDERLY WITH ANTIHYPERTENSIVE DRUG TREATMENT.
    J Hypertens. 2022;40.
    >> Share

  782. D'AMICO F, Grasso R, D'Amico R
    PHYSICAL PERFOMANCE IN HYPERTENSE ELDERLY PEOPLE AND RISK OF FALL.
    J Hypertens. 2022;40.
    >> Share

  783. FERREIRA F, Freitas E, Souza D, Rodrigues C, et al
    THE ACTION OF ANTIHYPERTENSIVES ON CENTRAL VESSEL STIFFNESS IN THE ELDERLY: A SUBSTUDY OF EVOUPIU (BRAZILIAN STUDY OF PULSE WAVE VELOCITY IN ELDERLY).
    J Hypertens. 2022;40.
    >> Share

  784. KANTOLA IM, Kantola T
    THE CHANGE IN QUALITY OF LIFE IN DRUG TREATED HYPERTENSIVE PATIENTS AFTER 10 YEARS OF ANTIHYPERTENSIVE TREATMENT.
    J Hypertens. 2022;40.
    >> Share

  785. KISTERS KLAUS K, Sophia K, Uwe G
    SERUM AND IONIZED MAGNESIUM IN ELDERLY HYPERTENSIVES.
    J Hypertens. 2022;40.
    >> Share

  786. MZOUGHI K, Bergaoui Z, Soltani C, Belkahla N, et al
    ASSESSMENT OF THE KNOWLEDGE ABOUT HYPERTENSION IN THE TUNISIAN ELDERLY.
    J Hypertens. 2022;40.
    >> Share

  787. THANH HN, Trong KHP, Huu AN, Xuan GNT, et al
    PREVALENCE OF HYPERTENSION AND DISTRIBUTION OF BODY MASS INDEX LEVELS AMONG OLDER ADULTS WITH TYPE 2 DIABETES MELLITUS IN VIETNAM: A MULTICENTRE STUDY.
    J Hypertens. 2022;40.
    >> Share

  788. RIVASI G, Tortu V, D'Andria MF, Turrin G, et al
    PREVALENCE AND CLINICAL CORRELATES OF FRAILTY IN HYPERTENSIVE OLDER ADULTS.
    J Hypertens. 2022;40.
    >> Share

  789. SANCHEZ MS, Qin JC, Vinas-Esmel E, Mas MC, et al
    AMBULATORY BLOOD PRESSURE MEASUREMENT AS A PREDICTOR OF HYPERTENSION MEDIATED TARGET ORGAN DAMAGE IN VERY ELDERLY POPULATION: THE MAPACHESS STUDY.
    J Hypertens. 2022;40.
    >> Share

  790. LIAO CT, Toh HS, Yang CT, Wei D, et al
    COST-EFFECTIVENESS OF INTENSIVE VERSUS STANDARD BLOOD-PRESSURE CONTROL IN OLDER PATIENTS WITH HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  791. LEE HY, Cho MC
    CARDIOVASCULAR EVENTS ACCORDING TO FOLLOW-UP INTERVAL IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2022;40.
    >> Share

  792. BURNIER M, Persu A, Azizi M, Prejbisz A, et al
    PATIENT PERSPECTIVES ON TREATMENT ADHERENCE IN HYPERTENSION: PRELIMINARY RESULTS OF AN ESH SURVEY IN FIVE COUNTRIES.
    J Hypertens. 2022;40.
    >> Share

  793. KUZIOR A, Hernandez-Lazaro A, De Leon-Durango R, Rios-Gomez C, et al
    INITIATION OF EMPAGLIFLOZIN THERAPY IS ASSOCIATED WITH A CLINICALLY RELEVANT DECREASE IN BLOOD PRESSURE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND UNCONTROLLED HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  794. DE LA SIERRA A, Ruilope L, Martinez-Camblor P, Vinyoles E, et al
    TIME DOSING OF ANTIHYPERTENSIVE TREATMENT AND PROGNOSIS.
    J Hypertens. 2022;40.
    >> Share

  795. HEISEL A, Vuurboom MD, Daams JG, De Rie MA, et al
    INDIVIDUAL ANTIHYPERTENSIVE MEDICATION AND SKIN CANCER RISK: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2022;40.
    >> Share

  796. FRAGKOULIS C, Polyzos D, Mavroudis A, Dimitriadis K, et al
    AGE AS A RISK FACTOR FOR CARDIOVASCULAR EVENTS IN PATIENTS WITH HYPERTENSIVE CRISES AFTER 12-MONTH FOLLOW-UP: A GREEK REGISTRY.
    J Hypertens. 2022;40.
    >> Share

  797. FORJAZ CLM, Oliveira-Silva LG, Silva-Junior ND, Pio-Abreu A, et al
    ACUTE POST-DYNAMIC, ISOMETRIC AND COMBINED RESISTANCE EXERCISE HYPOTENSION IN PATIENTS WITH HYPERTENSION: A RANDOMIZED STUDY.
    J Hypertens. 2022;40.
    >> Share

  798. PATHAK A, Weber M, Poulos C, Coulter J, et al
    PATIENT PREFERENCES FOR PHARMACEUTICAL AND INTERVENTIONAL HYPERTENSION TREATMENTS: RESULTS FROM A DISCRETE CHOICE EXPERIMENT.
    J Hypertens. 2022;40.
    >> Share

  799. ESLER M, Cao K, Lobo M, Sharp ASP, et al
    CLINICAL EVENT REDUCTIONS IN HIGH-RISK HYPERTENSION PATIENTS TREATED WITH RENAL DENERVATION: 10-YEAR PROJECTIONS BASED ON 3-YEAR FOLLOW-UP FROM THE GLOBAL SYMPLICITY REGISTRY.
    J Hypertens. 2022;40.
    >> Share

  800. PERSU A, Georges CMG, Ritscher S, Pappaccogli M, et al
    PSYCHOLOGICAL DETERMINANTS OF DRUG ADHERENCE AND SEVERITY OF HYPERTENSION IN PATIENTS WITH RESISTANT VS. CONTROLLED HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  801. POSTADZHIYAN A, Tochev S, Andreeva L, Rifai N, et al
    EFFECT OF RENAL DENERVATION ON CARDIO ANKLE VASCULAR INDEX IN SUBJECTS WITH RESISTANT HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  802. MISERQUE L, Boscaro M, Kotliar C, Obrego S, et al
    HIDDEN CENTRAL HYPERTENSION AND SPURIOUS HYPERTENSION IN ELDERLY PEOPLE.
    J Hypertens. 2022;40.
    >> Share

  803. PECLY IMD, Fernandes ACTC, Bica RBDS, Flumingnan VSM, et al
    KIDNEY SUBCLINICAL LESIONS IN HYPERTENSION PHENOTYPES DEFINED BY HOME BLOOD PRESSURE MONITORING AMONG YOUNG ADULTS ENROLLED IN A FAMILY HEALTH STRATEGY UNIT.
    J Hypertens. 2022;40.
    >> Share

  804. NORDB OP, Landolt L, Eikrem O, Scherer A, et al
    COMPARATIVE TRANSCRIPTOMIC ANALYSIS IDENTIFIES EPITHELIAL-MESENCHYMAL TRANSITION AND INFLAMMATION AS COMMON PATHOGENETIC MECHANISMS IN HYPERTENSIVE AND DIABETIC NEPHROPATHY.
    J Hypertens. 2022;40.
    >> Share

  805. JENKINS S, Gupta P, Khunti K, Cross A, et al
    THE EFFECT OF BIOFEEDBACK ON HYPERTENSION AND DIABETES: PRELIMINARY RESULTS FROM A SYSTEMATIC REVIEW.
    J Hypertens. 2022;40.
    >> Share

  806. SCHLAICH M, Sesa-Ashton J, Lee R, Lambert E, et al
    CATHETER-BASED RENAL DENERVATION - LONG TERM SAFETY AND BLOOD PRESSURE REDUCTION IN PATIENTS WITH RESISTANT HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

  807. LAZARIDIS A, Gavriilaki E, Dolgyras P, Koletsos N, et al
    HIGH MOBILITY GROUP BOX-1 IS INCREASED IN NEWLY DIAGNOSED ESSENTIAL HYPERTENSIVES AND CORRELATES WITH HYPERTENSION-MEDIATED TARGET ORGAN DAMAGE.
    J Hypertens. 2022;40.
    >> Share

  808. ALOSAIMI H, Maffia P, Padmanabhan S, Guzik T, et al
    ASSESSING THE IMPACT OF IMMUNOSUPPRESSIVE THERAPIES ON INCIDENCE OF HYPERTENSION IN PATIENTS WITH RHEUMATOID ARTHRITIS AND OTHER AUTOIMMUNE DISEASES: A SYSTEMATIC REVIEW.
    J Hypertens. 2022;40.
    >> Share

  809. MERCADO-ASIS L, Ona DI, Bonzon D, Vilela G, et al
    BURDEN OF DISEASE OF HYPERTENSION IN THE PHILIPPINES PROJECTED IN 2050.
    J Hypertens. 2022;40.
    >> Share

  810. TIMASHEVA Y, Balkhiyarova Z, Prokopenko I
    DISENTANGLING THE SHARED HERITABILITY OF THE PREDISPOSITION TO HYPERTENSION AND TYPE 2 DIABETES.
    J Hypertens. 2022;40.
    >> Share

  811. GUERROT D, Hamzaoui M, Groussard D, Nezam D, et al
    ENDOTHELIUM-SPECIFIC DEFICIENCY OF POLYCYSTIN-1 PROMOTES HYPERTENSION AND CARDIOVASCULAR DISORDERS.
    J Hypertens. 2022;40.
    >> Share

  812. GOMES J, Ferreira P, Adao R, Rocha C, et al
    THERAPEUTIC EFFECTS OF NEBULIZATION- BASED DELIVERY OF ANTI-MIR-146A IN EXPERIMENTAL PULMONARY ARTERIAL HYPERTENSION.
    J Hypertens. 2022;40.
    >> Share

    May 2022
  813. KHAN NA, Stergiou GS, Omboni S, Kario K, et al
    Virtual management of hypertension: lessons from the COVID-19 pandemic-International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension.
    J Hypertens. 2022 May 17. pii: 00004872-990000000-00001.
    >> Share

  814. STOSCHITZKY K
    Diuretics at bedtime hypertension treatment.
    J Hypertens. 2022;40:1051.
    >> Share

  815. KREUTZ R, Brunstrom M, Thomopoulos C, Carlberg B, et al
    Prescribing blood pressure lowering drugs irrespective of blood pressure?
    J Hypertens. 2022;40:1050-1051.
    >> Share

  816. CHACHOO J, Mushtaq N, Jan S, Majid S, et al
    Clinical variables accompanying salt-sensitive essential hypertension in ethnic Kashmiri population.
    J Hypertens. 2022;40:916-923.
    >> Share

  817. BLOK S, Haggenburg S, Collard D, Van Der Linden EL, et al
    The association between socioeconomic status and prevalence, awareness, treatment and control of hypertension in different ethnic groups: the Healthy Life in an Urban Setting study.
    J Hypertens. 2022;40:897-907.
    >> Share

  818. PEI J, Wang X, Zheng K, Su W, et al
    Effect of body size and intensive blood pressure management on cardiovascular and serious adverse events.
    J Hypertens. 2022;40:878-887.
    >> Share

  819. ITO H, Okamoto R, Ali Y, Zhe Y, et al
    Cardiorenai protective effects of sodium-glucose cotransporter 2 inhibition in combination with angiotensin II type 1 receptor blockade in salt-sensitive Dahl rats.
    J Hypertens. 2022;40:956-968.
    >> Share

  820. PUTRA SED, Reichetzeder C, von Websky K, Neuber C, et al
    Association between placental global DNA methylation and blood pressure during human pregnancy.
    J Hypertens. 2022;40:1002-1009.
    >> Share

  821. KREUTZ R, Brunstrom M, Thomopoulos C, Carlberg B, et al
    Do recent meta-analyses truly prove that treatment with blood pressure-lowering drugs is beneficial at any blood pressure value, no matter how low? A critical review.
    J Hypertens. 2022;40:839-846.
    >> Share

  822. ZADEH SST, Moazzeni SS, Matsushita K, Hasheminia M, et al
    Application of the 2017 American college of cardiology/American Heart Association Blood Pressure Guidelines for cardiovascular outcomes among Tehranian residents.
    J Hypertens. 2022;40:924-932.
    >> Share

  823. BOERSTRA BA, Soepnel LM, Nicolaou V, Kolkenbeck-Ruh A, et al
    The impact of maternal hyperglycaemia first detected in pregnancy on offspring blood pressure in Soweto, South Africa.
    J Hypertens. 2022;40:969-977.
    >> Share

    April 2022
  824. WANG Y, Jia H, Mu JJ
    Reply to 'Plasma PAPP-A2 and genetic variations with hypertension'.
    J Hypertens. 2022;40:837-838.
    >> Share

  825. SOOKAROMDEE P, Wiwanitkit V
    Plasma PAPP-A2 and genetic variations with hypertension.
    J Hypertens. 2022;40:837.
    >> Share

  826. BEN-ELTRIKI M, Cassels A, Erviti J, Wright JM, et al
    Reply to 'Why we do not need a single independent international hypertension clinical practice guideline'.
    J Hypertens. 2022;40:835-836.
    >> Share

  827. YOON SG, Lee SK, Kim SH, Shin C, et al
    Differences in estimated glomerular filtration rate are associated with different patterns of 24-h ambulatory blood pressure in the general population.
    J Hypertens. 2022;40:804-810.
    >> Share

  828. LI J, Imano H, Kitamura A, Kiyama M, et al
    Retinal microvascular abnormalities and risks of incident stroke and its subtypes: The Circulatory Risk in Communities Study.
    J Hypertens. 2022;40:732-740.
    >> Share

  829. SHAWKY NM, Dalmasso C, Ojeda NB, Zuchowski Y, et al
    Consequences of hyperandrogenemia during pregnancy in female offspring: attenuated response to angiotensin II.
    J Hypertens. 2022;40:712-722.
    >> Share

  830. XU SK, Chen X, Sheng CS, Cheng YB, et al
    Comparison of the mean of the first two blood pressure readings with the overall mean of three readings on a single occasion.
    J Hypertens. 2022;40:699-703.
    >> Share

    March 2022
  831. SCHWILLENS EJM, Mostard GJM, Stifft F, van Twist DJL, et al
    Exaggerated natriuresis after renal artery balloon angioplasty for flash pulmonary oedema: a potential complication in one-kidney renovascular hypertension.
    J Hypertens. 2022 Mar 4. pii: 00004872-900000000-96476.
    >> Share

  832. CAI A, Liu L, Zhou D, Tang S, et al
    Influences of achieved SBP on age and sex-related left ventricular structural alteration in community hypertensive populations.
    J Hypertens. 2022 Mar 2. pii: 00004872-900000000-96478.
    >> Share

  833. AGOSTINUCCI K, Hutcheson R, Hossain S, Pascale JV, et al
    Blockade of 20-hydroxyeicosatetraenoic acid receptor lowers blood pressure and alters vascular function in mice with smooth muscle-specific overexpression of CYP4A12-20-HETE synthase.
    J Hypertens. 2022;40:498-511.
    >> Share

  834. YADAV A, Beilin LJ, Huang RC, Vlaskovsky P, et al
    The relationship between intrauterine foetal growth trajectories and blood pressure in young adults.
    J Hypertens. 2022;40:478-489.
    >> Share

  835. XIAO MZX, Whitney D, Guo N, Bentley J, et al
    Trends in eclampsia in the United States, 2009-2017: a population-based study.
    J Hypertens. 2022;40:490-497.
    >> Share

  836. DE HAVENON A, Petersen N, Wolcott Z, Goldstein E, et al
    Effect of dihydropyridine calcium channel blockers on blood pressure variability in the SPRINT trial: a treatment effects approach.
    J Hypertens. 2022;40:462-469.
    >> Share

    February 2022
  837. GENG Q, Hou F, Zhang Y, Wang Z, et al
    Effects of different doses of canagliflozin on blood pressure and lipids in patients with type 2 diabetes: a meta-analysis.
    J Hypertens. 2022 Feb 25. pii: 00004872-900000000-96482.
    >> Share

  838. HUCK DM, Rosenberg MA, Stauffer BL
    Nebivolol and incident cardiovascular events in hypertensive patients compared with nonvasodilatory beta blockers.
    J Hypertens. 2022 Feb 23. pii: 00004872-900000000-96483.
    >> Share

  839. SHAKESPEAR-DRUERY J, De Cocker K, Biddle SJH, Bennie J, et al
    Associations between duration and volume of muscle-strengthening exercise and clinically assessed hypertension among 10 519 UK adults: a cross-sectional study.
    J Hypertens. 2022 Feb 21. pii: 00004872-900000000-96487.
    >> Share

  840. SARNECKI J, Obrycki L, Feber J, Chelstowska S, et al
    Isolated systolic hypertension is associated with increased left ventricular mass index and aortic stiffness in adolescents: a cardiac magnetic resonance study.
    J Hypertens. 2022 Feb 21. pii: 00004872-900000000-96486.
    >> Share

  841. BENOIT J, Gaudissard J, Doublet J, Boulestreauw R, et al
    Adrenal BORDeAux reGistry: Bordeaux single-center study of hypertensive patients with primary hyperaldosteronism.
    J Hypertens. 2022 Feb 18. pii: 00004872-900000000-96488.
    >> Share

  842. RAHMAN M, Judah G, Murphy D, Garfield SF, et al
    Which domains of the theoretical domains framework should be targeted in interventions to increase adherence to antihypertensives? A systematic review.
    J Hypertens. 2022 Feb 11. pii: 00004872-900000000-96495.
    >> Share

  843. VAN DER LINDEN EL, Meeks KAC, Klipstein-Grobusch K, Bahendeka S, et al
    Hypertension determinants among Ghanaians differ according to location of residence: the Research on Obesity and Diabetes among African Migrants study.
    J Hypertens. 2022 Feb 11. pii: 00004872-900000000-96494.
    >> Share

  844. BREWSTER LM, Boermeester AS, Seedat YK, Van Montfrans GA, et al
    Initial combination therapy for hypertension in patients of African ancestry: a systematic review and meta-analysis.
    J Hypertens. 2022 Feb 7. pii: 00004872-900000000-96501.
    >> Share

  845. MCGRATH B, McEvoy JW
    Isolated diastolic hypertension in the UK Biobank: correspondence regarding Isolated systolic and diastolic hypertension by the 2017 American College of Cardiology/American Heart Association guidelines and risk of cardiovascular disease: a large prosp
    J Hypertens. 2022;40:409-410.
    >> Share

  846. LI G, Shi C, Li T, Ouyang N, et al
    A nomogram integrating non-ECG factors with ECG to screen left ventricular hypertrophy among hypertensive patients from northern China.
    J Hypertens. 2022;40:264-273.
    >> Share

  847. TSUJIMOTO Y, Kataoka Y, Banno M, Taito S, et al
    Association of low birthweight and premature birth with hypertensive disorders in pregnancy: a systematic review and meta-analysis.
    J Hypertens. 2022;40:205-212.
    >> Share

  848. GAO M, Wells JCK, Li L
    Secular trends in blood pressure trajectories in Chinese children and adolescents: the impact of changing physical growth.
    J Hypertens. 2022;40:389-397.
    >> Share

  849. ASAYAMA K, Ohkubo T, Rakugi H, Miyakawa M, et al
    Direct comparison of the reproducibility of in-office and self-measured home blood pressures.
    J Hypertens. 2022;40:398-407.
    >> Share

  850. MEER R, Boateng D, Klipstein-Grobusch K, Norris SA, et al
    Incidence and correlates of high blood pressure from childhood to adulthood: the Birth to Twenty study.
    J Hypertens. 2022;40:274-282.
    >> Share

  851. FISHER NDL, Kirtane AJ, Daemen J, Rader F, et al
    Plasma renin and aldosterone concentrations related to endovascular ultrasound renal denervation in the RADIANCE-HTN SOLO trial.
    J Hypertens. 2022;40:221-228.
    >> Share

    January 2022
  852. TADIC M, Gherbesi E, Sala C, Carugo S, et al
    Effect of long-term antihypertensive therapy on myocardial strain: a meta-analysis.
    J Hypertens. 2022 Jan 31. pii: 00004872-900000000-96505.
    >> Share

  853. WANG Y
    Stage 1 hypertension and risk of cardiovascular disease mortality in United States adults with or without diabetes.
    J Hypertens. 2022 Jan 31. pii: 00004872-900000000-96504.
    >> Share

  854. HINDERLITER AL, Lin FC, Viera LA, Olsson E, et al
    Hypertension-mediated organ damage in masked hypertension.
    J Hypertens. 2022 Jan 31. pii: 00004872-900000000-96502.
    >> Share

  855. KOVELL LC, Meyerovitz CV, Skaritanov E, Ayturk D, et al
    Hypertension and contraceptive use among women of child-bearing age in the United States from 2001 to 2018.
    J Hypertens. 2022 Jan 25. pii: 00004872-900000000-96509.
    >> Share

  856. SEEMAN T, Blazik R, Fencl F, Blahova K, et al
    Ambulatory blood pressure and hypertension control in children with autosomal recessive polycystic kidney disease: clinical experience from two central European tertiary centres.
    J Hypertens. 2022 Jan 25. pii: 00004872-900000000-96507.
    >> Share

  857. OJJI DB, Baldridge AS, Orji IA, Shedul GL, et al
    Characteristics, treatment, and control of hypertension in public primary healthcare centers in Nigeria: baseline results from the Hypertension Treatment in Nigeria Program.
    J Hypertens. 2022 Jan 14. pii: 00004872-900000000-96513.
    >> Share

  858. FOTI K, Hardy ST, Chang AR, Selvin E, et al
    BMI and blood pressure control among United States adults with hypertension.
    J Hypertens. 2022 Jan 6. pii: 00004872-900000000-96517.
    >> Share

  859. SAUNDERS A, Nuredini GN, Kirkham FA, Drazich E, et al
    White-coat hypertension/effect is associated with higher arterial stiffness and stroke events.
    J Hypertens. 2022 Jan 6. pii: 00004872-900000000-96516.
    >> Share

  860. PEETERS LEJ, van der Net JB, Schoenmakers-Buis K, van der Meer IM, et al
    Introducing the importance and difficulties of a three-step approach to improve nonadherence to antihypertensive drugs: a case series.
    J Hypertens. 2022;40:189-193.
    >> Share

  861. ZAFRIR B, Aker A, Asaf Y, Saliba W, et al
    Blood pressure response during treadmill exercise testing and the risk for future cardiovascular events and new-onset hypertension.
    J Hypertens. 2022;40:143-152.
    >> Share

  862. PARK YJ, Yang PS, Yu HT, Kim TH, et al
    Association of proteinuria and hypertension with incident atrial fibrillation in an elderly population: nationwide data from a community-based elderly cohort.
    J Hypertens. 2022;40:128-135.
    >> Share

  863. CUSPIDI C, Tadic M
    Cardiovascular risk stratification: how important is the hypertensive response to exercise?
    J Hypertens. 2022;40:27-29.
    >> Share

  864. ARDISSINO G, Perrone M, Ghiglia S, Salice P, et al
    Fluid intake and blood pressure in children: the Salus per Aquam project.
    J Hypertens. 2022;40:171-179.
    >> Share

  865. CRAIG A, Gafane-Matemane L, Smith W, Mels C, et al
    Elevated blood pressure positively associates with alpha-1 microglobulin in prepubescent children: the ExAMIN Youth SA study.
    J Hypertens. 2022;40:136-142.
    >> Share

  866. BAE E, Rocco MV, Lee J, Park JY, et al
    Impact of DBP on all-cause and cardiovascular mortality: results from the National Health and Nutrition Examination survey, 1999-2014.
    J Hypertens. 2022;40:108-116.
    >> Share

  867. LIU W, Ye Y, Wang L, Gao C, et al
    Central versus ambulatory blood pressure for predicting mortality and cardiovascular events in hemodialysis patients: a multicenter cohort study.
    J Hypertens. 2022;40:180-188.
    >> Share

  868. RYUZAKI M, Miyashita K, Sato M, Inoue H, et al
    Activation of the intestinal tissue renin-angiotensin system by transient sodium loading in salt-sensitive rats.
    J Hypertens. 2022;40:33-45.
    >> Share

    December 2021
  869. GAMBARO A, Lombardi G, Ribichini FL, Mantovani A, et al
    Impact of early glomerular filtration rate decline in response to antihypertensive treatment on risk of end-stage kidney disease and cardiovascular outcomes: a systematic review and meta-analysis.
    J Hypertens. 2021 Dec 20. pii: 00004872-900000000-96523.
    >> Share

  870. BAPOLISI A, Maurage P, Pappaccogli M, Georges CMG, et al
    Association between post-traumatic stress disorder and hypertension in Congolese exposed to violence: a case-control study.
    J Hypertens. 2021 Dec 13. pii: 00004872-900000000-96524.
    >> Share

  871. GORI M, Berzuini C, D'Elia E, Ghirardi A, et al
    Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients.
    J Hypertens. 2021 Dec 9. pii: 00004872-900000000-96525.
    >> Share

  872. YUSUF SM, Norton GR, Peterson V, Libhaber CD, et al
    Marked intrafamilial aggregation and heritability of aortic flow in a community with prevalent volume-dependent hypertension in Africa.
    J Hypertens. 2021 Dec 7. pii: 00004872-900000000-96529.
    >> Share

  873. YUN B, Sim J, Jeong I, Lee S, et al
    Does severe subacute noise exposure increase risk of new onset hypertension beyond conventional risk factors? A 30 000 person-years cohort study.
    J Hypertens. 2021 Dec 7. pii: 00004872-900000000-96527.
    >> Share

  874. LI C, Ma L, Wang Q, Shao X, et al
    Rho kinase inhibition ameliorates vascular remodeling and blood pressure elevations in a rat model of apatinib-induced hypertension.
    J Hypertens. 2021 Dec 2. pii: 00004872-900000000-96531.
    >> Share

  875. EVERETT M, Setoguchi S, Visaria A
    Considerations when assessing the effect of nightshifts on hypertension prevalence.
    J Hypertens. 2021;39:2534.
    >> Share

  876. KIM BS, Kim HJ, Lyu M, Kim WD, et al
    Clinical characteristics, practice patterns, and outcomes of patients with acute severe hypertension visiting the emergency department.
    J Hypertens. 2021;39:2506-2513.
    >> Share

  877. ABDALLA M, Sakhuja S, Akinyelure OP, Thomas SJ, et al
    The association of actigraphy-assessed sleep duration with sleep blood pressure, nocturnal hypertension, and nondipping blood pressure: the coronary artery risk development in young adults (CARDIA) study.
    J Hypertens. 2021;39:2478-2487.
    >> Share

  878. SIAFI E, Andrikou I, Konstantinidis D, Kakouri N, et al
    Fatty liver index and hypertension-mediated organ damage in never-treated hypertensive patients without diabetes mellitus.
    J Hypertens. 2021;39:2470-2477.
    >> Share

  879. MALAN N, Norton GR, Peterson VR, Yusuf SM, et al
    Independent relationships between renal mechanisms and systemic flow, but not resistance to flow in primary hypertension in Africa.
    J Hypertens. 2021;39:2446-2454.
    >> Share

  880. MOORE MN, Climie RE, Otahal P, Schultz MG, et al
    Exercise blood pressure and cardiovascular disease risk: a systematic review and meta-analysis of cross-sectional studies.
    J Hypertens. 2021;39:2395-2402.
    >> Share

  881. TSIRIMIAGKOU C, Karatzi K, Argyris A, Basdeki ED, et al
    Dietary sodium and cardiovascular morbidity/mortality: a brief commentary on the 'J-shape hypothesis'.
    J Hypertens. 2021;39:2335-2343.
    >> Share

  882. TODKAR S, Padwal R, Cloutier L
    Knowledge, perception and practice of Quebec nurses for ambulatory and clinic blood pressure measurement methods: are we there yet?
    J Hypertens. 2021;39:2455-2462.
    >> Share

    November 2021
  883. BATTA D, Korosi B, Gyongyosi H, Nemcsik-Bencze Z, et al
    Cross-sectional comparison of office and ambulatory pulse wave velocity by two methods, and their changes after lifestyle or medical interventions in hypertension.
    J Hypertens. 2021 Nov 26. pii: 00004872-900000000-96534.
    >> Share

  884. CARNAGARIN R, Nolde JM, Lee R, Lugo-Gavidia LM, et al
    Renal denervation alters ambulatory blood pressure-derived salt sensitivity index in patients with uncontrolled hypertension.
    J Hypertens. 2021 Nov 22. pii: 00004872-900000000-96535.
    >> Share

  885. MENSAH EA, Daneshtalab N, Tabrizchi R
    Differential biomechanics in resistance arteries of male compared with female Dahl hypertensive rats.
    J Hypertens. 2021 Nov 18. pii: 00004872-900000000-96536.
    >> Share

  886. BA DM, Gao X, Chinchilli VM, Liao D, et al
    Red and processed meat consumption and food insecurity are associated with hypertension; analysis of the national health and nutrition examination survey data, 2003-2016.
    J Hypertens. 2021 Nov 15. pii: 00004872-900000000-96539.
    >> Share

  887. LIN M, Heizhati M, Gan L, Yao X, et al
    Higher aldosterone is associated with increased renal impairment risk in patients with hypertension and abnormal glucose metabolism: a longitudinal study.
    J Hypertens. 2021 Nov 15. pii: 00004872-900000000-96538.
    >> Share

  888. PALMU J, Tikkanen E, Havulinna AS, Vartiainen E, et al
    Comprehensive biomarker profiling of hypertension in 36 985 Finnish individuals.
    J Hypertens. 2021 Nov 15. pii: 00004872-900000000-96537.
    >> Share

  889. SILVA AA, Perilhao MS, Portes LA, Serra AJ, et al
    Physical exercise attenuates stress-induced hypertension in rats but not the impairments on the myocardial mechanics.
    J Hypertens. 2021 Nov 11. pii: 00004872-900000000-96542.
    >> Share

  890. FUJIWARA A, Ozawa M, Sumida K, Hirawa N, et al
    LPIN1 is a new target gene for essential hypertension.
    J Hypertens. 2021 Nov 11. pii: 00004872-900000000-96540.
    >> Share


  891. Aldosterone contributes to hypertension in male mice inducibly overexpressing human endothelin-1 in endothelium: Erratum.
    J Hypertens. 2021;39:2333.
    >> Share

  892. GIUDICI A, Palombo C, Kozakova M, Morizzo C, et al
    Noninvasive carotid pressure-diameter loops to identify viscoelastic properties in ageing, hypertension and type 2 diabetes.
    J Hypertens. 2021;39:2307-2317.
    >> Share

  893. LUNYERA J, Park YM, Ward JB, Gaston SA, et al
    A prospective study of multiple sleep dimensions and hypertension risk among white, black and Hispanic/Latina women: findings from the Sister Study.
    J Hypertens. 2021;39:2210-2219.
    >> Share

  894. ZHAO Y, Liu Y, Sun Q, Han J, et al
    Effects of blood pressure and heart rate circadian rhythms on left atrial function.
    J Hypertens. 2021;39:2318-2324.
    >> Share

  895. KRUGER R, Kruger HS, Monyeki MA, Pienaar AE, et al
    A demographic approach to assess elevated blood pressure and obesity in prepubescent children: the ExAMIN Youth South Africa study.
    J Hypertens. 2021;39:2190-2199.
    >> Share

  896. GIUDICI A, Khir AW, Reesink KD, Delhaas T, et al
    Five years of cardio-ankle vascular index (CAVI) and CAVI0: how close are we to a pressure-independent index of arterial stiffness?
    J Hypertens. 2021;39:2128-2138.
    >> Share

  897. SANTIAGO-HERNANDEZ A, Martin-Lorenzo M, Martinez PJ, Gomez-Serrano M, et al
    Early renal and vascular damage within the normoalbuminuria condition.
    J Hypertens. 2021;39:2220-2231.
    >> Share

  898. ZHUO M, Yang D, Goldfarb-Rumyantzev A, Brown RS, et al
    The association of SBP with mortality in patients with stage 1-4 chronic kidney disease.
    J Hypertens. 2021;39:2250-2257.
    >> Share

  899. SAITO K, Kurihara I, Itoh H, Ichijo T, et al
    Subtype-specific trends in the clinical picture of primary aldosteronism over a 13-year period.
    J Hypertens. 2021;39:2325-2332.
    >> Share

  900. PAN F, He P, Pu X, Gao H, et al
    Influence of aging and increased blood pressure on oscillometric cuff pressure waveform characteristics.
    J Hypertens. 2021;39:2157-2163.
    >> Share

  901. SUTHERLAND K, Dissanayake HU, Trzepizur W, Gagnadoux F, et al
    Circadian blood pressure profile and blood pressure changes following oral appliance therapy for obstructive sleep apnoea.
    J Hypertens. 2021;39:2272-2280.
    >> Share

  902. ZHANG J, Song J, Zhou L, Zhou W, et al
    Lower ambulatory nocturnal SBP is associated with less cardiovascular and renal damage in normotensive hospitalized patients with chronic kidney disease.
    J Hypertens. 2021;39:2241-2249.
    >> Share

    October 2021
  903. KIM HJ, Jeon J, Song TJ, Kim J, et al
    Association between oral health and cardiovascular outcomes in patients with hypertension: a nationwide cohort study.
    J Hypertens. 2021 Oct 19. pii: 00004872-900000000-96549.
    >> Share

  904. SONG Y, Nie L, Wei D, Liu P, et al
    Serum cortisol-to-cortisone ratio and 11-deoxycortisol are associated with hypertension and blood pressure in Chinese rural population: a cross sectional study.
    J Hypertens. 2021 Oct 19. pii: 00004872-900000000-96548.
    >> Share

  905. SISO-ALMIRALL A, Kostov B, Blat E, Garcia N, et al
    Validity and reliability of 1-h automated office blood pressure measurement for the diagnosis of hypertension.
    J Hypertens. 2021 Oct 13. pii: 00004872-900000000-96551.
    >> Share

  906. KAWADA T
    Cancer, hypertension and risk for cardiovascular disease.
    J Hypertens. 2021;39:2122.
    >> Share

  907. ZHOU Y, Liu L, Fan F, Hong-Yun Y, et al
    Relation between elevated first SBP from baseline (delta SBP) and postoperative outcome.
    J Hypertens. 2021;39:1982-1990.
    >> Share

  908. HISAMATSU T, Ohkubo T, Hozawa A, Fujiyoshi A, et al
    Association of self-measured home, ambulatory, and strictly measured office blood pressure and their variability with intracranial arterial stenosis.
    J Hypertens. 2021;39:2030-2039.
    >> Share

  909. OMBONI S, Ballatore T, Rizzi F, Tomassini F, et al
    Feasibility of 24-h blood pressure telemonitoring in community pharmacies: the TEMPLAR project.
    J Hypertens. 2021;39:2075-2081.
    >> Share

  910. RIBBE M, Kern S, Wetterberg H, Ryden L, et al
    Time trends in the relation between blood pressure and dementia in 85-year-olds.
    J Hypertens. 2021;39:1964-1971.
    >> Share

  911. NOTEN S, van den Berg-Emons RJG, Thorpe DE, Heyn PC, et al
    Blood pressure in adults with cerebral palsy: a systematic review and meta-analysis of individual participant data.
    J Hypertens. 2021;39:1942-1955.
    >> Share

  912. PALLIKADAVATH S, Chambers L, Shepherd D, Sukhnani M, et al
    The association of blood pressure variability with adverse outcomes in a primary care chronic kidney disease cohort.
    J Hypertens. 2021;39:2067-2074.
    >> Share

  913. DE HAAS S, Spaanderman MEA, van Kuijk SMJ, van Drongelen J, et al
    Adaptation of left ventricular diastolic function to pregnancy: a systematic review and meta-analysis.
    J Hypertens. 2021;39:1934-1941.
    >> Share

  914. WIENER A, Goldstein P, Doenyas K, Okon-Singer H, et al
    Abnormalities in emotional and motor reactions among young prehypertensive individuals: employing continuous blood pressure analysis.
    J Hypertens. 2021;39:2040-2050.
    >> Share

    September 2021
  915. KOROGIANNOU M, Sarafidis P, Theodorakopoulou MP, Alexandrou ME, et al
    Sex differences in ambulatory blood pressure levels, control, and phenotypes of hypertension in kidney transplant recipients.
    J Hypertens. 2021 Sep 27. pii: 00004872-900000000-96554.
    >> Share

  916. MIURA T, Sakuyama A, Xu L, Qiu J, et al
    Febuxostat ameliorates high salt intake-induced hypertension and renal damage in Dahl salt-sensitive rats.
    J Hypertens. 2021 Sep 7. pii: 00004872-900000000-96557.
    >> Share

  917. VAN APELDOORN JAN, van der Linden EL, Bahendeka S, Beune E, et al
    C-reactive protein and hypertension among Ghanaian migrants and their homeland counterparts: the Research on Obesity and Diabetes among African Migrants study.
    J Hypertens. 2021 Sep 2. pii: 00004872-900000000-96560.
    >> Share

  918. CUGLAN B, Atmaca H, Yalta K, Yetkin E, et al
    Uterine fibroids in hypertension and pregnancy.
    J Hypertens. 2021;39:1926.
    >> Share

  919. NOLDE JM, Frost S, Kannenkeril D, Lugo-Gavidia LM, et al
    Capillary vascular density in the retina of hypertensive patients is associated with a non-dipping pattern independent of mean ambulatory blood pressure.
    J Hypertens. 2021;39:1826-1834.
    >> Share

  920. KONOPELSKI P, Konop M, Perlejewski K, Bukowska-Osko I, et al
    Genetically determined hypertensive phenotype affects gut microbiota composition, but not vice versa.
    J Hypertens. 2021;39:1790-1799.
    >> Share

  921. COOK KL, Chappell MC
    Gut dysbiosis and hypertension: is it cause or effect?
    J Hypertens. 2021;39:1768-1770.
    >> Share

  922. SHI J, Ren Y, Liu S, Zhao Q, et al
    Circulating miR-3656 induces human umbilical vein endothelial cell injury by targeting eNOS and ADAMTS13: a novel biomarker for hypertension.
    J Hypertens. 2021 Sep 1. pii: 00004872-900000000-96566.
    >> Share

  923. ZHAO W, Gao F, Lv L, Chen X, et al
    The interaction of hypertension and homocysteine increases the risk of mortality among middle-aged and older population in the United States.
    J Hypertens. 2021 Sep 1. pii: 00004872-900000000-96565.
    >> Share

  924. GOULAS I, Farmakis I, Doundoulakis I, Antza C, et al
    Comparison of the 2017 American Academy of Pediatrics with the fourth report and the 2016 European Society of Hypertension guidelines for the diagnosis of hypertension and the detection of left ventricular hypertrophy in children and adolescents: a sy
    J Hypertens. 2021 Sep 1. pii: 00004872-900000000-96564.
    >> Share

  925. BASSAREO PP
    Magnitude and significance of interarm blood pressure differences in children and adolescents.
    J Hypertens. 2021;39:1927-1928.
    >> Share

  926. CUSPIDI C, Tadic M, Grassi G
    Blood pressure variability: a new therapeutic target on the horizon.
    J Hypertens. 2021;39:1771-1773.
    >> Share

  927. CHANG HC, Wu CL, Lee YH, Gu YH, et al
    Impact of dietary intake of sodium and potassium on short-term blood pressure variability.
    J Hypertens. 2021;39:1835-1843.
    >> Share

  928. CAI E, Chen L, Wang Y, An D, et al
    Predictive value of within-visit and visit-to-visit blood pressure variability for all-cause mortality: the Minhang Study.
    J Hypertens. 2021;39:1844-1851.
    >> Share

  929. HILKENS NA, Klijn CJM, Richard E
    Blood pressure, blood pressure variability and the risk of poststroke dementia.
    J Hypertens. 2021;39:1859-1864.
    >> Share

    August 2021
  930. MARTINEZ-GARCIA MA
    The effect of continuous positive airway pressure on patients with resistant and refractory hypertension: lessons from the HIPARCO programme.
    J Hypertens. 2021 Aug 25. pii: 00004872-900000000-96574.
    >> Share

  931. THANGARAJ SS, Oxlund CS, Fonseca MPD, Svenningsen P, et al
    The mineralocorticoid receptor blocker spironolactone lowers plasma interferon-[gamma] and interleukin-6 in patients with type 2 diabetes and treatment-resistant hypertension.
    J Hypertens. 2021 Aug 23. pii: 00004872-900000000-96579.
    >> Share

  932. PAINI A, Tarozzi L, Bertacchini F, Aggiusti C, et al
    Cardiovascular prognosis in patients admitted to an emergency department with hypertensive emergencies and urgencies.
    J Hypertens. 2021 Aug 20. pii: 00004872-900000000-96587.
    >> Share

  933. KIM SM, Kim DH, Ryu DR, Lee S, et al
    Optimal target blood pressure for major adverse cardiovascular and cerebrovascular events in hypertensive patients: a nationwide population-based study.
    J Hypertens. 2021 Aug 20. pii: 00004872-900000000-96583.
    >> Share

  934. LI Y, Hossain E, Arifen N, Srivastava AK, et al
    Sirtuin-1 contributes to the overexpression of Gialpha proteins and hyperproliferation of vascular smooth muscle cells from spontaneously hypertensive rats.
    J Hypertens. 2021 Aug 20. pii: 00004872-900000000-96582.
    >> Share

  935. OZEKI A, Oogaki Y, Henmi Y, Karasawa T, et al
    Elevated S100A9 in preeclampsia induces soluble endoglin and IL-1beta secretion and hypertension via the NLRP3 inflammasome.
    J Hypertens. 2021 Aug 18. pii: 00004872-900000000-96588.
    >> Share

  936. NEUFCOURT L, Zins M, Berkman LF, Grimaud O, et al
    Socioeconomic disparities and risk of hypertension among older Americans: the Health and Retirement Study.
    J Hypertens. 2021 Aug 13. pii: 00004872-900000000-96590.
    >> Share

  937. LEMBO M, Manzi MV, Mancusi C, Morisco C, et al
    Advanced imaging tools for evaluating cardiac morphological and functional impairment in hypertensive disease.
    J Hypertens. 2021 Aug 12. pii: 00004872-900000000-96597.
    >> Share

  938. POST A, Kremer D, Swarte JC, Sokooti S, et al
    Plasma creatine concentration is associated with incident hypertension in a cohort enriched for the presence of high urinary albumin concentration: the Prevention of Renal and Vascular Endstage Disease study.
    J Hypertens. 2021 Aug 9. pii: 00004872-900000000-96598.
    >> Share

  939. BOULESTREAU R, Lucas L, Cremer A, Debeugny S, et al
    Neurologically asymptomatic patients frequently present cerebral injuries during malignant hypertension: a MRI study.
    J Hypertens. 2021 Aug 2. pii: 00004872-900000000-96606.
    >> Share

  940. YU S, Zhang Y
    The association between isolated systolic or diastolic hypertension and cardiovascular risk.
    J Hypertens. 2021;39:1552-1554.
    >> Share

  941. BODER P, Mary S, Mark PB, Leiper J, et al
    Mechanistic interactions of uromodulin with the thick ascending limb: perspectives in physiology and hypertension.
    J Hypertens. 2021;39:1490-1504.
    >> Share

  942. HISAMATSU T, Lloyd-Jones DM, Colangelo LA, Liu K, et al
    Urinary sodium and potassium excretions in young adulthood and blood pressure by middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
    J Hypertens. 2021;39:1586-1593.
    >> Share

  943. WANG N, Harris K, Chalmers J, Harrap S, et al
    Combination blood pressure lowering in the presence or absence of background statin and aspirin therapy: a combined analysis of PROGRESS and ADVANCE Trials.
    J Hypertens. 2021;39:1689-1696.
    >> Share

  944. YANNOUTSOS A, Lin F, Billuart O, Buronfosse A, et al
    Low admission blood pressure as a marker of poor 1-year survival in patients with revascularized critical limb ischemia.
    J Hypertens. 2021;39:1611-1620.
    >> Share

  945. CUSPIDI C, Tadic M, Sala C, Carugo S, et al
    Reverse dipping and subclinical cardiac organ damage: a meta-analysis of echocardiographic studies.
    J Hypertens. 2021;39:1505-1512.
    >> Share

    July 2021
  946. KIFER D, Louca P, Cvetko A, Deris H, et al
    N-glycosylation of immunoglobulin G predicts incident hypertension.
    J Hypertens. 2021 Jul 19. pii: 00004872-900000000-96614.
    >> Share

  947. LIU F, Hidru TH, Yang X, Xia Y, et al
    Reply to 'Cancer, hypertension and risk for cardiovascular disease'.
    J Hypertens. 2021 Jul 16. pii: 00004872-900000000-96618.
    >> Share

  948. DONG J, Dong H, Yan Y, Cheng H, et al
    Prevalence of hypertension and hypertension phenotypes after three visits in Chinese urban children.
    J Hypertens. 2021 Jul 16. pii: 00004872-900000000-96617.
    >> Share

  949. PARATI G, Stergiou GS, Bilo G, Kollias A, et al
    Home blood pressure monitoring: methodology, clinical relevance and practical application: a 2021 position paper by the Working Group on Blood Pressure Monitoring and Cardiovascular Variability of the European Society of Hypertension.
    J Hypertens. 2021 Jul 15. pii: 00004872-900000000-96622.
    >> Share

  950. LIU J, Bu X, Wei L, Wang X, et al
    Global burden of cardiovascular diseases attributable to hypertension in young adults from 1990 to 2019.
    J Hypertens. 2021 Jul 15. pii: 00004872-900000000-96620.
    >> Share

  951. SCHMIEDER RE, Mahfoud F, Mancia G, Azizi M, et al
    European Society of Hypertension position paper on renal denervation 2021.
    J Hypertens. 2021 Jul 13. pii: 00004872-900000000-96628.
    >> Share

  952. CARRA MC, Fessi S, Detzen L, Darnaud C, et al
    Self-reported periodontal health and incident hypertension: longitudinal evidence from the NutriNet-Sante e-cohort.
    J Hypertens. 2021 Jul 13. pii: 00004872-900000000-96626.
    >> Share

  953. SCHRADER B, Schrader J, Vaske B, Elsasser A, et al
    Football beats hypertension: results of the 3F (Fit&Fun with Football) study.
    J Hypertens. 2021 Jul 13. pii: 00004872-900000000-96625.
    >> Share

  954. KIKUCHI Y, Tanaka F, Nakamura M, Tanno K, et al
    Utility of urinary albumin excretion as an index for stratifying the residual cardiovascular risk in patients undergoing antihypertensive agents treatment.
    J Hypertens. 2021 Jul 13. pii: 00004872-900000000-96623.
    >> Share

  955. CHEN H, Wu W, Fang W, Chen Z, et al
    Does an increase in estimated pulse wave velocity increase the incidence of hypertension?
    J Hypertens. 2021 Jul 12. pii: 00004872-900000000-96629.
    >> Share

  956. BELLO H, Woodiwiss AJ, Naran R, Peterson VR, et al
    Impact of stroke work on the ability of left ventricular mass to account for pressure effects on function in a community with prevalent systemic flow-dependent hypertension.
    J Hypertens. 2021 Jul 6. pii: 00004872-900000000-96634.
    >> Share

  957. LOUTRADIS C, Sarafidis PA, Ekart R, Tsouchnikas I, et al
    Ambulatory blood pressure changes with lung ultrasound-guided dry-weight reduction in hypertensive hemodialysis patients: 12-month results of a randomized controlled trial.
    J Hypertens. 2021;39:1444-1452.
    >> Share

  958. GOEL S, Jaswal N, Sharma S, Gill SS, et al
    Development of integrated model of communication for implementing media strategy to prevent hypertension in a northern state of India.
    J Hypertens. 2021;39:1333-1340.
    >> Share

  959. SAEED S, Edvardsen T
    Basal septal hypertrophy in hypertension; about time to introduce an objective and reproducible quantification.
    J Hypertens. 2021;39:1316-1318.
    >> Share

  960. MANCUSI C
    Aortic strain in hypertensive patients, are we ready for it?
    J Hypertens. 2021;39:1314-1315.
    >> Share

  961. TADIC M, Grassi G
    The interactions between antihypertensive drugs and novel anticancer therapy.
    J Hypertens. 2021;39:1303-1305.
    >> Share

  962. KICHENADASSE G, Miners JO, Mangoni AA, Rowland A, et al
    Effect of concomitant use of antihypertensives and immune check point inhibitors on cancer outcomessname.
    J Hypertens. 2021;39:1274-1281.
    >> Share

  963. SAEED S, Tadic M, Larsen TH, Grassi G, et al
    Coronavirus disease 2019 and cardiovascular complications: focused clinical review.
    J Hypertens. 2021;39:1282-1292.
    >> Share

  964. KREUTZ R, Kjeldsen SE, Mancia G
    Why we do not need a single independent international hypertension clinical practice guideline.
    J Hypertens. 2021 Jul 1. pii: 00004872-900000000-96638.
    >> Share

  965. FAN WG, Wang WY, Meng YX, Sharman JE, et al
    Within-visit and between-visit intra-individual blood pressure variability in an unselected adult population from rural China.
    J Hypertens. 2021;39:1346-1351.
    >> Share

  966. CLARKE MM, Harrington HA, Glenning JP, Zannino D, et al
    Magnitude and significance of interarm blood pressure differences in children and adolescents.
    J Hypertens. 2021;39:1341-1345.
    >> Share

  967. MARCINIAK M, Gilbert A, Loncaric F, Fernandes JF, et al
    Septal curvature as a robust and reproducible marker for basal septal hypertrophy.
    J Hypertens. 2021;39:1421-1428.
    >> Share

  968. NOLDE JM, Lugo-Gavidia LM, Kannenkeril D, Chan J, et al
    Increased pulse wave velocity in patients with an orthostatic blood pressure rise independent of other cardiovascular risk factors.
    J Hypertens. 2021;39:1352-1360.
    >> Share

  969. SEIDEL M, Pagonas N, Seibert FS, Bauer F, et al
    The differential impact of aerobic and isometric handgrip exercise on blood pressure variability and central aortic blood pressure.
    J Hypertens. 2021;39:1269-1273.
    >> Share

    June 2021
  970. TUPPIN P, Denis P, Gastaldi C, Olie V, et al
    Characteristics of people with severe hypertension in France and determinants of medication persistence after 6 years.
    J Hypertens. 2021 Jun 23. pii: 00004872-900000000-96642.
    >> Share

  971. TADIC M, Sala C, Carugo S, Mancia G, et al
    Myocardial strain and left ventricular geometry: a meta- echocardiographic studies in systemic hypertension.
    J Hypertens. 2021 Jun 14. pii: 00004872-900000000-96649.
    >> Share

  972. BAROCHINER J, Aparicio LS, Martinez R, Alfie J, et al
    Prognostic value of masked uncontrolled apparent resistant hypertension detected through home blood pressure monitoring.
    J Hypertens. 2021 Jun 14. pii: 00004872-900000000-96648.
    >> Share

  973. KASIAKOGIAS A, Rosei EA, Camafort M, Ehret G, et al
    Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension.
    J Hypertens. 2021 Jun 7. pii: 00004872-900000000-96653.
    >> Share

  974. THOMOPOULOS C, Andrikou I, Konstantinidis D, Iliakis P, et al
    Isolated diastolic vs. systolic hypertension phenotypes and outcomes: prospective cohort of newly diagnosed individuals with hypertension.
    J Hypertens. 2021 Jun 4. pii: 00004872-900000000-96658.
    >> Share

  975. LEE CH, Han KD, Yoo J, Kwak MS, et al
    Synergistic harmful interaction between sustained physical inactivity and hypertension/diabetes mellitus on the risk of all-cause mortality: a retrospective observational cohort study.
    J Hypertens. 2021 Jun 4. pii: 00004872-900000000-96655.
    >> Share

  976. ZHU Y, Liu Y, Wu C, Li H, et al
    Enterococcus faecalis contributes to hypertension and renal injury in Sprague-Dawley rats by disturbing lipid metabolism.
    J Hypertens. 2021;39:1112-1124.
    >> Share

  977. MURRAY E, Rossitto G, Delles C
    Haemodynamic assessment in hypertension: the soloists and the orchestra.
    J Hypertens. 2021;39:1109-1111.
    >> Share

  978. SCHLAICH MP, Kiuchi MG, Nolde JM, Lugo-Gavidia LM, et al
    Therapeutic inertia in hypertension management - status quo in primary care.
    J Hypertens. 2021;39:1107-1108.
    >> Share

  979. EGAN BM, Sutherland SE
    Editorial commentary on 'Country of birth and mortality risk in hypertension with and without diabetes: the Swedish Primary Care Cardiovascular Database'.
    J Hypertens. 2021;39:1104-1106.
    >> Share

  980. AGNIHOTHRI S, Cui L, Rajan B, Banerjee A, et al
    Mobile health application usage and quality of care at a hypertension clinic: an observational cohort study.
    J Hypertens. 2021 Jun 1. pii: 00004872-900000000-96660.
    >> Share

  981. KAWADA T
    Blood pressure and atrial fibrillation: a risk assessment.
    J Hypertens. 2021;39:1261.
    >> Share


  982. Association of age and blood pressure among 3.3 million adults: insights from China PEACE million persons project.
    J Hypertens. 2021;39:1143-1154.
    >> Share

  983. ROSELEUR J, Gonzalez-Chica DA, Bernardo CO, Geisler BP, et al
    Blood pressure control in Australian general practice: analysis using general practice records of 1.2 million patients from the MedicineInsight database.
    J Hypertens. 2021;39:1134-1142.
    >> Share

  984. ROUSH GC, Messerli FH
    Chlorthalidone versus hydrochlorothiazide: major cardiovascular events, blood pressure, left ventricular mass, and adverse effects.
    J Hypertens. 2021;39:1254-1260.
    >> Share

  985. KIM W, Kim SH, Choi CU, Lee SK, et al
    Role of arterial stiffness in the association between hand grip strength and cardiovascular events: the Korean Genome and Epidemiology Study.
    J Hypertens. 2021;39:1203-1209.
    >> Share

    May 2021
  986. HALIMI JM, Ortiz A, Sarafidis PA, Mallamaci F, et al
    Hypertension in kidney transplantation: a consensus statement of the 'hypertension and the kidney' working group of the European Society of Hypertension.
    J Hypertens. 2021 May 28. pii: 00004872-900000000-96664.
    >> Share

  987. TADIC M, Sala C, Carugo S, Mancia G, et al
    Myocardial strain in hypertension: a meta-analysis of two-dimensional speckle tracking echocardiographic studies.
    J Hypertens. 2021 May 28. pii: 00004872-900000000-96663.
    >> Share

  988. BERILLO O, Coelho SC, Mahjoub N, Offermanns S, et al
    Aldosterone contributes to hypertension in male mice inducibly overexpressing human endothelin-1 in endothelium.
    J Hypertens. 2021 May 25. pii: 00004872-900000000-96665.
    >> Share

  989. MANCUSI C, Trimarco V, Losi MA, Canciello G, et al
    Impact of visit-to-visit blood pressure variability on hypertensive-mediated target organ damage and future cardiovascular events: the Campania salute network.
    J Hypertens. 2021 May 17. pii: 00004872-900000000-96669.
    >> Share

  990. CHAUDHARY P, Velkoska E, Wainford RD
    An exploratory analysis of comparative plasma metabolomic and lipidomic profiling in salt-sensitive and salt-resistant individuals from The Dietary Approaches to Stop Hypertension Sodium Trial.
    J Hypertens. 2021 May 17. pii: 00004872-900000000-96667.
    >> Share

  991. IKEDA S, Shinohara K, Enzan N, Matsushima S, et al
    Effectiveness of statin intensive therapy in type 2 diabetes mellitus with high visit-to-visit blood pressure variability.
    J Hypertens. 2021 May 17. pii: 00004872-900000000-96668.
    >> Share

  992. FAN J, Jia X, Wang Y, Zhao Y, et al
    Birth weight, childhood obesity and risk of hypertension: a Mendelian randomization study.
    J Hypertens. 2021 May 14. pii: 00004872-900000000-96673.
    >> Share

  993. AJAMU S, Fenner RC, Grigorova YN, Cezayirli D, et al
    Association of central arterial stiffness with hippocampal blood flow and N-acetyl aspartate concentration in hypertensive adult Dahl salt sensitive rats.
    J Hypertens. 2021 May 14. pii: 00004872-900000000-96671.
    >> Share

  994. LOUCA P, Nogal A, Wells PM, Asnicar F, et al
    Gut microbiome diversity and composition is associated with hypertension in women.
    J Hypertens. 2021 May 10. pii: 00004872-900000000-96678.
    >> Share

  995. JOHANSSON MAK, Ostgren CJ, Engvall J, Swahn E, et al
    Relationships between cardiovascular risk factors and white-coat hypertension diagnosed by home blood pressure recordings in a middle-aged population.
    J Hypertens. 2021 May 10. pii: 00004872-900000000-96676.
    >> Share

  996. ZHANG L, Li J, Li N, Sun N, et al
    Trends in cause-related comorbidities in hospitalized patients with secondary hypertension in China from 2013 to 2016: a retrospective analysis of hospital quality monitoring system data.
    J Hypertens. 2021 May 10. pii: 00004872-900000000-96675.
    >> Share

  997. TURER CB, Doney A, Bowen ME, Menzies C, et al
    Determining pediatric hypertension criteria: concordance between observed physician methods and guideline-recommended methods.
    J Hypertens. 2021 May 6. pii: 00004872-900000000-96679.
    >> Share

  998. VISARIA A, Raju P, Islam S, James J, et al
    Understanding the impact of blood pressure guidelines and variability on hypertension diagnoses.
    J Hypertens. 2021;39:1044-1045.
    >> Share

  999. WANG Y, Zhang T, Zhang Y, Yu Y, et al
    Effects of inverted photoperiods on the blood pressure and carotid artery of spontaneously hypertensive rats and Wistar-Kyoto rats.
    J Hypertens. 2021;39:871-879.
    >> Share

  1000. PULGAR VM
    Uterine leiomyoma and hypertensive disorders in pregnancy.
    J Hypertens. 2021;39:869-870.
    >> Share

  1001. KYAW T, Bobik A
    Is angiogenic CD4+ T-cell mediated inflammation responsible for endothelial dysfunction in essential hypertension?
    J Hypertens. 2021;39:867-868.
    >> Share

  1002. TOSELLO F, Guala A, D'ascenzo F, Bollati M, et al
    Central pulse pressure is inversely associated with proximal aortic remodelling.
    J Hypertens. 2021;39:919-925.
    >> Share

  1003. THOMOPOULOS C, Bazoukis G, Grassi G, Tsioufis C, et al
    Monotherapy vs combination treatments of different complexity: a meta-analysis of blood pressure lowering randomized outcome trials.
    J Hypertens. 2021;39:846-855.
    >> Share

  1004. CREMER A, Doublet J, Boulestreau R, Gaudissard J, et al
    Short-term blood pressure variability, arterial stiffness, and cardiovascular events: results from the Bordeaux cohort.
    J Hypertens. 2021;39:947-951.
    >> Share

  1005. LUCHI WM, Crajoinas RO, Martins FL, Castro PC, et al
    High blood pressure induced by vitamin D deficiency is associated with renal overexpression and hyperphosphorylation of Na+-K+-2Cl- cotransporter type 2.
    J Hypertens. 2021;39:880-891.
    >> Share

  1006. ESLER MD, Jennings G, Schlaich M, Lambert G, et al
    The adrenal medulla in cardiovascular medicine: an untold story.
    J Hypertens. 2021;39:819-829.
    >> Share

  1007. NEWTON J, Singh C, Sinha MD
    Measurement of SBP at home by parents using hand-held Doppler device and aneroid sphygmomanometer: a single-centre experience.
    J Hypertens. 2021;39:904-910.
    >> Share

    April 2021
  1008. ABAD-GARCIA MF, Gonzalez-Teruel A, Bolanos-Pizarro M, Lurbe I Ferrer E, et al
    Scientific mapping of the research output on hypertension in children and adolescents, 2010-2018.
    J Hypertens. 2021 Apr 28. pii: 00004872-900000000-96681.
    >> Share

  1009. KOW CS, Hasan SS
    Intensive blood pressure-lowering strategy should also be offered to older patients.
    J Hypertens. 2021;39:812-813.
    >> Share

  1010. ALSHAARAWY O, Vanderziel A
    Visit-to-visit variability in blood pressure among cannabis users participating in the Third National Health and Nutrition Examination Survey.
    J Hypertens. 2021;39:621-626.
    >> Share

  1011. HEFFERNAN KS, Jae SY, Loprinzi PD
    Estimated pulse wave velocity is associated with residual-specific mortality: findings from the National Health and Nutrition Examination Survey.
    J Hypertens. 2021;39:698-702.
    >> Share

  1012. COWELL OR, Mistry N, Deighton K, Matu J, et al
    Effects of a Mediterranean diet on blood pressure: a systematic review and meta-analysis of randomized controlled trials and observational studies.
    J Hypertens. 2021;39:729-739.
    >> Share

  1013. CUSPIDI C, Tadic M, Sala C, Quarti-Trevano F, et al
    Regression of left ventricular hypertrophy in primary aldosteronism after adrenalectomy: a meta-analysis of echocardiographic studies.
    J Hypertens. 2021;39:775-783.
    >> Share

    March 2021
  1014. TODKAR S, Padwal R, Michaud A, Cloutier L, et al
    Knowledge, perception and practice of health professionals regarding blood pressure measurement methods: a scoping review.
    J Hypertens. 2021;39:391-399.
    >> Share

  1015. CAI P, Peng Y, Chen Y, Wang Y, et al
    Blood pressure characteristics of subclinical hypothyroidism: an observation study combined with office blood pressure and 24-h ambulatory blood pressure.
    J Hypertens. 2021;39:453-460.
    >> Share

    February 2021
  1016. BOHM M, Schumacher H, Teo KK, Lonn EM, et al
    Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk.
    J Hypertens. 2021 Feb 3. pii: 00004872-900000000-96717.
    >> Share

  1017. OUYANG M, Munoz-Venturelli P, Billot L, Wang X, et al
    Low blood pressure and adverse outcomes in acute stroke: HeadPoST study explanations.
    J Hypertens. 2021;39:273-279.
    >> Share

  1018. MALOBERTI A, Bombelli M, Facchetti R, Barbagallo CM, et al
    Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study.
    J Hypertens. 2021;39:333-340.
    >> Share

  1019. EDWARDS JJ, Taylor KA, Cottam C, Jalaludeen N, et al
    Ambulatory blood pressure adaptations to high-intensity interval training: a randomized controlled study.
    J Hypertens. 2021;39:341-348.
    >> Share

  1020. SALVETTI M, Paini A, Bertacchini F, Aggiusti C, et al
    Myocardial mechano-energetic efficiency in primary aldosteronism.
    J Hypertens. 2021;39:318-324.
    >> Share

    January 2021
  1021. GIBBS J, Gaskin E, Ji C, Miller MA, et al
    The effect of plant-based dietary patterns on blood pressure: a systematic review and meta-analysis of controlled intervention trials.
    J Hypertens. 2021;39:23-37.
    >> Share

  1022. MATSUMOTO K, Jin Z, Homma S, Elkind MSV, et al
    Office, central and ambulatory blood pressure for predicting incident atrial fibrillation in older adults.
    J Hypertens. 2021;39:46-52.
    >> Share

  1023. CUSPIDI C, Tadic M, Sala C, Quarti-Trevano F, et al
    Left ventricular mass reduction and hypertrophy regression following renal artery revascularization: a meta-analysis.
    J Hypertens. 2021;39:4-11.
    >> Share

  1024. MUIESAN ML, Salvetti M, Virdis A, Masi S, et al
    Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study.
    J Hypertens. 2021;39:62-69.
    >> Share

    December 2020
  1025. THOMOPOULOS C, Bazoukis G, Tsioufis C, Mancia G, et al
    Reply.
    J Hypertens. 2020;38:2544-2545.
    >> Share

  1026. SCHLAICH MP, Nolde JM, Carnagarin R, Schlaich LI, et al
    Vascular compression of the rostral ventrolateral medulla: a relevant indicator of sympathetically driven blood pressure variability?
    J Hypertens. 2020;38:2380-2381.
    >> Share

    May 2020
  1027. GRASSI G, Biffi A, Dell'Oro R, Quarti Trevano F, et al
    Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis.
    J Hypertens. 2020 May 7. doi: 10.1097/HJH.0000000000002431.
    >> Share

    February 2020
  1028. PAINI A, Aggiusti C, Bertacchini F, Stassaldi D, et al
    Relationship between arterial stiffness and unattended or attended blood pressure values.
    J Hypertens. 2020;38:243-248.
    >> Share

  1029. MEYER ML, Klein BE, Klein R, Palta P, et al
    Central arterial stiffness and retinal vessel calibers: the Atherosclerosis Risk in Communities Study-Neurocognitive Study.
    J Hypertens. 2020;38:266-273.
    >> Share

  1030. DENG AY, Menard A
    Biological convergence of three human and animal model quantitative trait loci for blood pressure.
    J Hypertens. 2020;38:322-331.
    >> Share

  1031. KAYSER A, Beck E, Hoeltzenbein M, Zinke S, et al
    Neonatal effects of intrauterine metoprolol/bisoprolol exposure during the second and third trimester: a cohort study with two comparison groups.
    J Hypertens. 2020;38:354-361.
    >> Share

  1032. DI STEFANO C, Sobrero G, Milazzo V, Vallelonga F, et al
    Cardiac organ damage in patients with Parkinson's disease and reverse dipping.
    J Hypertens. 2020;38:289-294.
    >> Share

  1033. TADIC M, Cuspidi C, Majstorovic A, Pencic B, et al
    The association between 24-h blood pressure patterns and left ventricular mechanics.
    J Hypertens. 2020;38:282-288.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016